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Predictors of Depressive and Anxiety Symptoms among African American HIVpositive Women
Abstract
This descriptive correlation study had four purposes: describe depressive and anxiety symptom levels in
pregnant and non-pregnant African American (AA) HIV-positive women, examine the association between
underlying vulnerabilities and depressive symptoms in HIV-positive AA women, determine the association
between underlying vulnerabilities and anxiety symptoms in AA HIV-positive women, and determine the
predictors of depressive and anxiety symptoms among African American HIV-positive women. A
convenience sample of 80 African American HIV-positive women was recruited from university-based
obstetrics/-gynecology and infectious disease practices in a large metropolitan city in the Mid-South.
Depressive symptoms were measured with the Center for Epidemiologic Studies Depression Scale (CESD) and Edinburgh Postnatal depression Scale (EPDS). Anxiety symptoms were measured with the Beck
Anxiety Inventory (BAI). Sleep quality was measured with the Pittsburg Sleep Quality Index (PSQI). An
investigator-developed demographic data form was used to obtain patient characteristics including data
about inherited and acquired vulnerabilities. Inherited vulnerabilities included family history of mood
disorders and family history of alcohol and/or drug use. Acquired vulnerabilities included educational
level, income level, alcohol and/or use, HIV disclosure status, sleep quality, and history of sexual assault.
The stress diathesis theory provided the conceptual basis for the study. The sample consisted of both
pregnant (n = 20) and non-pregnant (n = 60) women. Participants were typically single (57.5%), middleaged (33.21 ± 10.7 years), and had completed high school (30%) or some college (35%). Poverty was
prevalent in the sample, with 70.5% reporting annual household incomes below $10,000. Most women
(92.5%) had disclosed their HIV status. Almost half of the sample (42%) reported a history of sexual
assault. Substance abuse was higher in the non-pregnant group of women (40%) than the non-pregnant
group (5%) of women. Median depressive symptom scores for the total sample were mildly elevated.
Median anxiety symptom scores for the total sample illustrated little or no anxiety symptoms. Poor sleep
quality was prevalent in both groups and was associated with elevated CES-D, EPDS, and BAI scores in
both groups of women. Family history of mood disorders was associated with elevated CES-D scores in
the group of pregnant women, and elevated BAI scores in both groups. HIV disclosure was associated
with elevated CES-D scores in the pregnant group, and substance use with elevated CES-D scores, in the
non-pregnant group. Non-pregnant HIV-positive women had higher depressive symptom scores on both
the CES-D and EPDS when compared to pregnant HIV-positive women. Regression analyses were
performed to determine which independent variables predicted elevated depressive and anxiety symptom
scores. Substance use and poor sleep quality were statistically significant predictors, accounting for 55 %
of the variance in CES-D scores, 43% of the variance in EPDS scores, and 53% of the variance in BAI
scores. Future studies should include testing interventions that improve sleep quality. Untreated mood
disorders are problematic in HIV-positive patients, as depression is associated with decreased adherence
to highly active antiretroviral medications. Ongoing assessments of depressive and anxiety symptoms are
necessary, as clinically significant levels resulting in referrals were warranted.
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ABSTRACT
This descriptive correlation study had four purposes: describe depressive and
anxiety symptom levels in pregnant and non-pregnant African American (AA) HIVpositive women, examine the association between underlying vulnerabilities and
depressive symptoms in HIV-positive AA women, determine the association between
underlying vulnerabilities and anxiety symptoms in AA HIV-positive women, and
determine the predictors of depressive and anxiety symptoms among African American
HIV-positive women. A convenience sample of 80 African American HIV-positive
women was recruited from university-based obstetrics/-gynecology and infectious
disease practices in a large metropolitan city in the Mid-South. Depressive symptoms
were measured with the Center for Epidemiologic Studies Depression Scale (CES-D)
and Edinburgh Postnatal depression Scale (EPDS). Anxiety symptoms were measured
with the Beck Anxiety Inventory (BAI). Sleep quality was measured with the Pittsburg
Sleep Quality Index (PSQI). An investigator-developed demographic data form was
used to obtain patient characteristics including data about inherited and acquired
vulnerabilities. Inherited vulnerabilities included family history of mood disorders and
family history of alcohol and/or drug use. Acquired vulnerabilities included educational
level, income level, alcohol and/or use, HIV disclosure status, sleep quality, and history
of sexual assault. The stress diathesis theory provided the conceptual basis for the
study. The sample consisted of both pregnant (n = 20) and non-pregnant (n = 60)
women. Participants were typically single (57.5%), middle-aged (33.21 ± 10.7 years),
and had completed high school (30%) or some college (35%). Poverty was prevalent in
the sample, with 70.5% reporting annual household incomes below $10,000. Most
women (92.5%) had disclosed their HIV status. Almost half of the sample (42%)
reported a history of sexual assault. Substance abuse was higher in the non-pregnant
group of women (40%) than the non-pregnant group (5%) of women. Median
depressive symptom scores for the total sample were mildly elevated. Median anxiety
symptom scores for the total sample illustrated little or no anxiety symptoms. Poor
sleep quality was prevalent in both groups and was associated with elevated CES-D,
EPDS, and BAI scores in both groups of women. Family history of mood disorders was
associated with elevated CES-D scores in the group of pregnant women, and elevated
BAI scores in both groups. HIV disclosure was associated with elevated CES-D scores
in the pregnant group, and substance use with elevated CES-D scores, in the nonpregnant group. Non-pregnant HIV-positive women had higher depressive symptom
scores on both the CES-D and EPDS when compared to pregnant HIV-positive women.
Regression analyses were performed to determine which independent variables
predicted elevated depressive and anxiety symptom scores. Substance use and poor
sleep quality were statistically significant predictors, accounting for 55 % of the
variance in CES-D scores, 43% of the variance in EPDS scores, and 53% of the
variance in BAI scores. Future studies should include testing interventions that improve
sleep quality. Untreated mood disorders are problematic in HIV-positive patients, as
depression is associated with decreased adherence to highly active antiretroviral
medications. Ongoing assessments of depressive and anxiety symptoms are necessary,
as clinically significant levels resulting in referrals were warranted.
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CHAPTER 1. INTRODUCTION
OVERVIEW
The human immunodeficiency virus (HIV), the virus that causes the fatal disease
acquired immune deficiency syndrome (AIDS), is a significant health problem in the
United States. The Centers for Disease Control and Prevention (CDC) reported an
estimated one million HIV cases in the United States through 2003 (Branson et al., 2006;
CDC, 2006). Each year, there are 40,000 new cases of HIV in the United States. HIV is
the leading cause of death among Black women between the ages of 25-34 and the third
leading cause of death among Black women between the ages of 35-44 (Centers for
Disease Control and Prevention, 2007a).
The most common mode for HIV transmission in the United States is sexual
contact, followed by parenteral exposure to contaminated blood or blood products as
occurs with intravenous drug abuse or blood transfusion recipients, and lastly, between
mother and fetus (Roper, 1991). In 2006, 80% of women diagnosed with HIV in the
United States were infected through heterosexual exposure (Centers for Control and
Prevention, 2008; Centers for Disease Control and Prevention, 2004). Injection drug use
among women accounted for 19% of cases. In addition to the direct risks associated with
sharing of needles during intravenous drug use, drug use is also linked to decreased
inhibitions and increased sexual risk taking, which further propagates the heterosexual
spread of the epidemic (Centers for Disease Control and Prevention, 2004). Women using
non-injectable drugs (i.e., cocaine, “crack”, methamphetamine) are at greater risk for
heterosexual HIV transmission as they trade sexual encounters for drugs or money
(Centers for Disease Control and Prevention, 2004). Although the routes of transmission
of the virus are known, the incidence of infection continues to increase.
The AIDS epidemic has had a major effect on morbidity and mortality in women.
Studies of international AIDS research found that more women between the ages of 13
and 25 years are being infected than women in other age groups that women are infected
at a much younger age than men, and that in developing countries, as many or more
women are infected than men. Since 1985, the proportion of all AIDS cases reported in
the United States among adult and adolescent women has more than tripled, from 7% in
1985 to 25% in 1999 (Centers for Disease Control and Prevention, 2004). A dramatic
increase in the numbers of HIV cases has been documented in women of color (Centers
for Disease Control and Prevention, 2004).
The prevalence of HIV transmission among women is disproportionate, affecting
racial and ethnic minorities, especially African-American and Hispanic women, at a
much higher rate (Centers for Disease Control and Prevention, 2004). Of the 9708
women diagnosed with HIV in the United States in 2005, 66% were African American
(Centers for Control and Prevention, 2008). African Americans make up only 13% of
the total U. S. population, yet African Americans account for approximately 49% of the
new cases of HIV (Centers for Control and Prevention, 2008). African Americans are
disproportionately affected by HIV/AIDS across all stages of the disease. Sixty-three
1

percent of the AIDS cases among women in the United States were among AfricanAmerican women (Centers for Disease Control and Prevention, 2004). HIV was the
leading cause of death among African American women between the ages of 25 and 44
years in 2002 (Centers for Disease Control and Prevention, 2004).
Transmission patterns indicate that the rate of heterosexual transmission of HIV is
increasing, directly affecting women of childbearing age. The importance of this growing
epidemic among women is significant, encompassing women’s physical, emotional,
spiritual, and social needs. These needs are often compounded by the additional
responsibility of children, some of whom may also be infected with the virus. Although
the use of antiretroviral drugs in pregnancy has drastically reduced perinatal transmission
of HIV, perinatal transmission accounted for 9300 cases of pediatric HIV in the United
States (CDC, 2006). The burden of these needs coupled with many complex social
factors increases the risk of depression and anxiety in this population. HIV-positive
women with children are more likely than men to suffer from chronic sorrow related to
their illness, fear of death, poverty, and social isolation (Morrison et al., 2002).
The causes of depression and anxiety have been connected to both biological and
biobehavioral factors. Biological and genetic factors, including family history of mood
disorders, increase the risk of depression (Gutman & Nemeroff, 2003). Stressful life
events have been linked to depression (Mazure & Maciejewski, 2003). History of sexual
abuse in depressed adolescents has been shown to increase the likelihood of psychiatric
hospitalization or depressive relapse (Barbe, Bridge, Birmaher, Kolko, & Brent, 2004).
As the medical community continues to learn more about the course of HIV infection and
the consequences of HIV transmission among women, the identification of depression
and anxiety in this population becomes imperative. HIV has become a chronic illness,
with increasing numbers of available treatment regimens, and increasing life expectancy.
The denial of appropriate assessment and treatment of depressive and anxiety symptoms
in this population would be neglectful and unethical.
According to the Surgeon General’s Report on Mental Health (USDHHS, 1999),
the current annual prevalence estimate for mental disorders is about 20% of the U. S.
population. Mood disturbances are the most frequently diagnosed mental health
disturbances in the U. S. and more common in persons with chronic disorders such as
HIV/AIDS (USDHHS, 1999). Depression and anxiety commonly occur simultaneously.
There are many studies describing either depression or anxiety, with fewer studies
examining the co-morbidity of these common diagnoses.
Hirschfeld (Hirschfeld, 2001) examined the co-morbidity of major depression and
anxiety in primary care settings, concluding that 10 to 20% of office visits were related to
a depressive or anxiety-related episode, and over 50% of these patients experienced both
depression and anxiety. Murphy and colleagues (2004) investigated the prevalence and
comorbidity of anxiety and depression in the general population, reporting anxiety as
twice as common as depression, and more prevalent in the female population. In a metaanalysis of studies that explored depression, Ciesla and Roberts (Ciesla & Roberts, 2001)
reported that HIV-positive persons were twice as likely to experience depression as their
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HIV-negative counterparts. African Americans may be less likely to suffer from major
depression than non-Hispanic whites (USDHHS, 1999).
The prevalence of major depression in persons with HIV infection ranges from
22% to 36% (Bing et al., 2001; Ferrando et al., 1998; Rabkin, Wagner, & Rabkin, 1999).
Untreated depression along with other co-morbid conditions may increase clinic visits,
hospitalizations, substance abuse, and risky behaviors, as well as reduce adherence to
treatment and quality of life (Valente, 2003). Stressful life events, such as learning of the
diagnosis of HIV, the death of a partner or friend with HIV, the onset of HIV-related
symptoms, HIV treatment failure, and progressive disease exacerbations leading to an
AIDS diagnosis may increase depressive symptoms (Valente, 2003). Like untreated
depression, these stressful events may also increase alcohol and substance use (Valente,
2003) and increase levels of anxiety. Studies (Croughan, Miller, Wagelin, & Whitman,
1982; Kosten, Anton, & Rounsaville, 1992) have demonstrated that increased life
stressors are often associated with increased injected drug and crack cocaine use, as well
as increased levels of psychological distress. As stress increases, high-risk sexual
behavior may escalate (Low-Beer et al., 2000).
In newly diagnosed HIV-positive patients, high rates of anxiety are experienced
after learning of their diagnosis (Croughan, Miller, Wagelin, & Whitman, 1982; Jones,
Garsia, Wu, Job, & Dunn, 1995; Krikorian, Kay, & Liang, 1995; Rabkin, Johnson et al.,
1997). Depressive symptoms among women with HIV are associated with HIV disease
progression (Ickovics et al., 2001; Mayne, Vittinghoff, Chesney, Barrett, & Coates,
1996). HIV-positive women with chronic depressive symptoms were twice as likely to
die as HIV-positive women with limited or no depressive symptoms (Ickovics et al.,
2001). The complex challenges of the disease and its treatments along with diseaserelated physiological changes increase the predisposition to depression and anxiety in this
population (Moore et al., 1999; Valente, 2003).Depression and anxiety produce or create
a more significant problem for people with a concomitant diagnosis of HIV because the
feelings of loneliness, helplessness, hopelessness, and despair may lead to suicide
(Valente & Saunders, 1997).
There are many different factors that may play roles in the development of
depression and anxiety in HIV-positive persons. Inherited and acquired risk factors
associated with depression and anxiety, combined with side effects of antiretroviral
medications, distressing events related to stigma and shame of the diagnosis of HIV and
the loss of a partner through abandonment following disclosure or death all may
contribute to an environment that increases the risk for depression and anxiety. Patients
with HIV infection are also subject to overwhelmingly complex treatment regimens.
Drug resistance and intolerance, metabolic complications and toxicities, noncompliance,
and virulent strains of the disease often lead to treatment failures and regimen changes.
Tsao and colleagues (Tsao, Dobalian, Moreau, & Dobalian, 2004) reported that HIVpositive patients with HIV-related symptoms were more likely to suffer from persisting
depression and anxiety or develop new cases of anxiety and depression. In addition,
depression and anxiety have been related to an increase in other physical illnesses such as
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cardiac disorders, hypertension, gastrointestinal disorders, genitourinary disorders, and
migraines (M. C. Harter, Conway, & Merikangas, 2003).
PURPOSE OF THE STUDY
The incidence of HIV transmission continues to increase. The CDC reported a
cumulative estimated number of 525,442 deaths of persons with AIDS through 2005 in
the 50 states and the District of Columbia (Centers for Control and Prevention, 2007;
Centers for Disease Control and Prevention, 2004). The prevalence of HIV infections in
the heterosexual community has led to an epidemic that directly affects women of
childbearing age. Women are at increased risk for major depression (Blazer, Kessler,
McGonagle, & Swartz, 1994; Blehar & Oren, 1995; M. C. Harter, Conway, &
Merikangas, 2003; R. C. Kessler, McGonagle, Swartz, Blazer, & Nelson, 1993)
irrespective of their HIV status and at even greater risk for depression in the presence of
HIV infection (Rabkin, Johnson et al., 1997). Identifying the predictors of depression and
anxiety in HIV-positive women can lead to early detection and treatment of depression
and anxiety in this vulnerable population. This study collected information on both
pregnant and non-pregnant African American HIV-positive women. The inclusion of
pregnant women is an important aspect of the study, as African American women of
childbearing age represent a significant portion of new HIV cases in the United States.
Pregnant women often have different needs and concerns than non-pregnant women.
These differences have the potential to influence anxiety and depressive symptoms, and,
thus need to be examined. Therefore, the purposes of this study of HIV-positive women
are fourfold: (1) to determine the levels of depressive and anxiety symptoms in African
American women who are HIV-positive; (2) to describe the underlying vulnerabilities,
both inherited and acquired, for depressive and anxiety symptoms in African American
women who are HIV-positive; (3) to identify which vulnerabilities may serve as
predictors of depressive and anxiety symptoms among African American HIV-positive
women; and (4) to describe the differences in predictors of depressive and anxiety
symptoms among African American HIV-positive women.
AIMS AND RESEARCH QUESTIONS
This study was guided by the existing literature including gaps in knowledge
regarding symptoms of depression and anxiety in women who are HIV-positive. Study
aims were examined within one clinical population of African American women seeking
treatment in two large university-based clinics that provide healthcare for women with
HIV/AIDS. The specific aims and research questions that guided this study were:
Specific Aim One
Specific Aim One was to examine the levels of depressive and anxiety symptoms
in African American women (pregnant and non-pregnant) who were HIV-positive in a
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southeastern urban university obstetrics and gynecology and infectious disease practice
using the following questions.
a.
b.
c.
d.

What were the levels of depressive symptoms in pregnant African-American
women who were HIV-positive?
What were the levels of anxiety symptoms in pregnant African-American women
who were HIV-positive?
What were the levels of depressive symptoms in non-pregnant African-American
women who were HIV-positive?
What were the levels of anxiety symptoms in non-pregnant African-American
women who were HIV-positive?

Specific Aim Two
Specific Aim Two was to examine the associations among inherited (family
history of mood disorders, family history of alcohol and/or drug use) and acquired
(educational level, income level, alcohol and/or drug use, HIV disclosure status, sleep
quality, history of sexual abuse or assault) vulnerabilities and depressive symptoms in
African American women who were HIV-positive using the following questions.
a.
b.

c.
d.

What was the relationship of inherited vulnerabilities (family history of mood
disorders, family history of alcohol and/or drug use) to depressive symptoms in
pregnant African American women who were HIV-positive?
What was the relationship of acquired vulnerabilities (educational level, income
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of
sexual abuse or assault) to depressive symptoms in pregnant African American
women who were HIV-positive?
What was the relationship of inherited vulnerabilities (family history of mood
disorders, family history of alcohol and/or drug use) to depressive symptoms in
non-pregnant African American women who were HIV-positive?
What was the relationship of acquired vulnerabilities (educational level, income
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of
sexual abuse or assault) to depressive symptoms in non-pregnant African
American women who were HIV-positive?

Specific Aim Three
Specific Aim Three was to examine the associations among inherited (family
history of mood disorders, family history of alcohol and/or drug use) and acquired
(educational level, income level, alcohol and/or drug use, HIV disclosure status, sleep
quality, history of sexual abuse or assault) vulnerabilities and anxiety symptoms in
African American women who were HIV-positive using the following questions.
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a.
b.

c.
d.

What was the relationship of inherited vulnerabilities (family history of mood
disorders, family history of alcohol and/or drug use) to anxiety symptoms in
pregnant African American women who were HIV-positive?
What was the relationship of acquired vulnerabilities (educational level, income
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of
sexual abuse or assault) to anxiety symptoms in pregnant African American
women who were HIV-positive?
What was the relationship of inherited vulnerabilities (family history of mood
disorders, family history of alcohol and/or drug use) to anxiety symptoms in nonpregnant African American women who were HIV-positive?
What was the relationship of acquired vulnerabilities (educational level, income
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of
sexual abuse or assault) to anxiety symptoms in non-pregnant African American
women who were HIV-positive?

Specific Aim Four
Specific Aim Four was to examine the influence of inherited vulnerabilities
(family history of mood disorders, family history of alcohol and/or drug use) and
acquired vulnerabilities (educational level, income level, alcohol and/or drug use, HIV
disclosure status, sleep quality, history of sexual abuse or assault) on depressive
symptoms in non-pregnant African American women who were HIV-positive.
a.

b.

What was the influence of inherited vulnerabilities (family history of mood
disorders, family history of alcohol and/or drug use) on the level of depressive
symptoms reported by non-pregnant African-American women who were HIVpositive?
What was the influence of acquired vulnerabilities (educational level, income
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of
sexual abuse or assault) on the level of depressive symptoms reported by nonpregnant African-American women who were HIV-positive?

Specific Aim Five
Specific Aim Five was to examine the influence of inherited vulnerabilities
(family history of mood disorders, family history of alcohol and/or drug use) and
acquired vulnerabilities (educational level, income level, alcohol and/or drug use, HIV
disclosure status, sleep quality, history of sexual abuse or assault) on anxiety symptoms
in non-pregnant African American women who were HIV-positive.
a.

What was the influence of inherited vulnerabilities (family history of mood
disorders, family history of alcohol and/or drug use) on the level of anxiety
symptoms reported by non-pregnant African-American women who were HIV
positive?
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b.

What was the influence of acquired vulnerabilities (educational level, income
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of
sexual abuse or assault) on the level of anxiety symptoms reported by nonpregnant African-American women who were HIV positive?
CONCEPTUAL FRAMEWORK

A conceptual framework is defined as interrelated concepts or abstractions that
are assembled together in some rational scheme by virtue of their relevance to this
common theme (Polit & Hungler, 1995). The conceptual framework that guided this
study served to organize the empirical data, formulate the research questions, select the
study instruments and interpret study findings. Furthermore, the conceptual framework
aided in the exploration of existing knowledge gaps, which may facilitate development of
future theories that might improve understanding of the factors that predict depressive
and anxiety symptoms in the study population, and strategies to improve patient
outcomes. The proposed study investigated inherited and acquired vulnerabilities as
predictors of depressive and anxiety symptoms among African American HIV-positive
women.
The stress diathesis model proposes that vulnerability factors contribute to the
onset of depression when there is an interaction between these factors and negative life
events (A. T. Beck, 1967; Monroe & Simons, 1991). According to this model,
individuals form a psychological vulnerability to depression through stressful life events
that influence the development of negative cognitive schemas (Sacco & Beck, 1995).
Predispositions to mood disorders are developed as negative schemas become latent
during cycles of recovery but have the potential to be reactivated. The cascade of events
begins when a traumatic event, or event that is reminiscent of a previous trauma, occurs
and thereby reactivates the negative cognitive process, leading to negative experiences
and symptoms (Sacco & Beck, 1995).
Some persons, even under conditions of extreme stress, do not experience a
diathesis that leads to mental health compromise (B. P. Dohrenwend & Dohrenwend,
1979). All individuals experience daily and chronic stress, all with different backgrounds
and predispositions, resulting in different responses to stressors. The concept of allostatic
load plays an integral part in the stress diathesis model. Sterling and Eyer (Sterling &
Eyer, 1998) identified allostasis as the ability to achieve stability through change. There
is a broad range of behavioral responses to stressful life events. Positive outcomes, such
as coping, are the result of successful adaptation to stressors. It is when the body is
unable to adapt to stressful life events that injury occurs. McEwen (Bruce S. McEwen,
2002) explored the relationship of allostasis and allostatic load on mood disorders.
Allostasis (Bruce S. McEwen, 2002) refers to the adaptation that occurs as a response to
stress. The process is complicated when adaptation is altered, either for biological or
situational reasons, resulting in an allostatic state. An allostatic state results when there is
the failure to turn off mediators after stress (Bruce S. McEwen, 2002). When adaptation
fails, the result is injury. Cumulative effects of stress may be the result of repeated
failures in adaptation. Allostatic load is the long-term effect of repeated injury to the
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body. McEwen (Bruce S. McEwen, 2002) describes four situations associated with high
allostatic load: (1) frequent stress, (2) repeated stressors, (3) inability to turn off allostatic
responses after the stress is over, and (4) the trigger of compensatory responses due to
inadequate allostatic responses. Increased allostatic load has an effect on virtually every
body system, resulting in impaired immunity, obesity, atherosclerosis, and bone
demineralization (Bruce S. McEwen, 2002). Prolonged allostatic load increased the risk
for permanent damage to the brain in rats (Lowy, Wittenberg, & Yamamoto, 1995).
Allostatic load can be caused by genetic or developmental disturbances that prevent
adequate coping. Individual responses to daily stressors are influenced by neurobiological
factors, which effect the interpretation and response to stress (Bruce S. McEwen, 2002).
Hans Selye was one of the first scientists to explore the physiologic stress
response. Selye (1976) noted that the secretion of excess adrenocorticotrophic hormone
by the pituitary gland results in an increased release of glucocorticoids from the adrenal
cortex. This classic neuroendocrine response is present during both positive and negative
periods of stress (Selye, 1974). Excessive hypothalamic-pituitary-adrenal and
nonadrenergic system activity and dysfunction of the serotonergic system play a role in
the pathophysiology of suicidal behavior (van Heeringen, 2003). The effect of stressful
life events on neurobiological systems and the dysfunction of neurobiological systems
have been linked to suicidal behavior, impulsivity, aggression, and increased levels of
anxiety (van Heeringen, 2003).
Stressful life events, whether acute or chronic, lead to increased cortisol secretion
in both healthy and depressed persons (B. S. McEwen, 2006; Sher, 2004). The amount or
level of stress cannot predict outcomes, as there are individual variations in responses,
and the theory that some people have underlying vulnerabilities to depression and other
mood disorders. The prevention of stress is not feasible; therefore successful coping
strategies are suggested in order to maintain homeostasis in stressful situations.
The physiological stress response has been correlated with lifestyle. Early adverse
experiences (Gutman & Nemeroff, 2003) and sleep deprivation (McEwen, 2006;
McEwen & Wingfield, 2003) affect the physiologic stress response. Early adverse
experiences may sensitize corticotropin-releasing factor processes (Gutman & Nemeroff,
2003). Depression in adults may also be linked to the disruption of neurological pathways
caused by early adverse life experiences. Poor quality of sleep or disruptions of sleep
patterns may result in hypothalamic-pituitary-adrenal axis dysregulation, while short
periods of sleep deprivation have been shown to cause increased levels of cortisol,
glucose, insulin, and insulin resistance (B. S. McEwen, 2006; Plat et al., 1999).
Hypercortisolism has been linked depressive disorders (Sher, 2004).
Increased allostatic load can result in adverse outcomes. The physiologic changes
that occur as a result of increased allostatic load may affect the immune system, resulting
in the expression of inflammatory, infectious, and autoimmune diseases (United States
Department of Health and Human Services [USDHHS], (USDHHS, 1999). Long term
effects of chronic depression may be associated with increased allostatic load, resulting in
pathophysiologic changes (B. S. McEwen, 1998). There is a potential for adverse cardiac
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outcomes and increased platelet reactivity with concomitant long-term increased
allostatic load and major depression (Heuser, 2002; Lederbogen et al., 2001; Thayer,
Smith, Rossy, Sollers, & Friedman, 1998).
Although the precise etiology of mood disorders is unknown, there is evidence
that the interplay of biological, psychological, social, and cultural factors results in mood
disorders for some individuals (USDHHS, 1999). There is increased evidence that there
are biologic and physiologic causes of mood disorders. Responses to stressful life events
may vary. However, the body’s successful adaptation to stress results in allostasis,
appropriate responses, and successful coping. It is when the body is unable to adapt to
stressful life events that mood disorders are often expressed (Bruce S. McEwen, 2002).
Prolongations of stressors that result in a physiologic stress response have the potential to
cause adverse outcomes.
Although it is impossible to predict who will develop a mood disorder, the
assessment of lifestyle, individual and family history, and presence and type of current
stressors is an important aspect of evaluation of mood disorders. Thus, in the current
study, these underlying vulnerabilities were examined as potential predictors of
depressive and anxiety symptoms. Underlying inherited vulnerabilities that were
examined in this study included family history of mood disorders and family history of
alcohol and/or drug use. Underlying acquired vulnerabilities assessed in the current study
included educational level, income level (annual household income), alcohol and/or drug
use, HIV disclosure status, sleep quality, and history of sexual abuse or assault.
The evaluation of potential predictors of psychopathology is essential in the
comprehensive care of women with HIV infection. Healthcare providers often overlook
the importance and prevalence of depression and anxiety in this population. However, all
persons have underlying vulnerabilities, both inherited and acquired, which have the
potential to trigger a cascade of events resulting in disrupted mental processes.
The stress diathesis model appropriately describes and explains this process,
therefore serving as an appropriate conceptual framework for this study. The stress
diathesis model has been used to understand depressive and anxiety in this population
(Ickovics et al., 2001), and has been shown to be useful for understanding depression and
anxiety in general (Monroe & Simons, 1991). Therefore, this study tested the utility of
the stress diathesis model in this population. Figure 1.1 depicts the stress diathesis model
as it applied to the conceptual framework of the current study.
Definition of Major Concepts
A variety of theoretical and operational definitions have been published for the
concepts of interest within the current study. For the purpose of the current study, the
following definitions were used in order to provide conceptual consistency and clarity.
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Interaction of Vulnerabilities
& Negative Life Events
Inherited Vulnerabilities
Family history mood
disorder
Family history of alcohol
and/or drug use
Acquired Vulnerabilities
Alcohol and/or Drug Use
Educational Level
Income Level
Sleep Quality
Disclosure Status
History of Sexual Assault

Allostasis
Ability to adapt to
stress, achieve
stability

Positive Outcome
Successful Coping

Allostatic
Load
Long-term effect of
repeated injury

Negative Outcome
Depressive Symptoms
Anxiety Symptoms
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Figure 1.1 Conceptual Framework Depicting the Stress Diathesis Model with Inherited
and Acquired Vulnerabilities.
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HIV-positive women
In this study, the theoretical definition of HIV-positive women is women that have
been diagnosed with the human immunodeficiency virus by their health care professional
with positive HIV antibody testing, including the HIV-1 ELISA and HIV-1 Western Blot.
The diagnosis of HIV was confirmed by medical chart abstraction. This concept was
quantified as English-speaking African American females who were over the age of 18
years, who had been diagnosed with HIV, and were receiving care at a university
outpatient obstetrics and gynecology clinic or outpatient infectious disease clinic.
African American
The theoretical definition for African American is pertaining to or characteristic of
Americans of African ancestry (Mish, 1997). The definition of African American will be
operationalized through self-report. Participants must have lifelong residence in the
United States in order to eliminate the influence that cultural differences might play in the
interpretation of study instruments.
Depression
Depression refers to a reduction of the level of functioning; a sinking of spirits so
as to constitute a clinically discernible condition (Hensyl, 1990). The NIMH (National
Institute of Mental Health, n/d) describes three main types of depression: dysthymia,
major depression, and bipolar disorder. The operational definition of depression that was
used for this study was Center for Epidemiologic Studies Depression Scale (Radloff,
1977) or Edinburgh Postnatal Depression Scale (Cox, Holden, & Sagovsky, 1987) scores
at or above the recommended cut-off for additional evaluation. No attempt was made to
assign a diagnosis to participants’ symptoms. The study described the level of depressive
symptoms that were present in study participants and compared their symptoms with
other populations.
Anxiety
The theoretical definition of anxiety is an apprehension of danger and dread
accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly
identifiable stimulus (Hensyl, 1990). The NIMH (National Institute of Mental Health,
n/d) defines generalized anxiety disorder as a chronic disorder, which results in feelings
of impending disaster, often related to money, health, family, or work. Sources of anxiety
are not always identifiable. The operational definition of anxiety that was used for this
study was a positive score on the Beck Anxiety Inventory (A. T. Beck, Epstein, Brown,
& Steer, 1988). The proposed study instrument did not serve as a tool for diagnosing
anxiety, but rather as a means to assess the level of anxiety symptoms reported by study
participants and therefore determine the need for further assessment of anxiety symptoms
in this population. The proposed study findings will provide additional insights that may
guide recommendations for future assessments in this population.
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General Definitions
Health
Health is defined as a state of complete physical, mental and social well being and
not merely the absence of disease or infirmity (World Health Organization, 1992). Health
can be defined as a state (at one time) or a continuum (over a longer period of time). This
study used a comprehensive definition of health that included both mental and physical
health, and was measured through self-reporting of subjective symptoms, and
documentation of disease markers (CD4 count), which were obtained through medical
record chart abstraction.
Mental Health
Mental health is defined as emotional, behavioral, and social maturity or
normality; the absence of a mental or behavioral disorder; a state of psychological wellbeing in which the individual has achieved a satisfactory integration of his instinctual
drives acceptable to both himself and his social milieu (Hensyl, 1990). For the purposes
of the proposed study, mental health was theoretically defined as the scores on the CESD (Radloff, 1977), EPDS (Cox et al., 1987), and Beck Anxiety Inventory (A. T. Beck et
al., 1988).
Inherited Vulnerabilities
The term inherit can be defined as to receive from one’s ancestors (Mish, 1997).
Vulnerability can be defined as susceptibility to wounds, or capability of being wounded
(Mish, 1997). In the current study, the term vulnerabilities referred to susceptibility to
mood disorders. In the current study, inherited vulnerabilities were defined as family
history of mood disorders and family history of alcohol and/or drug use. The underlying
predispositions to biologic and familial manifestations of mood disorders are key
concepts in the stress diathesis model. This definition is consistent with components of
the stress diathesis theory that serves as the conceptual framework for this study. The
inherited vulnerabilities of the sample were individual characteristics that were
determined through self-report.
Acquired Vulnerabilities
The term acquired can be defined as gained by or as a result of effort or
experience (Mish, 1997). Vulnerability can be defined as susceptibility to wounds, or
capability of being wounded (Mish, 1997). In the current study, acquired vulnerabilities
were defined as educational level, income level, alcohol and/or drug use, HIV disclosure
status, sleep quality, and history of sexual abuse or assault. This definition is consistent
with the stress diathesis theory that serves as the conceptual framework for this study.
These acquired vulnerabilities of the sample were individual characteristics that were
determined through self-report.
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Concept Relationships
The identification of inherited and acquired vulnerability cannot solely predict
depressive or anxiety symptoms in a person. There are many different variables that
influence mental health, all of which may never be identified. Variables included in
inherited vulnerability are the following: family history of mood disorders, and family
history of alcohol and/or drug use. Researchers (Moore et al., 1999; Perkins et al., 1994;
Rabkin, Ferrando, Jacobsberg, & Fishman, 1997) have documented an increased
prevalence of depression among HIV-positive women (30-60%), when compared to HIVpositive men (20% or less). Researchers have demonstrated that minority status is often
associated with poverty and lower socioeconomic status (Wilhelm & Parker, 1994), and
that lower socioeconomic status is associated with greater risk for mood disorders
(USDHHS, 1999). Minority women are at greater risk for feelings of isolation and
alienation, which may lead to unhealthy behaviors and coping mechanisms, therefore
increasing their risk for depressive symptoms (Boyd-Franklin, 1987). Family history of
mood disorders has also been correlated with adult depression and anxiety (Gutman &
Nemeroff, 2003).
Variables included in acquired vulnerability are the following: educational level,
income level, alcohol and/or drug use, HIV disclosure status, sleep quality, and history of
sexual abuse or assault. Moore and colleagues (Moore et al., 1999) reported that
disadvantaged socioeconomic and environmental backgrounds were more related to
depressive symptoms than HIV infection. Adverse life events are also predictors of
depressive symptoms in women with HIV (Moore et al., 1999). Insomnia has been
associated with psychiatric disorders, including depression (Lustberg & Reynolds, 2000).
The assessment of sleep patterns, sleep preparation practices (also known as sleep
hygiene), sleep quality and duration of sleep are important aspects of comprehensive
sleep assessments. The relationship of sleep disturbances to depression and anxiety has
been documented. Socioeconomically disadvantaged women, regardless of HIV status,
have many barriers and adversities that make health maintenance and promotion difficult
(Moore et al., 1999). The identification of reported histories of sexual abuse or assault is
pertinent to the assessment of mental health. The relationship between a history of child
sexual abuse and adult depression and anxiety has been well documented (Barbe et al.,
2004; Barker-Collo, Read, Barker-Collo, & Read, 2003; Walrath et al., 2003). Adult
sexual abuse or assault has been associated with increased feelings of sadness and
dysphoria (M. Conway, Mendelson, Giannopoulos, Csank, & Holm, 2004).
Depression has been explained through several cognitive stress diathesis models
in the literature (Hilsman & Garber, 1995; Monroe & Simons, 1991). The intersection of
underlying predispositions with a major life stressor has the potential to activate a
cascade of events that result in psychopathology (Monroe & Simons, 1991). The
identification of persons with vulnerabilities to mental illness is essential in evaluating
risks of a major mental health disorder. Although the presence of predispositions to
psychopathology will not always activate the diathesis that results in a significant event,
it is important to identify the underlying predispositions in persons at greater risk for
depression and anxiety. Gender and the presence of a HIV diagnosis have been
documented (Ciesla & Roberts, 2001; J. M. Murphy et al., 2004; National Institute of
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Mental Health, n/d) to have a direct impact on increased levels of depressive symptoms.
Therefore, the evaluation of underlying predispositions, or vulnerabilities, is critical to
monitoring the potential onset of depressive symptoms, as well as symptoms of anxiety in
the study population.
SIGNIFICANCE OF STUDY
Although the routes of HIV transmission are well documented and prevention
inexpensive (i.e. abstinence, condom use), the rates of HIV cases and heterosexual
transmission of HIV continue to increase. Women of childbearing age are at a greater risk
for depression and anxiety than the general population. The cost of mental illness in the
United States is staggering, ranking second to cardiovascular conditions in the burden of
disease in established market economies (USDHHS, 1999). Depression can lead to poor
self-esteem, feelings of hopelessness, and suicide. “Mental problems affect and are
affected by chronic conditions such as cancer, heart disease, diabetes and HIV/AIDS.
Untreated, they bring about poor health behaviour, non-compliance with prescribed
medical regimens, diminished immune functioning, and negative disease outcomes”
(World Health Organization, 2004).
The identification of depressive and anxiety symptoms among HIV-positive
women is imperative and relevant to nursing practice for the following reasons: (1) to
identify the levels of depressive and anxiety in one clinical population; (2) to provide the
preliminary evidence as to whether there is a need for implementing early screening and
subsequent evaluation, diagnosis, and treatment of depressive and anxiety symptoms in
this vulnerable population; and (3) to provide an environment for the developing and
implementing of therapeutic interventions. The findings of this study may give
practitioners cause to be aware of potential inherited and acquired vulnerabilities that
increase the risk for mood disorders such as depression and anxiety among their female
African American patients who are HIV-positive. It is through the identification of
predictors of depressive and anxiety symptoms, that the proper screening, diagnosis, and
treatment of depression and anxiety can be instigated. The findings from this study
identified the relationship between the research variables and depressive and anxiety
symptoms in one sample, which addressed gaps in existing literature related to this area
of inquiry.
Nurse clinicians have the unique opportunity to influence their environment
through research, education, and practice. The knowledge gained from this research
study added to the existing information regarding HIV-infected women. This research
study is significant, in that there are few studies describing the predictors of depression
and anxiety among HIV positive women in general and African American HIV-positive
women in particular. This research study may provide the baseline information, which
can lead to early identification and treatment of anxiety and depression in HIV-positive
women.
Nurse clinicians must provide education to not only their patients, but also to their
co-workers and communities regarding HIV transmission, depression, and anxiety.
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Although HIV, depression, and anxiety are subjects that are avoided in many social
situations, nurses have the opportunity to bridge the gap between science and practice.
The identification of depressive and anxiety symptoms in HIV-positive women is critical
to long-term success of antiretroviral treatment and adherence to medical appointments.
The long-term ramifications of the identification, assessment, and treatment of depressive
and anxiety symptoms in HIV-positive women include decreased health care costs related
to decreased numbers of inpatient hospitalizations and increased longevity of successful
highly active antiretroviral treatment (HAART) regimens. Successful long-term HAART
treatment leads to better patient outcomes as patients experience complete virologic
control and immune reconstitution, as well as decreased transmission of drug resistant
viruses (Havlir & Richman, 1996). Depression has been associated with poor adherence
to medication regimens among HIV-positive persons (Gordillo, del Amo, Soriano, &
Gonzalez-Lahoz, 1999; Starace et al., 2002; Wagner et al., 2006).
It is imperative that nurses explore the predictors of depression and anxiety
among their HIV-positive clients. This information is vital to the development of
counseling strategies and treatment interventions that can be implemented in order to
maintain stable mental and physical health in these patients with complicated health care
needs.
Assumptions
The following assumptions for this study were used in the development of study
framework, design, and interpretation of the results. The assumptions surrounding this
study are the following:
1.

2.
3.
4.
5.

Women who agree to participate in the study are aware of their family history of
depression and anxiety. Several researchers have described the influence of
genetic factors and family history on depression (Gutman & Nemeroff, 2003;
Reinherz et al., 2003).
Women who agree to participate in the research study will be able to read and
understand the study’s instrumentation.
Women who participate in the study will answer the instruments honestly.
Positive HIV status is a stressor for the subjects in this sample.
The concepts in the study framework are relevant for the study sample and
population.

Limitations
The investigator for this research study identified several potential limitations.
These limitations were methodological in nature. The techniques used to minimize them
are discussed.
1.

Non-probability sampling (convenience sampling) was used and consisted of
HIV-positive women receiving care at university clinics. This sampling method
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contributed to a weaker design than if random sampling had been utilized. A
random sampling procedure increases the likelihood of generalizability by
guaranteeing that each unit of the population has a non-zero chance of selection
(Hulley, 2001). A convenience sampling method was appropriate due to the
limited existing body of knowledge regarding the subject matter and economic
considerations that alternative sampling methods required. The use of nonprobability sampling limits external validity by limiting the generalizability of the
findings to target populations (Penhazur & Schmelkin, 1991). The sample was
entirely composed of HIV-positive women engaged in medical care, thus
decreasing the generalizability to African American female HIV-positive
populations who are not receiving medical care.
2.

The potential inability of the subjects to honestly report symptoms of depression
and anxiety was another limitation of the study. The stigma that is often
associated with mental health issues may encourage subjects to underreport
symptoms. The questionnaires did not contain subject identifiers, which should
have encouraged truthful reporting. LoBiondo-Wood and Haber (Lo-BiondoWood & Haber, 1994) suggest that anonymity may be important when the study
deals with sensitive issues.

3.

Women who are severely depressed may not be represented in the study as their
levels of depression may have prevented them from accessing care or
participating in the study.

4.

Subjects were at different stages of their disease, and had different durations of
diagnosis. Data were collected during only a single time point, therefore
decreasing the external validity of the findings. The identification of different
levels of severity of depressive symptoms during different stages of disease and
length of diagnosis will, however, add to the body of existing literature regarding
HIV-positive women.

5.

The women accessed their care in a metropolitan area, thus the results may not be
generalized to similar populations living in rural settings.

6.

Socioeconomic and demographic characteristics of the sample may differ from
the HIV-positive women that seek care in private practice facilities.
SUMMARY

The prevalence of HIV infection among women has become a significant health
problem in the United States. The numbers of heterosexually transmitted infections have
increased significantly in the last decade (Centers for Control and Prevention, 2007).
Despite education regarding HIV prevention, the numbers of new infections continue to
rise. Women of childbearing age represent a substantial number of new HIV infections
each year, and the rates continue to climb among minority women (Centers for Control
and Prevention, 2007; Centers for Disease Control and Prevention, 2005, 2007b).
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Women who have been diagnosed with HIV have compounding issues that often
complicate the course of the disease. Women often experience additional stressors such
as the following: stigma, isolation, and shame that is often associated with HIV; loss of
family or partner support following disclosure of HIV status; responsibilities of being the
primary caregiver to children; guilt associated with potential mother to child HIV
transmission; and anxiety regarding permanency planning for their children. When these
stressors are combined with the diagnosis of HIV, there may be an increase in
experiencing significant depression and anxiety. Women are often burdened with
additional stressors such as single parenthood, caring for children and/or aging parents,
work and home responsibilities (Barroso, Pence, Salahuddin, Harmon, & Leserman,
2008).
Women experience hormonal factors that occur during menstrual cycle changes,
pregnancy, miscarriage, postpartum period, pre-menopause, and menopause, all of which
may contribute to the increased rate of depression in women (Barroso et al., 2008).
Physiological and or genetic factors have also been associated with depressive disorders,
and may have impacted the development of depression and anxiety (Barroso et al., 2008).
Therefore, it is important that both pregnant and non-pregnant women be included in
studies. The inclusion of pregnant and non-pregnant women will add to the body of
knowledge regarding women with HIV.
In this chapter, the problem, purpose of the study, aims and research questions,
definition of terms, conceptual framework, concept relationships assumptions,
limitations, significance of study, and significance to nursing were discussed. The next
chapter presents the review of literature.
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CHAPTER 2. REVIEW OF LITERATURE
OVERVIEW
Much of the earlier published literature regarding depression and HIV has focused
on HIV-positive men (Atkinson et al., 1988; Perkins et al., 1994; Rabkin, Goetz et al.,
1997), homosexual men (Atkinson et al., 1988; Rabkin, Goetz et al., 1997), and
populations of substance abusers (Lipsitz et al., 1994; Rabkin, Johnson et al., 1997),
reflecting the original transmission patterns of the virus observed in the United States.
Current epidemiologic trends illustrate that African American women of childbearing age
are the fastest growing group of newly diagnosed HIV infected persons in the United
States (Centers for Disease Control and Prevention, 2005 2007c). More recently
published literature about persons who are HIV positive focuses on the impact of
depression on morbidity and mortality in this population. A substantial proportion of this
literature documents the negative consequences of depressive symptoms on adherence to
HAART and medical appointments. Few studies examine the multiple inherited and
acquired vulnerabilities thought to influence the development of both depressive and
anxiety symptoms in this population. Although the current study focuses on African
American women who are HIV-positive, women in general may share similar
backgrounds and experiences that contribute to their vulnerability for mood disorders.
Therefore, within this chapter, specific attention will be given to describing inherited and
acquired vulnerabilities that increase the risk for depression and anxiety symptoms in a
sample of African American women who are HIV-positive. However before exploring
these vulnerabilities, the prevalence and epidemiology of HIV in the United States within
the general population and in specific populations will first be discussed followed by a
review of mood disorders in the general population and in specific populations.
HIV IN THE U.S. POPULATION: PREVALENCE AND EPIDEMIOLOGY
Research indicates that despite prevention education, prevalence rates for HIV
infection continue to increase in the United States. Surveillance data, although
comprehensive, can only provide an estimate of overall cases. The CDC began collecting
statistics on AIDS cases at the beginning of the epidemic, but currently collects
surveillance data for HIV. This process provides a more comprehensive illustration of the
epidemic, as earlier data did not account for healthy persons with HIV, who had not yet
developed AIDS. Reporting requirements vary by state; therefore, CDC surveillance data
only includes information from 33 states with confidential name-based HIV infection
reporting (Branson et al., 2006).
Approximately one million people are living with HIV in the United States
(Branson et al., 2006), including 250,000 persons that have not yet been diagnosed.
Surveillance data for HIV in the United States includes descriptions of cases by age,
race/ethnicity, sex, and transmission category. The prevalence and epidemiology of HIV
on African Americans and African American women, as well as HIV within the context
of pregnancy will be discussed in the next sections.
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HIV IN AFRICAN AMERICANS
More than half of new HIV infections (51%) in the United States occur in African
Americans (Centers for Disease Control and Prevention, 2007c). In general, minority
populations in the United States are disproportionately affected by HIV. African
Americans make up 12% of the total U.S. population, yet account for over 50% of the
new infections each year (Centers for Disease Control and Prevention, 2007c). The rapid
spread of HIV infection in African American communities has been accentuated by many
factors including poverty, racism, lack of education, barriers to health care, illicit drug
use, and high rates of sexually transmitted infections (Coleman, 2003; Mayberry, Mili, &
Ofili, 2000; Plowden & Young, 2003; Treadwell & Ro, 2003).
The stigma that is associated with HIV combined with the mistrust of
governmental research and educational programs in African American communities have
catapulted HIV to one of the leading causes of death among African Americans (CDC,
2006; Centers for Disease Control and Prevention, 2007b; Coleman, 2003; Plowden, &
Young, 2003; Treadwell, & Ro, 2003). The myth that HIV is a homosexual disease has
hindered HIV prevention efforts in African American communities and created a culture
of silence (Beatty, Wheeler, & Gaiter, 2004). This cycle has been counterproductive,
resulting in the perpetuation of myths and increases in compensatory sexual behavior
(marrying or having sex with the opposite sex) to prove one’s heterosexuality (Joint
United Nations Programme on HIV/AIDS [UNAIDS], (UNAIDS, 2000). This sequence
of events has resulted in discrimination and rejection of HIV-positive persons in African
American communities. Moreover, HIV-related shame and stigma has created another
minority within a minority population.
HIV AND AFRICAN AMERICAN WOMEN
HIV is now the leading cause of death among African American women 25 to 34
years of age in the United States (CDC, 2006; Centers for Disease Control and
Prevention, 2007a); however risk factors for HIV transmission vary by region. Among
women and adolescent females with AIDS, the most prevalent risk factor in the Northeast
was intravenous drug use, while heterosexual contact was the most prevalent risk factor
in the South (Centers for Control and Prevention, 2007). Although the primary focus of
the current study centered on African American women, minorities are grossly
underrepresented in much of the research literature. Minorities, both men and women, are
also under represented in HIV- related research studies nationwide.
Significant psychosocial issues facing African American HIV-positive women are
cited in the literature and include: poverty, low levels of education, stressors related to
caretaking roles, barriers to healthcare, depression, and poor access to quality healthcare
(Bunting, Bevier, & Baker, 1999; Centers for Disease & Prevention, 2007; Centers for
Disease Control and Prevention, 2005, 2007b; Heslin et al., 2005; Hu, Byers, Fleming, &
Ward, 1995; Washington, 2001). Women respond to the needs of their families, which
may result in a lack of self-care, often leading to negative health consequences.
Researchers reported that African American women who were HIV-positive were more
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likely to have a family member with HIV than White American women who were HIVpositive (Fiore et al., 2001). The result of family caretaking burden experienced by
African American HIV-positive women may impact their level of HIV care. Literature
reveals that caretaker burden affects the overall quality of life of HIV-positive women, as
the care of a HIV-infected child or partner often takes precedence over the care of the
woman who is HIV-positive (Fiore et al., 2001). As the rates of HIV continue to increase
among women of childbearing age, the impact of HIV on pregnancy becomes critical.
HIV in pregnant women will be discussed in the next section.
HIV IN PREGNANT WOMEN
Transmission patterns in the United States indicate increased heterosexual
transmission of HIV, with rising rates of infection documented in women. The prevalence
of HIV among women in the United States has directly affected women of childbearing
potential, with the majority of new infections documented in women between the ages of
25 to 44. The proportion of HIV/AIDS cases among women and adolescent girls (age 13
and older) increased by 14% between the years 1986 to 2001 (Centers for Disease
Control and Prevention, 2003). The concentration of infections among females aged 15 to
44 years directly impacts women during their highest years of fertility, thereby having an
impact on pregnancy.
Transmission of HIV from mother to child has greatly decreased since the advent
of antiretroviral therapy, with initial decreases noted with Zidovudine monotherapy
(22.6% to 7.6%) and even further reductions with HAART (Centers for Control and
Prevention, 2002). As women live longer, healthier lives with successful HIV treatment,
an increasing proportion of HIV-positive women are becoming pregnant (Cohan, 2003).
Although pregnancy has been associated with decreases in absolute CD4 cells, no studies
have indicated that pregnancy causes an increased rate of disease progression, HIV viral
load, or death (Centers for Disease Control and Prevention, 2002). Despite these hopeful
findings, HIV-positive women often view themselves as “bad mothers” or “bad women
for wanting to become mothers” (Sandelowski & Barroso, 2003).
Much of the literature regarding HIV and pregnancy is related to HIV treatment.
Antiretroviral distribution and metabolism is different in women when compared to men,
as women have higher percentages of body fat and lower percentages of lean muscle
mass than men (Anderson, 2002; Hader, Smith, Moore, & Holmberg, 2001). Limited
pharmacokinetic studies have addressed sex-related differences in regard to metabolism
of some antiretroviral agents in non-pregnant women (Anderson, 2002). Physiologic
changes that occur during pregnancy may change the pharmacokinetic profiles of some
antiretroviral agents (Anderson, 2002; Mirochnick, 2000), thereby prompting the need for
additional pharmacokinetic studies in pregnant women with HIV. No studies were found
in the literature describing the impact of pregnancy on depressive and anxiety symptoms
in HIV-positive women. Mood disorders, including depression and anxiety will be
discussed in the next sections.
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MOOD DISORDERS
According to the Surgeon General’s Report on Mental Health (USDHHS, 1999),
the current annual prevalence estimate for mental disorders is about 20% of the U. S.
population. Mood disturbances are the most frequently diagnosed mental health
disturbances in the U. S. and more common in persons with chronic disorders such as
HIV/AIDS (Barroso et al., 2008; National Institute of Mental Health, n/d). In primary
care settings, an estimated 10 to 20% of office visits are related to depressive symptoms
or an anxiety-related episode (Hirschfeld, 2001). Literature related to depression and
anxiety in the general population, as well as women, persons with HIV, African
Americans, and pregnant women will be discussed in the following sections.
Depression in the General Population
Depressive disorders include a wide range of specific illnesses including major
depressive disorder (MDD), dysthymia, and bipolar disorder (Barroso et al., 2008).
Depression is considered a major health problem and is one of the leading causes of
disability in the United States (R. C. Kessler et al., 2003; R. C. Kessler & Kessler, 2003).
Patients with depressive symptoms describe poor physical and social functioning, which
limits their activity (K. B. Wells, Stewart et al., 1989). Impaired functioning has a direct
impact on not only the patient, but also their families and communities.
An estimated 14.8 million adults or 6.7% of the U. S. population suffers from
depression in any given year (R. C. Kessler et al., 2005; Wang et al., 2005). Healthy
women in the general population are twice as likely to be diagnosed with depression as
their male counterparts (Blazer, Kessler, McGonagle, & Swartz, 1994; R. C. Kessler et
al., 2003; Wang et al., 2005); depression is the leading cause of disability in women (R.
C. Kessler, 2003). Despite these facts, research has shown that general practitioners
often fail to diagnose depression in primary care practices (Goldberg & Huxley, 1992; R.
C. Kessler et al., 2003).
A wide range of literature focuses on depression and its prevalence in the general
population (R. C. Kessler et al., 2005; R. C. Kessler, McGonagle, Zhao et al., 1994) with
prevalence rates ranging from 10 to 21.3% (R. C. Kessler, McGonagle, Zhao et al., 1994;
J. K. Myers et al., 1984; Olfson & Pincus, 1996; Olfson et al., 2000). Significant
depressive symptoms have been documented in primary care populations (K. B. Wells,
Golding, & Burnam, 1989), and depression is the most frequently studied outcome in
populations with chronic diseases such as diabetes (Gore, Krupski, Kwan, Fink, &
Litwin, 2005; M. Gore et al., 2005; Ludman et al., 2004; McKellar, Humphreys, & Piette,
2004), coronary artery disease (Rudisch & Nemeroff, 2003; Ruo et al., 2003), cancer (C.
H. Kroenke et al., 2005; Williams & Dale, 2006) and HIV (Ciesla & Roberts, 2001; LowBeer et al., 2000; Mock, Phillips, & Sowell, 2002).
Literature illustrating racial differences in diagnoses of depression has been
documented for decades (Neighbors, Jackson, Campbell, & Williams, 1989), however
disparity continues (Neighbors, Trierweiler, Ford, & Muroff, 2003). Depression is
21

diagnosed more frequently in White Americans than African Americans (Neighbors et
al., 2003); schizophrenia is diagnosed more frequently in African Americans (Neighbors
et al., 2003). The subjective nature of the clinical diagnosis of depression suggests that
clinicians’ bias may lead to inaccurate diagnoses despite the use of structured diagnostic
criteria (Neighbors et al., 2003).
In one of the largest national epidemiologic studies conducted, Kessler and
colleagues (R. C. Kessler, McGonagle, Zhao et al., 1994) examined prevalence rates of
depression in a sample of 8098 persons from communities in 48 states. Participants’ age
ranged from 15 to 54 years. Data were collected by trained interviewers using the
Composite International Diagnostic Interview (World Health Organization, 1990).
Lifetime prevalence of major depression was estimated at 17.1%. When the sample was
assessed for current depression (within the last 30 days), the prevalence rate averaged
4.9%. Distributions across age ranges were constant, but were twice as high in females as
in males. The highest lifetime prevalence rates (21.1%) were noted in African American
women between the ages of 35 to 44 years. These findings emphasize the need to screen
African American women for depression and justify the need for the current study as
many of the participants in the current study were women within these age ranges.
Additional results pertinent to the current study were: 1) persons in lower socioeconomic
ranges were at higher risk for depression than their more affluent counterparts and 2)
persons in urban areas were at greater risk rural participants. The current study was
implemented in an urban area and most participants were poor.
Anxiety in the General Population
The American Psychiatric Association (APA) classifies anxiety disorders as many
different, distinct disorders including: panic disorder, agoraphobia without panic disorder,
specific phobia, social anxiety disorder, generalized anxiety disorder, posttraumatic stress
disorder, obsessive-compulsive disorder, and separation anxiety disorder. The four most
common anxiety disorders are panic disorder, social anxiety disorder, generalized anxiety
disorder, and posttraumatic stress disorder (Gillock, Zayfert, Hegel, & Ferguson, 2005;
Issakidis, Sanderson, Corry, Andrews, & Lapsley, 2004; Wittchen, 2002; Wittchen et al.,
2002). Approximately 130 million people in the United States have a lifetime history of
anxiety (Regier et al., 1988). In studies of clinical samples, 50% or more of patients with
a primary anxiety disorder have at least one additional anxiety or mood disorder (Fiore et
al., 2001). An estimated 25% of all primary care patients have an anxiety disorder
(Sartorius, Ustun, Lecrubier, & Wittchen, 1996). Despite its high prevalence, only 15% to
36% of patients with anxiety are diagnosed in primary care settings (D. Kessler, Lloyd,
Lewis, & Gray, 1999).
In one of the largest replicated epidemiologic studies conducted (N = 9282),
Kessler and colleagues (R. C. Kessler et al., 2005) examined lifetime prevalence and age
of onset of DSM-IV diagnoses. Face-to-face assessments were conducted by trained
professional interviewers from the Institute for Social Research at the University of
Michigan, Ann Arbor, between February 2001 and April 2003. The response rate was
70.9%. The estimated lifetime prevalence of anxiety disorders in the general population
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was 28.8%. Median age of onset for anxiety disorders was quite young (11 years)
compared to depressive disorders (30 years).
In another epidemiologic study, patients from 15 primary care clinics in the U. S.
completed self-report questionnaires and a follow-up telephone interview (K. Kroenke,
Spitzer, Williams, Monahan, & Lowe, 2007). Demographic characteristics of the sample
included an average age of 47.1 years, majority female (69% of the sample was women),
and majority (81%) non-Hispanic White Americans. The sample was educated, like the
current study sample. Many of the participants (29%) had a high school degree or
equivalent and 39% had some college. Of the 965 participants, 19.5% had at least one
anxiety disorder (95% CI, 17% to 22.1%). Almost half (41%) of the participants
diagnosed with an anxiety disorder were not receiving treatment.
Prevalence of anxiety symptoms among women is twice as high as those for men
(Breslau, Schultz, & Peterson, 1995; J. M. Murphy et al., 2004; Olfson et al., 2000)
which informs the present study, as anxiety symptoms are not routinely and
systematically assessed in populations of women. Recent literature related to anxiety
includes investigation of genetic correlates for anxiety (Landgraf & Wigger, 2003).
Unlike depression, evidence does not support a significant association between family
history of anxiety disorders and a personal risk for anxiety disorders (USDHHS, 1999).
However, epidemiologic studies consistently document high rates of co-morbid
depression and anxiety within the general population (Brown, Campbell, Lehman,
Grisham, & Mancill, 2001; R. C. Kessler et al., 2005; R. C. Kessler, McGonagle, Nelson
et al., 1994; J. M. Murphy et al., 2004; Olfson et al., 2000). The next section will discuss
co-morbid depression and anxiety.
Co-morbid Depression and Anxiety in the General Population
Overlapping symptoms of anxiety and depression often occur in persons
diagnosed with mood disorders (Brown et al., 2001; R. C. Kessler et al., 2003; R. C.
Kessler, McGonagle, Nelson et al., 1994; J. M. Murphy et al., 2004). The significant rates
of co-morbidity have prompted investigation into overlapping symptoms, diagnostic
trends, and effective treatment regimens (R. C. Kessler et al., 2005; R. C. Kessler,
McGonagle, Nelson et al., 1994; Wang et al., 2005; Zimmerman & Chelminski, 2003).
Hirschfeld (Hirschfeld, 2001) recognized a lack of information regarding the co-existence
of these disorders in primary care settings, and subsequent epidemiologic studies (R. C.
Kessler et al., 2005) illustrate high levels of co-morbid conditions within both the general
population and in primary care populations (Rodriguez et al., 2004). Because previous
research indicates that the prevalence of depression and anxiety is higher in women than
men (Blehar & Oren, 1995; Breslau et al., 1995; J. M. Murphy et al., 2004; Olfson et al.,
2000) and these conditions often co-exist, it reasonable to expect women to experience
co-morbid depression and anxiety more often than men.
The need for routine screening is evident due to high prevalence rates and the fact
that depression and anxiety are common in the context of physical illnesses such as
cardiac disorders, hypertension, gastrointestinal disorders, genitourinary disorders, and
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migraines (M. C. Harter, Conway, & Merikangas, 2003). High prevalence rates of comorbid depression and anxiety have been noted in several national studies (Brown et al.,
2001; R. C. Kessler et al., 2005). Brown and colleagues (2001) reported high comorbidity rates in a sample (N = 1,127) of patients with diagnosed anxiety and mood
disorders who were seeking treatment at a university-based specialty clinic. Co-morbidity
for specific anxiety and mood disorders were noted in patients with generalized anxiety
disorder, with 65% having a current co-morbid mood disorder and 88% with a lifetime
co-morbid anxiety or mood disorder. Ninety-two percent of patients with post-traumatic
stress disorder had a current mood disorder and all had a lifetime history of a mood
disorder. Kessler and colleagues (R. C. Kessler et al., 2005) reported co-morbidity rates
for anxiety disorders, mood disorders, impulse control disorders, and substance use
disorders in a national epidemiologic study. In this sample of 5692 participants, 55% had
a single diagnosis, 22% had two diagnoses, and 23% had three or more diagnoses. The
numbers and types of diagnoses have illustrated racial differences.
Mood Disorders in the African American Population
Researchers examining mental health diagnoses by race and ethnicity have cited
racial differences in DSM diagnoses (Loring & Powell, 1988; Neighbors et al., 2003).
Schizophrenia is diagnosed more frequently in African Americans than White
Americans, while White Americans are more likely to receive a diagnosis of bipolar
disorder than African Americans (Neighbors et al., 2003). These differences in mental
health diagnoses were studied by Neighbors and colleagues (Neighbors et al., 2003),
through semi-structured diagnostic instruments administered to a group (N = 665) of
African American and White American psychiatric inpatients. Results indicated that race
was related to diagnosis and dependent upon accuracy of clinical judgment. Pre-existing
cultural beliefs may impact clinical decision making. The authors recommended that
cultural information be integrated into clinical training programs to decrease this bias.
Racial differences in access to mental health care have illustrated disparities that
affect African Americans. African Americans have less access to health care across
health care disciplines, including mental health and psychiatric services. Some reports
indicate that African Americans are more likely to have depression than their White
counterparts (Gazmararian, James, & Lepkowski, 1995; Hough, Brumitt, & Templin,
1999; Husaini et al., 1990; McBarnette, 1996); while other studies reveal that rates of
major depression are either higher than (Blazer, Kessler, McGonagle, & Swartz, 1994) or
equivalent to (Berkman et al., 1986; Murrell, Himmelfarb, & Wright, 1983) the rates
among non-Hispanic whites than African Americans. Plant and Sachs-Ericsson (Plant &
Sachs-Ericsson, 2004) reported that ethnic minority women report more depressive
symptoms than Caucasian women, while George and Lynch (George & Lynch, 2003)
reported that African Americans experience greater stress than White Americans and
therefore greater depressive symptoms than White Americans. Lower income levels have
been associated with greater stress levels due to the inability to meet basic needs, which
could increase depressive symptoms (B. P. Dohrenwend & Dohrenwend, 1969; Turner
& Lloyd, 1999). A plausible explanation for the difference in results of these studies was
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the large amount of missing income data in the Blazer and colleagues’ (Blazer et al.,
1994) study.
Teresi and colleagues (Teresi et al., 2002) explored racial differences in the
recognition of depressive symptomatology. In a population of nursing home residents,
(N = 270) African Americans had fewer depressive symptoms than other ethnic groups.
The referral of patients to psychiatry may have had an influence on these results, as the
authors noted that the persons with the most involvement with the patients (nursing
assistants) gave the most accurate report of depressive symptomatology compared to
other health care professionals (nurses, social workers) engaged in the care of the
patients. One possible reason for this difference in perceptions could be related to race.
Nursing assistants were more often African American, whereas nurses and social workers
in the study were predominately Caucasian.
Economic differences have been investigated as possible barriers to mental health
care among African Americans with conflicting results. Economic barriers such as
unemployment, low income, or lack of health insurance are often used to explain racial
disparities in health care among African Americans. However, research has shown that
African Americans who had health insurance were actually less likely to use mental
health services than White Americans (Snowden & Thomas, 2000). Furthermore, African
Americans have low overall rates of outpatient mental health service use (Alegria,
Canino, Rios, & et al., 2004; K. Wells, Klap, Koike, & Sherbourne, 2001). Moreover,
discrepancies in use of mental health services may be related to stigma related to mental
illness within African American communities. Stigmatization of mental illness is one of
the main reasons treatment is delayed until the disorder becomes debilitating or a crisis
develops (United States Department of Health and Human Services, 1999; Zhang &
Snowden, 1999). Literature illustrates low rates of mental health care by African
Americans. Although several reasons have been hypothesized, stigmatization remains a
strong force that must be addressed. The current study examined anxiety and depressive
symptoms among African American HIV-positive women, a population drenched in
shame, stigma, and isolation.
Depression and Anxiety in HIV-positive Patients
Mood disorders are common among persons living with HIV in the United States
(Bing et al., 2001; Ickovics et al., 2001; Moore et al., 1999; Morrison et al., 2002).
Depressive symptoms are the most commonly examined psychiatric symptom in HIV
populations. Early in the epidemic, homosexual men represented a large proportion of
samples in HIV literature, which appropriately reflected the HIV population at that time
(Atkinson et al., 1988; Bing et al., 2001; Ickovics et al., 2001; Leserman et al., 1999;
Lyketsos et al., 1996; Perkins et al., 1994; Rabkin, Goetz et al., 1997). Recent literature
describes the effects of mood disorders in HIV-positive women (Cruess et al., 2005;
Evans et al., 2002; Ickovics et al., 2001; Morrison et al., 2002; Perkins et al., 1994;
Rabkin, Goetz et al., 1997), as the HIV epidemic grew to impact demographically
different populations across the country.
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Many of the published research studies regarding mood disorders in the HIV
literature are cross-sectional, capturing information during one specific time point. HIV,
like many chronic diseases, has stages and progresses differently based on multitude of
factors. Cross-sectional studies may not accurately reflect the varying levels of depressive
and anxiety symptoms that occur throughout the course of the illness. Dissimilar findings
across studies may indicate differences within the sample, such as varying stages of
disease and varying lengths of HIV diagnosis which likely influences the intensity of
depressive symptoms.
HIV literature reveals varying rates of co-morbid depression and anxiety,
however similar trends are noted. Rates of mood disorders in a sample of HIV-positive
women (n = 93) were 19.4% for MDD, 4.3% for dysthymic disorder, 2.2% for
generalized anxiety disorder, and 10.8% for any anxiety disorder (Morrison et al., 2002).
Higher rates of depression and anxiety have been reported in populations of HIV-positive
men (n = 56), with rates as high as 30.3% for MDD and 39.3% for generalized anxiety
disorder (Atkinson et al., 1988). In general, higher rates of depressive disorders (MDD)
have been illustrated in HIV-positive groups, when compared to their HIV-negative
counterparts. Maj and colleagues (Maj et al., 1994) reported MDD rates of 7.14% in a
group of 602 HIV-positive men and women, compared to a lower rate of MDD (1.98%)
in the group of HIV-negative men and women (n = 353). Contrasting results were seen in
Rabkin and colleagues’(Rabkin, Goetz et al., 1997) study, with lower rates of MDD seen
in HIV-positive men (n = 183) than HIV-negative (n = 65) men (7.65% vs. 8.33%,
respectively). However, in this group of men, higher rates of dysthymic disorder
(13.11%) were seen in the group of HIV-positive men than the group of HIV-negative
men (4.76%), indicating the need for comprehensive assessment of a wider range of
mood disorders.
The prevalence of a wider range of psychiatric disorders among HIV-positive
men and women was assessed in a large (N = 2864) epidemiologic study (Bing et al.,
2001). Trained interviewers assessed major depression, dysthymia, generalized anxiety
disorders, and panic attacks. Results illustrated that almost half of the participants had
scores indicating presence of a psychiatric disorder. The most common disorders
included MDD (36%) and dysthymia (26.5%) with lower rates noted for generalized
anxiety disorder (15.8%) and panic attacks (10.5%). The high numbers of HIV-related
side effects in the sample may explain the higher rates of depressive disorders and
dysthymia in the study. Anxiety disorders were lower in this sample than seen in the
general population. A plausible explanation for this finding may be the high frequency of
marijuana use that was reported by the participants.
Previous studies provide consistent evidence that HIV-positive persons
experience significant levels of depression, yet the concept of depression has been used
broadly, with some studies focusing on diagnoses of specific mood disorders such as
MDD (Bing et al., 2001), while others focused on the presence of depressive symptoms
(Atkinson et al., 1988; Bing et al., 2001; Lipsitz et al., 1994; Perkins et al., 1994; Stern et
al., 1992). In some cases, the effects of mood disorders on HIV treatment are specified,
such as adherence to HAART or medical appointments (Starace et al., 2002), while other
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research has focused on the detrimental effects that depression has on HIV disease
progression (Cruess et al., 2003; Leserman, 2003), morbidity, and mortality (Ickovics et
al., 2001).
Thus, evidence suggests that when compared to their HIV-negative counterparts,
HIV-positive persons may experience greater levels of depressive and anxiety symptoms.
Studies must be viewed with caution, as prevalence rates vary greatly among studies.
Rates of depressive symptoms alone have ranged from 5% to 50% among HIV-positive
persons (Atkinson et al., 1988; Bing et al., 2001; Leserman, 2003; Lipsitz et al., 1994;
Perkins et al., 1994; Stern et al., 1992). The wide range of assessment techniques, varied
instrumentation, varied outcome measurements (depressive symptoms, anxiety
symptoms, MDD, dysthymia, generalized anxiety disorder), combined with differences
among samples (concomitant substance use and differences in HIV disease progression)
across studies makes comparison of findings difficult; however, similar trends are noted.
Because most studies in the HIV literature do not include an assessment of multiple risk
factors or vulnerabilities for mood disorders, this lack of consensus in findings is not
unexpected.
Depression and Anxiety in African American HIV-positive Women
Women of color are now one of the fastest growing groups of newly infected
persons with HIV (Centers for Disease Control and Prevention, 2002, 2005, 2007a;
Ickovics et al., 2001; Morrison et al., 2002). Consistent with the general HIV literature,
varying prevalence rates of mood disorders are documented in women who are HIVpositive. Prevalence rates of mood disorders vary from 30% to 60% among populations
of women who are HIV-positive (Ickovics et al., 2001; Morrison et al., 2002; D. K. Smith
et al., 1996; Taylor, Amodei, & Mangos, 1996). African American women, although
underrepresented in many other areas of research, were well represented in several HIV
studies. In Ickovics’ (Ickovics et al., 2001) study, 62% of the women in the sample were
African American, while Morrison’s study contained approximately 55% African
American women. Depressive symptoms are the most common mental health outcome
assessed in studies of HIV-positive women.
Consistent with earlier HIV literature that compared HIV-positive men with HIVnegative men higher rates of depressive symptoms have been documented in similar
populations of women. Ickovics and colleagues (Ickovics et al., 2001) examined the
prevalence of depressive symptoms among HIV-positive women (N = 765) in a
prospective longitudinal cohort study. The majority of the sample (62%) was African
American, unemployed (84%), and denied substance use during the study duration
(54%). Participants were evaluated every six months and required at least three study
visits for analysis. Depressive symptoms were measured using the CES-D (Radloff,
1977), which captured self-reported symptoms experienced within the past seven days.
Chronic depressive symptoms were defined as elevated CES-D scores (using the cut-off
score of 16 or higher) for 75% of their study visits, intermittent depressive symptoms
were defined as elevated CES-D scores for 26-74% of their study visits, and limited or no
depressive symptoms were classified as no more than 25% of their study visits revealing
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CES-D scores at or above 16. Almost half of the sample (42%) reported chronic
depressive symptoms, while 35% reported intermittent depressive symptoms.
Morrison and colleagues (Morrison et al., 2002) examined differences in mood
disorders, including depressive and anxiety symptoms, among HIV-positive and HIVnegative women in a large, longitudinal cohort study (N = 155). Although the authors did
not specifically document a case-control design, one is implied. The authors do not
indicate if participating women were matched according to race, age, or any other
demographic characteristic. There was a larger group of HIV-positive women (n = 93)
than HIV-negative women (n = 62). Racial distributions were similar in both groups, with
the majority of the sample being African American (55.9% in HIV-positive group; 53.2%
in the HIV-negative group).
Comprehensive measurements included physical and psychological exams,
interviews, and the completion of questionnaires [Hamilton Depression Rating Scale [(M.
Hamilton, 1967)] and Hamilton Anxiety Rating Scale [(M. Hamilton, 1959)]. The cohort
design allowed the researchers to follow populations over time and gather information
about the natural history of disease, examine sequences and patterns over time as well as
inferring causality, which may illustrate risk factors. Two groups of women were
followed from 1997-2000. Differences in the rates of depression and anxiety disorders in
the group of HIV-positive women were compared to a group of HIV-negative women.
Results indicated that HIV-positive women had higher prevalence rates of major
depressive disorder (19.4%) than HIV-negative women (4.8%) and these differences
were statistically significant (t = - 4.9, df = 152, p < 0.0001). Similar results were noted
for diagnoses of anxiety disorders, with 10.8% of the HIV-positive women being
diagnosed with any anxiety disorder and 2.2% of the HIV-positive women being
diagnosed with generalized anxiety disorder. Lower rates of any anxiety disorder were
noted in the HIV-negative group of women (6.5%), but the HIV-negative women had
higher rates of generalized anxiety disorder (3.2%) than their HIV-positive counterparts
(2.2%). Anxiety symptom scores were higher in the group of HIV-positive women when
compared to the HIV-negative group, and these differences were statistically significant
(t = - 4.5, df = 152, p < 0.0001). HIV-positive women (n = 47; 50.5%) also had higher
rates of active substance use than their HIV-negative counterparts (n = 19; 30.6%), a
difference that was statistically significant (odds ratio = 2.3, 95% CI = 1.2-4.6; p = 0.02,
Fisher’s exact test)
Demographic characteristics of women who are HIV-positive include multiple
complex factors which may influence the risk for mood disorders. Caregiving roles as
mothers and partners may add to stress and distress that is experienced by this population
(Fiore et al., 2001). Literature reveals that HIV-positive women report high levels of
fatigue and anxiety (Barroso, 2002; Barroso, Carlson, & Meynell, 2003; Barroso et al.,
2008; Meynell & Barroso, 2005) are frequent victims of violence (Leibschultz, Feinman,
Sullivan, Stein, & Samet, 2000), and live in poverty (Ickovics et al., 2001; Wohl et al.,
1998).
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African American women with HIV are a unique population with additional
stressors that may contribute to depressive and anxiety symptoms. Understanding the
psychological burden the diagnosis of HIV brings to patients is imperative to
appropriately counsel and guide them through the course of this chronic disease.
Additional research regarding possible vulnerabilities to depressive and anxiety
symptoms is necessary.
Depression and Anxiety in Pregnancy
In studies focused on mood disorders and pregnancy, the most frequently studied
mood disorder is postpartum depression. However, results from investigations designed
to examine predictors of postpartum depression consistently include antenatal depression
as one of the main risk factors for postpartum depression. Therefore, the assessment of
mood disorders in pregnancy remains a critical aspect of comprehensive prenatal care. In
the next section the correlates of mood disorders and pregnancy will be discussed.
Depression is the leading cause of disability in women (R. C. Kessler, 2003) and
often first appears following pregnancy. Fifty to seventy percent of women experience
psychological changes following childbirth (Mosack & Shore, 2003). The overall
psychological reactions commonly known as the “baby blues” include transient, mild
states of tearfulness, anxiety, restlessness, and irritability. Due to the high frequency of
occurrence, these symptoms are often considered a normal part of the postpartum period,
appearing as early as the first postpartum day. The duration of these symptoms is short,
lasting approximately ten days in most affected women. Symptoms may reappear after
exposure to decreased sleep quality and duration that are often associated with neonatal
care. Increase in dysmorphic syndrome disorders is often attributed to somatic changes,
not hormone level changes that occur immediately after childbirth (Dixit & Crum, 2000;
Holahan, Moos, Holahan, Cronkite, & Randall, 2003; Nott, Franklin, Armitage, &
Gelder, 1976; Schutte, Moos, & Brennan, 1995; Swain, O'Hara, Starr, & Gorman, 1997)
Over the past few decades, an increasing number of studies have led to the
identification of multiple variables that are correlated with post-partum depression. In
contrast to earlier theories that included dramatic hormone changes that occur during
pregnancy and immediately after delivery, the current etiology of mood disorders in
pregnancy suggests a multifactorial process (Casswell, Pledger, & Hooper, 2003;
Neighbors et al., 2003; L. E. Ross, Gilbert Evans, Sellers, & Romach, 2003).
Investigators have examined specific risk factors of post partum depression and found
that the most prevalent are: antenatal depression and anxiety, personal and family history
of depression, life stress, and lack of social support (C. T. Beck, 2001; P. Cooper &
Murray, 1997; P. J. Cooper & Murray, 1998; Howell, Mora, & Leventhal, 2006; O'Hara
& Gorman, 2004).
Early identification of vulnerable populations of women is essential. Prevalence
rates of postpartum depression vary widely; however research suggests that 10 to 50
percent of women experience postnatal depression. Varying rates are due to sampling
techniques, populations studied, and the wide variety of screening assessments used
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across studies. Postpartum depression is the most common disorder that affects women
following childbirth (C. T. Beck, 1998; Cox et al., 1987). Researchers have illustrated
that levels of depressive symptoms in the immediate postpartum period are significant
predictors of postpartum depression (Dennis, 2004; Hannah, Adams, Lee, Glover, &
Sandler, 1992).
In a longitudinal study, depressive symptoms of women (N = 217) that delivered
infants at two British hospitals were assessed at five days postpartum, and again at six
weeks postpartum using the EPDS (Hannah, Adams, Lee, Glover, & Sandler, 1992).
Results indicated that women with EPDS scores greater than nine at five days postpartum
were eight times more likely to have EPDS scores above nine, which is indicative of mild
depressive symptoms, at six weeks postpartum. Similar results were found in Dennis’
2004 study of Canadian mothers (N = 594) where women were screened with the EPDS
at one, four, and eight weeks postpartum. Elevated EPDS scores at one week postpartum
were associated elevated EPDS scores at both four and eight weeks postpartum (Dennis,
2004). Racial descriptions of the Canadian participants were not provided, limiting
comparisons to the current study of African American women.
Screening evaluations for post partum depression were evaluated in another study
of postpartum women in North Carolina (N = 391). The majority of the sample (84%)
was Caucasian and had at least a high school education (74%). Medical residents
compared screening with the use of the Edinburg Postnatal Depression Scale with routine
interviews of women that had delivered infants (Evins, Theofrastous, & Galvin, 2000).
Chi square analysis compared 79 women evaluated with the EPDS with 96 women
evaluated with clinical evaluations (structured interviews). Women were assigned to one
of the two screening measurements by delivery date. Results revealed the incidence of
postpartum depression detection with the Edinburgh Postnatal Depression Scale was
significantly higher than the incidence of spontaneous detection during routine clinical
evaluation (35.4% and 6.3%, respectively; p = .001). Investigators recommended that the
EPDS is an effective method for screening postpartum women for depressive symptoms.
The authors also recommend the EPDS as a useful instrument that should be introduced
to medical residents during their training and used in their post resident practice. Thus,
the evidence suggests that women with depressive symptoms immediately postpartum
continue to experience depressive symptoms weeks after delivery, suggesting the need
for early screening, identification and intervention. These results were important to the
current study, and emphasize the need to not only screen women for depressive
symptoms, but also train healthcare providers to implement early consistent screening in
their practices.
Mood disorders in pregnancy are a complex phenomenon which can have
devastating consequences on both the mother and the infant. Complex psychological
changes may occur in women during and after pregnancy, and may vary in duration,
intensity, and severity. One third of women that experience postpartum depression, but
are either untreated or undiagnosed, may continue to suffer from depression for one year.
Therefore, it is important that women be screened for signs and symptoms of depression
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as early as possible. Many women do not report symptoms of postpartum depression (C.
T. Beck & Gable, 2000), fearing social stigma (C. T. Beck, 2001).
In studies focused on postpartum depression, investigators have examined the
relationship between postpartum depression and major depression. The strongest
predictor of postpartum depression is the presence of prenatal depression (C. T. Beck,
1996; O'Hara & Gorman, 2004). Despite the grim realization of the effects of postpartum
depression and the prevalence of the condition, many women are not routinely screened.
Recognizing signs and symptoms of depression is imperative. Screening instruments
have been shown to be useful in identifying depression by identifying depressive
symptomatology. Use of such questionnaires may help identify women that experience
signs and symptoms of depression. The most widely used instrument is the Edinburgh
Postnatal Depression Screen (EPDS) (Cox et al., 1987), which was one of the instruments
used to measure depressive symptoms in the current study. Assessment of underlying
vulnerabilities for depression and anxiety may enhance screening procedures; inherited
and acquired vulnerabilities for these disorders will be discussed in the next section.
INHERITED VULNERABILITIES FOR MOOD DISORDERS
Human genetic makeup is determined by building blocks that are provided by
biologic family. The term inherit can be defined as to receive from one’s ancestors (Mish,
1997). Vulnerability reflects susceptibility to wounds, or capability of being wounded
(Mish, 1997). Inherited vulnerabilities are often the initial influences that affect not only
the early life experiences, but also lay the groundwork for future coping strategies and
lifestyle choices. In the current study, the term vulnerability referred to susceptibility to
mood disorders; both inherited and acquired vulnerabilities were examined. The current
study evaluated two inherited vulnerabilities that influence the risk for developing mood
disorders: family history of mood disorders and family history of alcohol and/or drug use.
Family History of Mood Disorders
Family history of mood disorders has long been acknowledged as a strong
predictor of mood disorders in many patients (Gershon et al., 1982; Klein, Lewinsohn,
Seeley, & Rohde, 2001; Weissman et al., 1987). Depressive symptoms are the most
frequently examined mood disorder in family history research. The method by which
family history information is ascertained varies across studies and ranges from a report of
a family member with a mental health history to structured interviews and psychological
assessment of family members to clinicians determining the presence or absence of
psychiatric diagnoses. The later is much more costly and labor intensive but may be more
accurate. The family history method has been shown to have good sensitivity in family
studies of depression (Kosten, Anton, & Rounsaville, 1992; Zimmerman & Chelminski,
2003) but less specificity. Conclusions about the relationship between family history of
mood disorders and individual presence of mood disorders may be equivocal because
most studies included self-report measures of family history. Despite acknowledged
limitations of subjective reports, in the current study, participants reported family history
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of mood disorders on the Demographic Data Instrument. Using this approach, however,
facilitates comparisons between the findings of the current study and findings of
published studies that determine family history using a similar approach.
Numerous studies have consistently shown that the children born to parents with
major depressive disorder have a three-fold risk of experiencing major depressive
disorder in their lifetime (Downey & Coyne, 1990; Kosten et al., 1992; Lieb, Isensee,
Hofler, Pfister, & Wittchen, 2002; Weissman et al., 1984; Williamson, Birmaher,
Axelson, Ryan, & Dahl, 2004; Zimmerman & Chelminski, 2003). Lieb and colleagues
(Lieb et al., 2002) conducted an analysis of demographic, structured interview, and
questionnaire data obtained as part of a prospective longitudinal study (N = 2427)
designed to explore the incidence, prevalence, and risk factors associated with mental
disorders. Subjects were recruited from a community sample in Munich Germany; racial
descriptions of the sample were not provided. Data were collected from adult
participants and their children at entry and then four years later. Most participants were
mothers (n = 1026) although some participants were fathers (n = 27) if the mother was
not available. Diagnoses of depression, anxiety, and substance use disorders were made
based on DSM-IV guidelines. Results indicated that major depression in a parent, either
the mother or the father, increased the risk for mental disorders in their male and female
children. Children’s diagnoses revealed that children born to two parents with depression
were at no greater risk for developing mental disorders than children born to one parent
with depression. However, onset of symptoms differed in children with one or both
affected parents, with earlier onset of depression noted in children with two affected
parents. Severity of depression among children (defined as the number of depressive
episodes and level of treatment seeking) was greater if a parent had a history of
depression. A limitation of the study was the assessment of only one parent. Interviews
were used to gather additional information regarding the nonparticipating parent and
most of the parents assessed were mothers. These aspects of methodology may have
compromised the results, as comprehensive assessments of both parents might yield
greater insights regarding the influence of this risk factor for mood disorders.
Much of the published literature regarding family history for mood disorders
focuses on parental histories or two specific generations of family members (Downey &
Coyne, 1990; Kosten et al., 1992; Lieb et al., 2002; Weissman et al., 1984; Williamson et
al., 2004; Zimmerman & Chelminski, 2003) however, multigenerational studies are now
being conducted to further examine the strength of familial history as a risk factor. A
three generation longitudinal study was conducted by Weissman and colleagues
(Weissman et al., 2005). The twenty year study included a sample (N = 161) of
grandchildren, their parents and grandparents. The third generation of the original cohort
study was the focus of this study. The original cohort study reported a total sample of 73
adolescents with MDD and 37 adolescents without MDD. The majority of the sample
was Caucasian (58.9% in sample with MDD; 59.4% without MDD). African Americans
represented 9.6% of the sample with MDD and 21.6% of the sample without MDD.
Clinicians blinded to family history data collected information from participants,
specifically lifetime history of diagnosis of a psychiatric disorder. This method of data
collection allowed a less biased approach to data collection. . High rates of psychiatric
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disorders were noted in the grandchildren with a two generation history of major
depression. Subjects with depressed grandparents also had increased risk of anxiety
(relative risk, 5.17; 95% confidence interval, 1.4-18.7; p = .01). Subjects with depressed
parents had an increased risk of any psychiatric disorder (relative risk, 5.52; 95%
confidence interval, 2.0-15.4; p = .002). Severity of impairment was measured with
multiple instruments, diagnostic interviews, and presence of divorce in the first and
second generations. Results indicated that the more impaired the depressed parent, the
higher the rate of mood disorders in the grandchildren (relative risk, 2.44; 95%
confidence interval, 1.1-5.5; p = .03). Results also indicated an association between
parental MDD and child diagnosis of MDD, which varied based upon the presence of
grandparental MDD status. Grandchildren whose parents and grandparents illustrated
moderately to severely impairing depression exhibited the highest rates of
psychopathology, indicating the need for multi-generational historical information.
Family psychiatric history has been shown to play an important part in adolescent
psychiatric assessment, furthering the notion that markers or vulnerabilities may be
present early in the developmental process. King and colleagues (King et al., 2006)
investigated the family psychiatric histories of a group of adolescents (N = 71) that were
being treated for MDD. Adolescents and their parents completed interviews and
questionnaires to assess the presence or absence of severe behavioral disinhibition. The
adolescents with increased behavioral disinhibition had a higher prevalence of drug use
disorders in their biological fathers, higher proportion of paternal second degree relatives
with alcohol use disorders, drug use disorders, and (King et al., 2006) psychiatric
hospitalizations. The adolescents with increased behavioral disinhibition also had a
higher prevalence of maternal second degree relatives with antisocial personality
disorder. Results from this study, as well as other psychiatric studies in children and
adolescents, encourage early screening and assessment of children with inherited
vulnerabilities for mood disorders. The current study examines the impact of inherited
vulnerabilities on depressive and anxiety symptoms.
Prevalence of family history of depression was examined in an exclusively female
community sample by Sullivan and colleagues (Sullivan et al., 1996). The authors
hypothesized that a family history of depression increased the likelihood that a person
would seek treatment for mental health evaluation; therefore they examined the
prevalence of depression within a community sample.
Family history of depression was assessed in three groups of women: (1) 54
women randomly selected from the community with depression in the prior year, (2) 41
women who entered a clinical trial for depression, and (3) 37 randomly selected women
from the community who had no history of depression in the prior year. Presence or
absence of depression in the parents and siblings of the women with depression was
assessed by the family history method. Depressed women had higher family history
scores of depression than other two groups (p < 0.00005 for both groups). As with many
family history studies, direct interviews with relatives were not completed. Therefore the
impact of differential reporting may have affected the study results.
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Although much of the family history literature focuses on genetic vulnerabilities,
research suggests that the impact of familial mental disorders can be explained through
both genetic and environmental factors (Beardslee, Versage, & Gladstone, 1998; Rutter,
Silberg, O'Connor, & Simonoff, 1999a, 1999b). The family history component of mental
disorders suggests a familial transmission of depression, with a possible category of
“familial subtype” of depression (Weissman, Warner, Wickamaratne, Moreau, & Olfson,
1997). However, both genetic and environmental factors influence depressive symptoms
in both children and their parents, and investigators have recently incorporated this
knowledge into their design (Sagrestano, Paikoff, Holmbeck, & Fendrich, 2003).
Sagrestano and colleagues (Sagrestano et al., 2003) conducted a longitudinal
study of child and parent depression in an inner city, urban, low-income population (N =
302). All children were African American adolescents, aged 9-15. Two time points
illustrated 7.3% of the parents and 3% of the children had depressive symptoms at the
first collection, with 5.4% of the parents and 2.8% of the children were clinically
depressed. Regression analysis revealed increases in conflict and decreases in parental
monitoring were associated with higher depressive symptomatology in the children.
Increases in conflict and decreases of positive parenting resulted in higher depressive
symptomatology in the adults. The longitudinal design was a strength of this study. The
current study was cross-sectional in nature, capturing data from participants at one timepoint, rather than multiple assessments over time.
No direct cause of mood disorders can be identified, although published literature
suggests that both genetic and environmental factors contribute to mood disorders.
Researchers note the importance of obtaining accurate histories regarding mood
disorders, especially parental diagnoses, as well as information related to family
interaction patterns, an environmental aspect of family history (Shiner & Marmorstein,
1998). The varying degrees of severity, co-morbidity occurrences, recurrence rates,
environmental factors, and treatment modalities make causal inferences difficult.
Therefore, additional research, particularly longitudinal multi-generational research
studies are needed. Environmental factors, such as family history of alcohol and/or drug
use, have also been examined in psychiatric literature, and will be discussed in the next
section.
Family History of Alcohol and/or Drug Use
Much of the previous literature regarding family history of alcohol and/or drug
use and has focused on the relationship between family history of alcohol and/or drug use
and the presence of individual mood disorders (Beardslee et al., 1998; Dixit & Crum,
2000; Maier, Lichtermann, & Minges, 1994; Todd, Geller, Neuman, Fox, & Hickok,
1996). Alcohol abuse disorder is considered a mood disorder; familial transmission of
alcohol dependence has been demonstrated (Reich, Cloninger, Van Eerdwegh, Rice, &
Mullaney, 1988; Reinherz, Paradis, Giaconia, Stashwick, & Fitzmaurice, 2003). When
compared to rates of alcoholism in the general population, increased rates of alcoholism
are present in persons with a family history of alcoholism. The following epidemiologic
study illustrates this finding.
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Rice and colleagues (Rice et al., 2003) examined the relative risk of alcohol
dependence in parents and siblings of alcohol dependent subjects (N = 4099) in
comparison with control subjects and their families (n = 1054). Survival analysis, using
Kaplan-Meier and Cox proportional hazards model, were calculated based on the age at
the onset of alcohol dependence. DSM-III-R criteria were used as the definition of
alcohol dependence. Men had higher rates than women; relatives of alcoholics had higher
rates than controls. Blacks (non-Hispanic) had lower relative risks than whites. Lower
levels of education had higher relative risks (RR, 2.83; p < 0.0001) rates than higher
levels of education. Interestingly, a father’s alcohol dependence was a significant
predictor (p < 0.0001) of alcohol dependence, whereas, a mother’s alcohol dependence
was not (p = 0.3). These results indicate that not only should family history of substance
use be assessed, but what specific relatives and what ages the dependence began are also
important aspects of a thorough history.
Much of the published literature regarding the relationship between family history
of alcohol and/or drug use and mood disorders has shown a positive relationship (Dixit &
Crum, 2000; Winokur & Coryell, 1991). In a sample of 1383 women in Baltimore,
women with family histories of alcohol and/or drug use were more likely to be depressed,
and more likely to report a lifetime history of another psychiatric disorder (Dixit & Crum,
2000). Higher rates of family history of alcohol and/or drug use were seen in depressed
women, but not in depressed men (Winokur & Coryell, 1991). Child or adolescent onset
of depression (MDD) has led investigators to examine risk factors for depression, and
familial history of both alcoholism and mood disorders remain strong correlates. Todd
and colleagues examined prevalence rates of alcoholism in relatives of children with
depression and bipolar disorder (Todd et al., 1996). The impact of family history of
alcohol and/or drug use is evident early; 39 of the 48 children or adolescents (81.25%)
with depression also had histories of alcoholism in either first or second degree relatives
(Todd et al., 1996). Rates were higher among children with bipolar disorder (41 of 47 or
87.23%) Although the prevalence rates of alcoholism have been high in samples of
depressed persons across many ages, these statistics do not imply causation, as research
objectives and methodology vary across studies.
Inherited vulnerabilities have been associated with mood disorders for decades
(Dixit & Crum, 2000; Downey & Coyne, 1990; Lieb et al., 2002; Maier et al., 1994;
Todd et al., 1996; Weissman et al., 1984; Williamson et al., 2004). Family history of
mood disorders and family history of alcohol and/or drug use have been the most
common genetic vulnerabilities for mood disorders. Although much of the published
literature focuses on the relationship between family history and depression, associations
have also been illustrated with other mood disorders, including bipolar disorder and
schizophrenia. The current study examined family history of both mood disorders and
alcohol and/or drug use in this population of African American women who were HIVpositive. Individuals are unique and have multi-faceted backgrounds, which provide
justification for the comprehensive assessment of risk factors for mood disorders,
including both inherited and acquired vulnerabilities. The acquired vulnerabilities for
mood disorders will be discussed in the next section.
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ACQUIRED VULNERABILITIES FOR MOOD DISORDERS
The etiology of mood disorders has been viewed as both inherited and acquired.
The ways of conceptualizing vulnerabilities to mood disorders are many and vary across
the literature. The relationship between some acquired vulnerabilities such as alcohol
and/or drug use, and mood disorders have been investigated for decades (Hesselbrock,
Meyer, & Keener, 1985; Holahan et al., 2003; Schutte et al., 1995) while others, such as
sleep quality are more recent explorations (Kripke et al., 2004; Lee, Portillo, &
Miramontes, 2001). The current study focuses on five acquired vulnerabilities: alcohol
and/or drug use, socioeconomic level, educational level, disclosure of HIV status, and
history of sexual abuse or assault. These individual acquired vulnerabilities will be
discussed in the next sections.
Alcohol and/or Drug Use and Mood Disorders
Studies examining the relationship between alcohol and/or drug use and mood
disorders were fairly consistent. Previous research indicates that alcohol and drug use has
been positively correlated with mood disorders Merikangas and colleagues (Merikangas
et al., 1998) report that alcohol and drug use is often related to emotional trauma,
psychological stress, and other mental health problems, with the substance being used as
self medication in order to relieve emotional pain. Results of a large epidemiologic study
(The Epidemiologic Catchment Area Study) indicated that approximately 30% of alcohol
and/or drug users in the United States had a psychiatric disorder (Regier et al., 1990).
Many studies have described the relationship between alcohol use and mood
disorders (Dixit & Crum, 2000; Holahan et al., 2003; Schutte et al., 1995). Differentiation
by gender is noted in patterns of alcohol use and rates of depression, with women
reporting heavier alcohol usage than men (Dixit & Crum, 2000; Holahan et al., 2003;
Schutte et al., 1995) and minorities, especially African Americans and Hispanics,
reporting higher rates of alcohol use than White Americans. Literature reveals disparities
in mental health care, particularly among African Americans and Hispanic Americans,
when compared to White Americans (K. Wells et al., 2001). Lack of mental health and
drug treatment services, decreased access to mental health care, and evaluation of quality
of mental health care all issues that need to be addressed in order to alleviate racial and
ethnic disparities (K. Wells et al., 2001).
A review of the literature reveals equivocal results regarding the timing of
depressive symptoms and the onset of heavy drinking. Helzer and Pryzbeck (Helzer &
Pryzbeck, 1988) report depression preceding alcoholism in women; but alcoholism
preceding depression in men. Similar findings were reported in a group of alcoholic
women by Hesselbrock and colleagues (Hesselbrock et al., 1985), with depression
preceding alcoholism. Contrasting results were reported by Wilsnack and colleagues
(Wilsnack, Klassen, & Wilsnack, 1986), with depression preceding heavy alcohol
consumption in women. Plausible explanations for these different findings could be
related to the cycle of self-medicating depressive symptoms, which may lead to
depression related to heavy alcohol consumption (Dixit & Crum, 2000). Literature also
36

reveals that alcohol abuse has also been identified as a risk factor for suicide (G. Murphy,
2000). Higher rates of attempted and completed suicides have been noted in alcohol
abusers than non-alcohol abusers (D. Lester, 2000).
HIV literature reflects high prevalence rates of depressive symptoms in
intravenous drug users with HIV (Turrina et al., 2001). The sample included two groups
of intravenous drug users, one HIV-positive, and the other HIV-negative. A group of
HIV-positive persons were recruited from an outpatient infectious disease clinic in Italy.
HIV negative persons were recruited from an outpatient methadone clinic. Major
depressive disorder was diagnosed using DSM-IIIR criteria. Depressive symptom levels
were higher in the group of HIV-positive persons (36.2%) when compared to their HIVnegative counterparts (15.7%). Specifically, 36.2% of the HIV-positive sample had a
diagnosis of major depressive disorder, compared to 15.7% in the HIV-negative group.
Similar findings were found for dysthymic disorder (7.1% and 3.9%, respectively).
Alcohol and/or drug use is one of many acquired vulnerabilities associated with
mood disorders. Socioeconomic status is another acquired vulnerability linked to mood
disorders, and will be discussed in the next section.
Socioeconomic Status
Most of the studies published over the past several decades that have investigated
income level and mood disorders have used varied measures of symptoms and diagnostic
criteria for mood disorders. Although many different symptoms and diagnoses have been
explored, depressive symptoms have been the most frequently examined mood disorder.
Socioeconomic status (SES) has been defined by several indicators, including income,
occupation, and education (Daly, Duncan, McDonough, & Williams, 2002). The
collection of information regarding SES provides information about an individual’s
access to social and economic resources (Daly et al., 2002). Researchers have found
ambiguous findings related to SES and depressive symptoms. For women, education is
the strongest of the SES predictors of depression (R. C. Kessler, 1982). For men, family
income is more important (R. C. Kessler, 1982). Of the three SES measures, education
and income are more important than occupational status for predicting distress (R. C.
Kessler, 1982). The current study defined socioeconomic status as annual household
income. Educational level and employment information were also captured on the
Demographic Data Instrument.
Populations of economically disadvantaged persons have higher rates of mood
disorders than their more affluent counterparts (B. P. Dohrenwend et al., 1992; Olfson et
al., 2000; Reiger, Farmer, & Rae, 1993). Inverse relationships between depressive
symptoms and income levels have been documented consistently in the literature, with
lower levels of income being associated with higher levels of depression (B. P.
Dohrenwend et al., 1992; Link, Lennon, & Dohrenwend, 1993)
Anxiety symptoms display a similar pattern (Mirowsky & Ross, 1989) with
inverse relationships illustrated in the literature. Individuals with higher income levels,
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tend to have lower levels of anxiety symptoms and distress (C. E. Ross & Mirowsky,
1989). Persons with lower incomes are less likely to seek mental health treatment and
often lack resources to access specialized mental health care, instead seeking mental
health treatment from their primary care provider
Poverty among HIV-positive women has been demonstrated (Bunting, Bevier, &
Baker, 1999; Hudson, Kirksey, & Holzemer, 2004). Literature suggests that poverty
makes women at risk for a multitude of problems, including poor access to health care.
Poverty in HIV-positive women has been associated with worrying about daily survival,
fears of domestic violence, poor self-esteem, and lack of health insurance, which leads to
difficulty accessing health care. Poverty and lack of insurance has been described as one
of the strongest factors related to the health care disparities among African Americans
(Mayberry, Mili, & Ofili, 2000). Previous studies have found that patients who are
women, members of racial and ethnic minorities, poorer, less educated, or uninsured are
less likely to receive needed care, due to lack of access to care (Ayanian, 1994; Kahn et
al., 1994; Smedley, 2006). Educational level will be discussed in the next section as
another acquired vulnerability for mood disorders.
Educational Level and Mood Disorders
Most of the literature published regarding educational level and mood disorders
has been consistent over time (Morrison et al., 2002; Wang et al., 2005). The interwoven
relationship between educational level and income is demonstrated in one’s access and
use of mental health services. Higher levels of education have been associated with
higher levels of income. Consequently, higher levels of income offer financial resources
to pay for mental health services. Persons with high levels of income are more likely to
have health insurance. Educated consumers are more likely to access mental health
services (Wang et al., 2005) and may be have greater knowledge regarding
pharmaceutical treatment of mood disorders (K. B. Wells, Stewart et al., 1989).
Morrison and colleagues (Morrison et al., 2002) illustrated the relationship
between educational levels and depressive symptoms in a sample of women (N = 155).
Depressive symptoms were measured in both HIV-positive (n = 93; 55.9% African
American) and HIV-negative (n = 62; 53.2% African American) women with the
Hamilton Depression Scale (M. Hamilton, 1967). Higher depressive symptom scores
were associated with less education in both groups of women, and these differences were
statistically significant (t = 2.1, df 152, p = 0.04; beta = -0.6, 95% CI= - 1.2 to -0.02).
Although educational level is an acquired vulnerability that has not been extensively
studied in HIV-positive women, the process of disclosure of one’s HIV status is a
concept that has been vastly explored in the HIV literature, and will be discussed in the
next section.
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Disclosure of HIV Status
Disclosure of one’s HIV status is a complex process, unique to that individual.
Therefore, disclosure is not an isolated event, but rather a series of events or processes
that are associated with both positive and negative outcomes (Kalichman, DiMarco,
Austin, Luke, & DiFonzo, 2003; Vanable, Carey, Blair, & Littlewood, 2006; Zea, Reisen,
Poppen, Bianchi, & Echeverry, 2005). Often, the very process of disclosure itself leads to
negative consequences such as isolation, abandonment, and abuse (Lovejoy, 1990). For
many women, disclosing one’s HIV status may lead to negative consequences that impact
not only the patient, but also their children (Schmidt & Goggin, 2002).
Negative consequences of HIV disclosure, including increased depressive and
anxiety symptoms have been illustrated in the literature. Unsupportive social and family
interactions have been associated with elevated depressive symptoms in populations of
HIV-positive women (Schrimshaw, 2003). Moreover, the idea of voluntarily disclosing
one’s HIV status, creating a situation that may lead to negative circumstances, is a
daunting one. Women often rely on their partners for environmental safety and security,
and fear that disclosure may lead to abandonment and rejection (Holt et al., 1998;
Metcalfe, Langstaff, Evans, Paterson, & Reid, 1998). Disclosure of HIV status for
women has additional consequences that affect not only their intimate relationships, but
also the safety and security of their children.
HIV literature illustrates the impact of stigma on HIV disclosure. Shame and
stigma associated with HIV often prevents patients from disclosing their serostatus to
friends, family members, and sexual partners (Jenkins & Coons, 1996 ; Moneyham et al.,
1996a, 1996b). Disclosure of one’s HIV status is a complex process, with the stigma of
the disease impacting both the reluctance to disclose and the aftermath of the disclosure
(Vanable et al., 2006). Although stigmatization associated with HIV has decreased since
the early years of the epidemic (Herek, Capitanio, & Widaman, 2002), HIV continues to
be surrounded in fear and stigma. Herek and colleagues (Herek et al., 2002) conducted a
nationwide survey exploring stigma related to HIV and reported that one in five
participants reported “fearing” someone with AIDS, while one in six admitted to having
feelings of “disgust” about persons with AIDS. Therefore, the stigma of HIV has
blanketed the disclosure process in fear and discrimination. Disclosure removes the veil
of secrecy. The idea of taking medication in secrecy often leads to decreased medication
adherence, increased denial of the disease, and further perpetuates the stigma and shame
that is associated with HIV. HIV-related stigma has been associated with an increase in
HIV-related symptoms, depressive symptoms, and receipt of recent psychiatric care
(Vanable et al., 2006).
Although some published studies in the HIV literature reveal negative outcomes
of HIV disclosure (Lovejoy, 1990; Vanable et al., 2006) most of the literature regarding
the impact of disclosure on depressive and anxiety symptoms is positive (Schmidt &
Goggin, 2002; Zea et al., 2005). Disclosure is essential to obtaining social support
(Moneyham et al., 1996a). HIV-positive women that disclose their status to a partner or
close friend demonstrated lower levels of emotional distress (D. K. Smith et al., 1996).
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Schmidt and Goggin (Schmidt & Goggin, 2002) found that through positive
disclosure experiences, some HIV-positive women gain an increased perception of social
support, resulting in fewer reported depressive symptoms. However, these researchers
also noted that HIV-positive single mothers reported less satisfaction from the disclosure
process, lower levels of perceived social support, and higher levels of depressive
symptoms. The emotional support that is provided as a side effect of the disclosure is
often the deciding factor in multiple daily activities which directly affect the lives of
those infected with HIV, such as adherence with complex medication regimens and
frequent medical appointments.
In a study of HIV-positive Latino gay and bisexual men (N=301), participants
were recruited from HIV clinics, hospitals, and community agencies in three metropolitan
cities in the United States (Zea et al., 2005). Men that disclosed their HIV status had
lower levels of depression and greater levels of self-esteem than those men that did not
disclose their HIV status. Quality of social support was associated with disclosure
patterns. Disclosure was highest among closest friends (85%), followed by primary male
partner (78%), followed by parents (37% to mother, 23% to father). Results indicate that
Latino men were selective with whom they disclosed their HIV status, but experienced
positive benefits in psychological well-being in the process. Despite the vast differences
in sample demographics, this study informs the current study as both Latino men and
African American women are minority populations and the groups shared the
stigmatizing diagnosis of HIV.
Stein and colleagues (Stein et al., 1998) examined the disclosure patterns of HIVpositive persons (N=203) to their sexual partners. Participants were recruited from two
outpatient urban hospital clinics, where persons HIV-positive persons sought healthcare.
The sample consisted of Black Americans (46%), Latino (23%), and White Americans
(27%). The majority of the sample was male (69%), which reflects the transmission
patterns and epidemiological history of HIV in the United States. The sample reported
varying risks for HIV transmission, with sexual transmission being the primary risk
factor (59%). Twenty percent of the sample identified themselves as bisexual or
homosexual males and 39% of the sample identified as heterosexual. Injection drug use
was reported in 41% of the sample. Of the 203 persons that were interviewed, 129
reported sexual activity within the past 6 months. The majority (60%) of the sample had
disclosed their HIV status to all of their sexual partners. In the persons that had not
disclosed their HIV status to their sex partner, half of them reported only one sex partner
in their lifetime. Failure to consistently use condoms during sexual activity was reported
in the majority of the sample (57%) of nondisclosures. Multiple regression analysis
revealed that persons with high levels of spousal support were 2.8 times more likely to
disclose their HIV status to their partners than persons without high levels of support.
Disclosure was 3.1 times more likely to occur in the white and Latino participants than
the black participants.
HIV literature reveals that disclosure of HIV status may also have an impact on
immune status. A study of 373 HIV-positive patients that were being treated in an
outpatient psychiatric setting participated in a study that investigated the relationship

40

between disclosure of HIV stats and disclosure of sexual orientation and their immune
function. Patients that had disclosed their HIV status showed increased CD4 counts over
time. Patients that had always been open about their sexual orientation also showed
immunologic benefit of disclosure (Boggs, 2007).
Although disclosure of HIV status is a major aspect of living with HIV, research
studies within the HIV literature regarding the disclosure process and ramifications of
HIV disclosure vary widely. Dissimilar findings across studies were most likely due to
differences in ways that disclosure was assessed (time from diagnosis, timing of
disclosure, and hierarchy of order of persons disclosed to). Literature illustrates that
stigma continues to retard the disclosure process. Moreover, failure to disclose HIV status
can have devastating effects on public health. The most effective means of HIV
prevention among sexually active persons is consistent condom use (Branson et al.,
2006). Niccolai, Dorst, Myers, and Kissinger (Niccolai, Dorst, Myers, & Kissinger,
1999) reported that lack of condom use among HIV-positive persons was prevalent in
those that did not disclose their HIV status to their partner. Disclosure patterns are vital
pieces of information with potential psychological ramifications, and should therefore be
tracked and studied in the future.
Sleep Quality and Mood Disorders
Evidence continues to accumulate supporting the association between sleep
disturbances and poor sleep quality with mood disorders. Research studies have shown
that 10% to 40% of adults have intermittent insomnia, while 15% of all adults report
long-term sleep difficulties (Ringdahl, Pereira, & Delzell, 2004). Sleep quality has also
been described as sleep efficiency, which is the ratio of total sleep time to time in bed or
the proportion of sleep during the time period generally filled by sleep (Buysse,
Reynolds, Monk, Berman, & Kupfer, 1989).
Consequences of poor sleep quality can be complex. Although traditionally given
less attention in prior research studies, estimation of sleep quality has become an
important aspect of comprehensive medical assessments. Research supports that fact that
people tend to overestimate their duration of sleep with subjective sleep assessments,
therefore studies with both subjective and objective sleep measurements are needed to
garner more precise data (Kripke et al., 2004). Poor sleep quality is a common complaint
among patients with alcohol use disorders (Dahl et al., 2003) and persons with mood
disorders (Kripke et al., 2004; Lee et al., 2001).
In a study of ethnicity and sleep, illumination, and mood disorders, Kripke and
colleagues (Kripke et al., 2004) measured sleep with both objective and subjective
means. The authors examined ethnic differences in sleep and depression in a sample (N =
459) of European American (72.2%) and Hispanic (13.7%), African American (9.4%),
Asian–pacific American (4.0%) and Native American (0.7%) postmenopausal women. In
this population of women, Hispanic and African American slept less than less than
European American women.
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Lee and Miramontes (Lee et al., 2001) examined the relationship between sleep,
depression, and fatigue in a group of HIV-positive women (N=100). Subjective
measurements of depressive symptoms and fatigue were captured by self report
questionnaires. Objective measurements of total sleep time, numbers of awakenings from
sleep, daytime activity, and sleep efficiency were captured using motion sensor bracelets
(wrist actigraphy). Consecutive activity was recorded for a continuous 48 hour time
period. Lower depressive symptoms were noted in women with higher sleep efficiency.
Sleep disturbances are of particular concern in the HIV population. Adverse
effects of poor sleep quality on immunity has been reported in healthy individuals and
individuals who are HIV-positive (Cruess et al., 2005). Researchers have found high
levels of sleep disturbances among the HIV-positive population (Lee et al., 2001; Mock
et al., 2002; Rubinstein & Selwyn, 1998). Insomnia is often one of the first symptoms
reported in persons newly diagnosed with HIV (Mock et al., 2002). Prevalence rates of
poor sleep quality vary across studies. Rubinstein and Selwyn (Rubinstein & Selwyn,
1998) reported that 73% of their sample of HIV-positive persons reported sleep
disturbances. Phillips and colleagues (Phillips et al., 2005) reported a 100% prevalence
rate of sleep disturbances as measured by the PSQI in their sample (N = 107) of HIVpositive men (n = 70) and HIV-positive women (n = 35). Mean PSQI score levels in this
sample were 12.3 ± 3.8 were well above the cut-off score of 5 for poor sleep quality on
the PSQI. African Americans were well represented in this study (n = 71, 82.6%), and
other demographic variables such as income and educational level were similar to those
in the current study.
Similar results were noted in Mock and colleagues’ 2002 (Mock et al., 2002)
study which included a sample of exclusively African American HIV-positive women (N
= 174). Demographic characteristics of the sample were similar to the current study,
especially marital status (52.3% of the sample was single) and income (54.9% o ft the
sample had annual household income levels less than 10,000. This sample of African
American women was at varying disease stages, and results were differentiated based on
stage and severity of illness. Depressive symptoms were measured with the CES-D I
(which eliminates somatic complaints) and sleep dysfunction was measured with the
PSQI. Results illustrated a high rate of fatigue (45.8%), depressive symptoms indicative
of clinical depression (59%), and sleep dysfunction (59%). The authors noted that sleep
disturbances often present before the diagnosis of HIV and become worse as severity of
illness develops.
Sexual Assault and Mood Disorders
History of sexual assault has been associated with depression and anxiety
disorders (Barbe et al., 2004; Barker-Collo & Read, 2003; M. Conway et al., 2004; Lee et
al., 2001; Mock et al., 2002; Peleikis, Mykletun, & Dahl, 2004; Rubinstein & Selwyn,
1998; Walrath et al., 2003). The long term effect that sexual abuse or assault has on an
individual varies. Dickinson and colleagues (Dickinson, deGruy, Dickinson, & Candib,
1998) describe a spectrum of resulting mood disorders, ranging from mild to complex
symptoms. Dickinson enrolled 99 women in a study to evaluate the existence of complex
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post traumatic stress syndrome in women that report a history of sexual abuse. Results
illustrated that varying degrees of symptoms were found in this group of women. The
most severely abused subjects were characterized by symptom patterns similar to those of
a complex post-traumatic stress syndrome. The type and duration of abuse often has a lot
to do with long term consequences.
The prevalence of childhood sexual abuse has been documented to be between
15-30% in adult women and between 25-77% in adult women with diagnoses of mental
illness (Lundqvist, Hansson, & Svedin, 2004). In studies focused on the impact of sexual
abuse or assault, associations with mood disorders have been reported (Barbe et al., 2004;
Barker-Collo & Read, 2003; M. Conway et al., 2004; Lee et al., 2001; Mock et al., 2002;
Peleikis et al., 2004; Rubinstein & Selwyn, 1998; Walrath et al., 2003).
Barbe and colleagues (Barbe et al., 2004) examined the relationship between
history of sexual abuse and depression among 107 adolescent females. Subjects had a
diagnosis of MDD by DSM-IIIR guidelines and were between the ages of 13 and 18.
Subjects were randomly assigned to one of three treatments: (1) cognitive behavioral
therapy, (2) systemic behavioral family therapy, or (3) nondirective supportive therapy
and then followed for three and a half years. Lifetime history of sexual abuse was
captured as either present or absent. Results indicated that girls with a lifetime history of
sexual abuse were more likely to have a psychiatric hospitalization or depressive relapse.
Cognitive behavioral therapy was the most efficacious treatment in the absence of sexual
abuse. Nondirective supportive therapy was most efficacious in the presence of sexual
abuse. These results suggest the need to screen adolescent girls for history of sexual
abuse as part of a psychosocial assessment.
Whereas most studies have focused on the emotional impact of sexual abuse,
Girdler and colleagues (Girdler et al., 2004) examined a pathophysiologic impact of
history of sexual abuse. These researchers examined the hypothalamic-pituitary-thyroid
axis hormone concentrations in a group of women (N= 50) during different phases of
their ovulatory cycles. Increased total T3 concentrations were noted in women with
histories of major depression; these increased concentrations also predicted their
premenstrual symptoms. The results indicated that women with histories of sexual abuse
had higher levels of conversion of T4 to T3 and increased binding of thyroid hormones in
women with both premenstrual dysphoric disorder and history of sexual abuse. These
results indicate that further pathophysiologic testing may be needed in women with mood
disorders.
SUMMARY OF THE REVIEW OF LITERATURE
Despite advances in research, mood disorders are often undiagnosed and
untreated in HIV-positive populations (Bing et al., 2001; M. Conway et al., 2004; Evans
et al., 1996). Although many health care providers assume that depression is a natural,
inevitable reaction to the diagnosis of HIV, patients who are HIV-positive are often under
screened for mood disorders. Diagnosis of mood disorders within the HIV-positive
population is complex, due to the overlapping somatic symptoms associated with
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HAART and signs and symptoms of specific HIV-related disorders (Norman et al., 1992;
Perkins et al., 1994). The prevalence of mood disorders in the HIV population is higher
than that of the general population. HIV has become a treatable chronic condition.
Longitudinal studies are needed to identify varying levels of depressive and anxiety symptoms
over time, examine underlying vulnerabilities to mood disorders in this population, as well as

to examine optimal treatment therapies over time.
HIV-positive women are part of a unique population with additional risks for
mood disorders. The majority of the responsibility of family caregiving falls on women,
adding additional stressors (Hooyman & Gonyea, 1999). HIV-positive women with
children are more likely than men to suffer from chronic sorrow related to their illness,
fear of death, poverty, and social isolation (Morrison et al., 2002). Although it is
impossible to accurately predict with certainty those that will develop depressive or
anxiety symptoms, the assessment of underlying vulnerabilities may aid the screening
process. Many cross-sectional studies have investigated levels of depressive and anxiety
symptoms at specific points of time, yet these studies do not account for the variety of
symptoms that may occur at different points in time in the trajectory of HIV-infection.
Most of the cross-sectional and longitudinal studies in the HIV literature support the
positive association between HIV and anxiety and depressive symptoms. Although
published studies examined predictors of depressive and anxiety symptoms among HIVpositive persons, demographic characteristics of the samples including race, gender, and
sexual preference vary greatly, making generalizability to populations of African
American HIV-positive women difficult.
HIV-positive women experience increased levels of depressive and anxiety
symptoms. Therefore, the present study will address the relationships between underlying
vulnerabilities; both inherited (family history of mood disorders, family history of alcohol
and/or drug use) and acquired (educational level, income level, alcohol and/or drug use,
HIV disclosure status, sleep quality, and history of sexual abuse and/or assault) to
depressive and anxiety symptoms. Because these relationships have not been previously
described using multiple risks as predictors in this population, findings will provide
significant insights regarding the experiences of this understudied population of African
American women who are HIV-positive. Specific aspects of the current study’s
methodology are presented in the next chapter.
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CHAPTER 3. METHODOLOGY
The incidence of HIV infection continues to increase, especially among the
heterosexual population (Centers for Disease Control and Prevention, 2007c). HIV is a
virus that is commonly spread through the exposure to infected blood and bodily fluids
during sexual activity (Centers for Disease Control and Prevention, 2000, 2003). Studies
demonstrate that there is a high prevalence of depression among HIV-positive persons
(Bing et al., 2001; Ferrando et al., 1998; Rabkin, Wagner, & Rabkin, 1999) as well as comorbid anxiety (Ciesla & Roberts, 2001). Additionally, HIV-positive women are at an
even greater risk for depression and anxiety (Bing et al., 2001; Ciesla & Roberts, 2001;
Moore et al., 1999). It is important that risk factors for depression and anxiety, both
inherited and acquired, be identified. Early identification and treatment of depression and
anxiety can have a direct impact on quality of life and treatment adherence in HIVpositive persons (Moore et al., 1999; Valente, 2003). The purposes of the study are
fourfold: (1) to describe the level of depressive and anxiety symptoms in African
American women who were HIV-positive; (2) to describe the underlying vulnerabilities,
both inherited and acquired, for depressive and anxiety symptoms in African American
women who were HIV-positive; (3) to identify which vulnerabilities serve as predictors
of depressive and anxiety symptoms among African American HIV-positive women; and
(4) to describe the differences in levels of depressive and anxiety symptoms among
African American HIV-positive pregnant and African American women. This chapter
explains the processes utilized to answer the research questions of this study. This chapter
explicates the research design, setting and sample, recruitment, inclusion and exclusion
criteria, sample size, instruments, procedures, consideration of human subjects, and data
analysis.
RESEARCH DESIGN
A non-experimental, descriptive, correlation design was employed to obtain
information on potential predictors of depressive and anxiety symptoms among African
American HIV-positive women. This descriptive correlation design was used to
accomplish the following objectives: 1) to describe the levels of anxiety and depressive
symptoms among African American women who were HIV-positive, 2) to identify the
inherited and acquired vulnerabilities that predict depressive and anxiety symptoms
among African American women who were HIV-positive, 3) to quantify the inherited
and acquired vulnerabilities that predict depressive and anxiety symptoms among African
American women who were HIV-positive, 4) to determine the predictors of anxiety and
depression symptoms among African American women who were HIV-positive, 5) to
determine the differences in levels of depressive and anxiety symptoms among African
American HIV-positive pregnant and African American HIV-positive non-pregnant
women, 6) to determine the relationship between predictors of depressive and anxiety
symptoms among African American HIV-positive pregnant and African American HIVpositive non-pregnant women, and 7) to determine the differences in levels of depressive
and anxiety symptoms among African American HIV-positive pregnant and African
American HIV-positive non-pregnant women.
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The study was cross-sectional as the variables were measured at a single point in
time. All instruments that measured depressive and anxiety symptoms have established
reliability and validity. According to Polit and Hungler (Polit & Hungler, 1995),
descriptive research is used to observe, describe, and document specific phenomena
rather than explaining the phenomena. Correlation research examines relationships
between variables (Polit & Hungler, 1995).
In a review of pertinent literature, the incidence of depression among HIVpositive persons has been well documented, however, information regarding the triggers,
or predictors of depression have not been fully explored. There was also a lack of
information regarding anxiety among HIV-positive persons, although anxiety is often
accompanied by a concomitant diagnosis of depression (Hirschfeld, 2001; J. M. Murphy
et al., 2004). Therefore, the underlying predictors of both depressive and anxiety
symptoms were addressed in this study.
SETTING AND SAMPLE
The setting was an outpatient university obstetrical and gynecological clinic and
an outpatient adult infectious disease clinic that specializes in HIV. Both ambulatory
clinics were located in the mid-south. Outpatient infectious disease clinics, the local
county health department, and other obstetrical and gynecological clinics in the midsouth area often refer their HIV-positive, female clients to the outpatient university clinic
for obstetrical and gynecological health care. Likewise, primary care providers, the local
county health department, and other obstetrical and gynecological clinics in the midsouth area also refer their HIV-positive, female clients to the outpatient adult infectious
disease clinic.
In the obstetrical clinic, a designated physician and nurse practitioner who had
extensive infectious disease and HIV treatment and management experience, provided
health care for this population of HIV-positive women. Although the clinic was open
each weekday, HIV-positive women were seen on two designated days each week.
Transportation and childcare were available to all HIV-positive women attending the
study obstetrics and gynecology clinic through community support agencies.
The adult infectious disease clinic employed seven physicians and two nurse
practitioners who had extensive infectious disease and HIV treatment and management
experience and who provided health care for this population of HIV-positive patients.
The clinic was open each weekday; HIV-positive men and women were seen Tuesday
through Friday. Mondays were reserved for new HIV-positive patients. Transportation
and childcare were available to all HIV-positive women attending the study clinics
through community support agencies.
The study employed a non-probability convenience sample drawn from African
American women, who were HIV positive, and were patients either in the outpatient
obstetrics and gynecology or the university outpatient infectious disease clinic in an
urban southeastern city. All women who met the inclusion criteria were potential
46

participants. The target population was African American HIV-positive women in the
mid-south, which was reflective of the HIV-infected population in the area, as well as in
the university’s clinic populations. This population was chosen because African
American women are underrepresented in published studies examining depressive and
anxiety symptoms in the HIV-positive population.
The obstetrics and gynecology clinic saw approximately 5000 women per month.
HIV-positive women represented approximately 3% of the clinic population.
Approximately 60% of the HIV-positive pregnant women seen in the practice were newly
diagnosed, while approximately 40% were women who knew of their HIV status and had
become pregnant. HIV-positive non-pregnant women receiving gynecological
consultation accounted for 10% of the HIV-positive women receiving care at the
university obstetrics and gynecology clinic. The infectious disease clinic exclusively saw
patients who were HIV-positive. The infectious disease clinic saw approximately 350
patients per month. Forty percent of the clinic population was women; 75% of the
population was African American. All African American HIV-positive women who
received medical care at the designated clinics between September 1, 2006 and February
28, 2007 were approached for study participation. Of the 90 who were approached, 80
gave consent and completed the study.
RECRUITMENT
The clinic nurse, nurse practitioner, social worker, or physician informed the
women who met study inclusion criteria about the study during their routine obstetrical or
infectious disease medical appointments. The researcher developed an implementation
plan that she discussed with clinic staff, and ensured that standardized recruitment
techniques were maintained throughout enrollment. The researcher periodically verified
that all interviewers appropriately implemented the recruitment plan, which provided
consistency to the data collection process. Training regarding potential questions and
answers, as well as an interview script was provided to the interviewers by the researcher.
All interviewers participated in role play activities that simulated the interview and data
collection process to ensure that plan was implemented appropriately and consistently.
Providers gave interested women’s contact information to the researcher. Women who
expressed interest were contacted by the researcher. These contacts with potential
participants by the investigator were either via telephone or through a personal visit
during their routine clinic appointment. African American women who were HIVpositive and who agreed to participate and met the study criteria completed the informed
consent process, signed the informed consent and completed the designated paper and
pencil instruments.
Inclusion Criteria
The sample population was African American women who were HIV-positive,
and were current patients in the university outpatient obstetrics and gynecology or
infectious disease clinic. The sample was recruited from HIV-positive women who were
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being treated in the special care clinic of the university obstetric and gynecologic clinic or
the university infectious disease clinic. Criteria for inclusion into this study were as
follows: 1) female gender, 2) self-identified as African American and non-Hispanic, 3)
HIV-positive as documented by HIV-ELISA and HIV Western Blot test results
abstracted from participant health records, 4) aged 18 years or greater on last birthday, 5)
possessing ability to read and write in the English language as verified by highest
educational level completed being at least the ninth grade, and 6) receiving medical care
at the university obstetrics and gynecology or infectious disease clinic.
Exclusion Criteria
Women were excluded if they had existing co-morbid diseases that contributed to the
potential inability of participants to answer questionnaires. Therefore participants were
excluded from participating in the study if they had the following diagnoses: 1) HIV
dementia, active Cytomegalovirus, or Toxoplasmosis; 2) mental retardation; and 3) latest
CD4 cell count < 200. Presence of compromised immune status, as measured by CD4
cell count less than 200 was collected from the medical record, and was used to
determine if the participant was at risk for developing AIDS dementia, CMV, or
toxoplasmosis, which could impact mental abilities, and possibly interfere with accurate
completion of instrumentation. Exclusion criteria were determined through medical
record review.
Sample Size
The sample size necessary to adequately conduct this study was determined by a
power analysis calculated on the basis of multiple regression analysis. A sample of 80
participants was interviewed. To ensure an adequate sample size, a minimum of 80
African American HIV-positive women were recruited for this study. Due to the volume
of patients available in each clinic, a three-to-one ratio was established by the researcher
in order to obtain an adequate sample size (three non-pregnant women to every pregnant
woman). A power analysis was performed to determine the number of subjects needed to
ensure an alpha of .05 using the statistical package Power Precision. The effect size was
chosen according to Cohen's criteria (Cohen, 1987) for a moderate effect size (r = .30).
This analysis ensured adequate numbers of subjects needed to detect clinically significant
results. Using an alpha set at .05, the proposed study had power of 0.80 with eight
independent variables included in the prediction model.
INSTRUMENTS
The investigator used multiple paper and pencil instruments to address the
variables of interest contained in the research questions. All instruments were placed in
packets and were numbered for tracking purposes. A copy of each instrument is provided
in Appendices A1-A4. Instruments that were included in each packet were the following:
a researcher-developed demographic data questionnaire, Pittsburgh Sleep Quality Index
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(PSQI), Center for Epidemiological Studies Depression Scale (CES-D), Edinburgh
Postnatal Depression Scale (EPDS), and the Beck Anxiety Inventory (BAI). Since the
demographic data questionnaire was developed by the researcher and had not been used
in the clinical setting, the instrument was administered to five randomly selected African
American women who were HIV-positive. These women were then excluded from
participating in the final study, as they had prior exposure to the instrumentation. This
pilot test of the researcher-developed demographic data questionnaire was performed in
order to determine the effectiveness of instructions, clarity of questionnaire items, and
time required to complete the questionnaire. The pilot test of the researcher-developed
questionnaire allowed the researcher to revise the instrument based on results of the pilot
test.
The study instruments were selected based on a review of literature and
professional experience, and their purpose was to gather specific information needed to
investigate the variables included in the research questions. The PSQI (Buysse et al.,
1989), CES-D (Radloff, 1977), EDPS (Cox et al., 1987) and the BAI (A. T. Beck et al.,
1988) have been used in African American, female, and HIV-positive populations, and
were conceptually congruent with the study. A blank at the top of each questionnaire was
used for a code number to track respondents. Coding allowed the researcher to quantify
the numbers of participants, as well as maintain confidentiality of the participants’
identities.
Demographic Data Instrument
The researcher-developed demographic instrument (Appendix A) is a self-report
and self-administered questionnaire that was designed to collect information regarding
participant characteristics, and included: age, marital status, employment status,
socioeconomic status (evaluated by reported annual income), educational level, religion,
HIV disclosure status, reproductive history, mental health history, sexual abuse and/or
assault history, alcohol and/or drug use, length of time since HIV diagnosis, and partner
information. Family characteristics collected in the demographic data instrument included
family history of mood disorders and family history of alcohol and/or drug use. Thus,
both inherited and acquired vulnerabilities were assessed with this scale. Each item
constructed for this instrument was subjected to testing with Question Understanding
AID or QUAID (Graesser, Cai, Louwerse, & Daniel, 2006). QUAID is a software
program that assists survey designers to improve the wording, syntax, and semantics of
survey questions. The tool identifies potential problems that survey respondents might
have with understanding the meaning of survey items. Thus the software allows the
survey item developer to review problems and improve the clarity of items and enhance
reliability and validity of answers. The QUAID program picks up problems such as
unfamiliar technical terms, vague or imprecise relative terms, vague or ambiguous noun
phrases, complex syntax, and working memory overload. The demographic data
instrument was pre-tested with five African American women who were HIV-positive in
order to identify confusing questions and ensure clarification. The 40-item instrument had
an estimated completion time of five minutes.
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Sleep Quality Instrument
The Pittsburgh Sleep Quality Index (PSQI) was used to evaluate multiple
dimensions of sleep quality (See Appendix B). The PSQI (Buysse et al., 1989) is a 19item, self-report, retrospective instrument designed to collect information regarding sleep
quality and sleep disturbances over a one month period. The 19-items are grouped into
seven equally weighted component scores including: 1) Subjective Sleep Quality (one
item); 2) Sleep Latency (two items); 3) Sleep Duration (one item); 4) Habitual Sleep
Efficiency (three items); 5) Sleep Disturbances (nine items); 6) Use of Sleeping
Medication (one item); and 7) Daytime Dysfunction (two items). The PSQI has been
widely used in a variety of populations, including populations of persons with chronic
pain (Currie, Wilson, & Curran, 2002; M. T. Smith, Perlis, Smith, Giles, & Carmody,
2000), renal disease/transplant (Carpenter & Andrykowski, 1998), cancer (Carpenter &
Andrykowski, 1998), and HIV (Currie et al., 2002; Mock et al., 2002; Nokes & Kendrew,
1996; Nokes & Kendrew, 2001; Phillips et al., 2005). The PSQI has also been used in
populations of African American HIV-positive women (Mock et al., 2002).
Items one through four are participant entry of usual bed time, usual awake time,
total minutes of sleep, and total minutes of sleep latency. Items five through 18 are fourpoint Likert-type scale responses related to frequency of problems, with zero indicating
not during the past month; one indicating less than once a week; two indicating once or
twice a week; and three indicating three or more times per week. Item 19 is a four-point
Likert-type scale rating of overall sleep quality. A score of zero is very good, one is fairly
good, two is fairly bad, and three is very bad.
The cumulative score range of the PQSI is zero to 21. Scoring the PSQI takes an
estimated five minutes as scores from each item are added for a summed Global Score.
Higher Global Scores are indicative of poorer sleep quality. A cut-off score of five or
greater is indicative of poor sleep quality.
The PSQI has demonstrated reliability and validity. High internal consistency was
demonstrated by Buyesse (Buysse et al., 1989), with a Cronbach’s alpha coefficient of
0.83 for the seven component scores. Criterion validity was established in order to
differentiate “good sleepers” from “poor sleepers”. When compared to more costly and
time consuming methods of sleep quality measurement (structured clinical interviews and
polysomnographic testing), the PSQI Global score of five or greater correctly identified
88.5% of patients and controls in the original report (Buysse et al., 1989). Cronbach’s
alpha coefficient of the PQSI in the current study was 0.80. The estimated time of
completion is five to ten minutes.
Depressive Symptom Instruments
Two instruments were used to screen for depressive symptoms in the sample. This
allowed the researcher to compare the participants’ scores on two different instruments
that were designed to capture similar information. This process also added to the body of
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knowledge regarding screening instruments in the African American population. This is
imperative, as much of the published literature focuses on white populations.
The Center for Epidemiological Studies-Depression Scale (CES-D) was used in
this study to measure the levels of depressive symptoms in the participants (see Appendix
C). The CES-D (Radloff, 1977) was developed by the Center for Epidemiological Studies
to measure the level of depressive symptoms in the general population. The CES-D has
the ability to identify persons that experience depressive symptoms, but would not
necessarily meet criteria to be diagnosed as clinically depressed (Moore et al., 1999). The
CES-D is a screening instrument, and its use is not intended for the diagnosis of
depression. The scale has been used extensively in the general and chronically ill
populations (Radloff, 1977), including HIV-infected populations (Currie et al., 2002;
Hudson et al., 2004; Lyketsos et al., 1996; Moore et al., 1999; Phillips et al., 2005),
specifically HIV-positive women (Hudson et al., 2004; Ickovics et al., 2001; Mock et al.,
2002).The CES-D has been used in populations of HIV-positive African Americans
(Low-Beer et al., 2000; Mock et al., 2002; Robbins, Phillips, Dudgeon, & Hand, 2004).
The CES-D contains 20 items, and assesses sleep disturbances, energy levels,
feelings of guilt and depressed mood, and appetite loss in the respondents. The CES-D
asks the individual to recall the presence of these issues in the prior week. Each item has
a range of zero to three, with rarely or none of the time equaling zero points, and most or
all of the time equaling three points. Scoring for positive items is reversed. Adding the
sum of answers completes scoring. Possible total scores range from zero to 60, with the
higher scores indicating the higher levels of depressive symptomatology. The total score
on the CES-D can be divided into four distinct categories, with zero to 15 indicating no
depressive symptoms, 16-20 mild distress, 21-30 moderate distress, and 31-60 severe
distress (Radloff, 1977).
The CES-D is an accurate instrument, with high internal consistency and testretest reliability and can be completed in five to 10 minutes. Items for the CES-D were
selected from several instruments, including: Beck’s Depression Inventory (A. T. Beck,
Rial, & Rickels, 1974) the Minnesota Multi-phasic Personality Inventory, Raskin’s
Depression Scale (Raskin, Schulterbrandt, Reatig, & McKeon, 1969), and Zung’s Selfrating Depression Scale (Zung, 1965). Therefore, the CES-D has both construct and
content validity.
The CES-D has been found to be reliable and valid in the general population, as
well as populations of women (Fogel & Martin, 1992; Hasin, Stinson, Ogburn, & Grant,
2007; Hudson et al., 2004; Low-Beer et al., 2000; Phillips et al., 2005; Sullivan et al.,
1996), including pregnant women (Hannah et al., 1992); and populations of both chronic
and terminal diseases, including HIV (Currie et al., 2002; Hudson et al., 2004; Lyketsos
et al., 1996; Moore et al., 1999; Phillips et al., 2005). The CES-D has demonstrated
reliability and validity in African American women (Hudson et al., 2004; Ickovics et al.,
2001; R. Lester & Petrie, 1998; Liebschutz et al., 2003; Mock et al., 2002). Therefore, the
CES-D is an appropriate instrument to use in a population of African American women
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who are HIV-positive. Cronbach’s alpha coefficient of the CES-D in the current study
was 0.90.
The Edinburgh Postnatal Depression Scale (EPDS) was used in this study to
measure the levels of depressive symptoms in the participants (see Appendix D). The
EPDS (Cox et al., 1987) was developed for screening postpartum women for depressive
symptoms. The EPDS has also been used as a screening tool in pregnancy (Murray,
Cooper, & Stein, 1991), and terminal illness (Lloyd-Williams, Friedman, & Rudd, 2000).
The EPDS has been well validated in both populations of women in the post-partum
period (Chabrol & Teissedre, 2004; Cox et al., 1987; Dennis, Janssen, & Singer, 2004;
Evins et al., 2000; Hannah et al., 1992) and populations of women with older children
(Cox, Chapman, Murray, & Jones, 1996).
Like the CES-D, the EPDS is a screening instrument and was not designed as an
instrument to diagnose depression. The EPDS is an accurate instrument, with high
sensitivity and specificity and test-retest reliability, and can be completed in less than five
minutes. The EPDS was specifically developed for assessing postpartum depression, as
other depression symptom instruments, specifically the Beck Depression Inventory (BDI)
and the CES-D, illustrated elevated depressive symptom scores in symptomatic pregnant
women due to the inclusion of somatic symptom assessments in the BDI and CES-D
(Holcomb, Stone, Lustman, Gavard, & Mostello, 1996; J. K. Myers & Weissman,
1980).
The EPDS (Cox et al., 1987) is a 10-item questionnaire that asks subjects to report
the severity of symptoms experienced in the last seven days. Each item on the EPDS has
a range of zero to three, with rarely or none of the time equaling zero points, and most or
all of the time equaling three points. Scoring for positive items is reversed. The sum of
the scores is used as a total score. A score of ten or higher is indicative of the need for
further screening. Total scores of 10-13 are indicative of mild depressive symptoms;
scores greater than 13 are indicative of moderate depressive symptoms (Cox et al., 1987).
Literature supports the use of the minimum score (threshold) of 10 as predictive
of postnatal depression (Chabrol & Teissedre, 2004; Hannah et al., 1992). EPDS scores at
five days postpartum have been highly correlated (Spearman rank correlation, r = 0.60; p
< .0001) with EPDS scores at six weeks postpartum (Hannah et al., 1992). EPDS scores
obtained at postpartum day two or three have been highly correlated (Spearman rank
correlation, r = 0.59; p < .0001) with EPDS scores obtained four to six weeks postpartum
(Chabrol & Teissedre, 2004).
There is a minimum score of zero and a maximum score of 30. Questions 3, 5-10
are reverse scored, discouraging the subject from answering the same way for each
question. Question 10 addresses suicidal thoughts, and must be carefully assessed. If a
subject has a total score less than ten, but notes suicidal tendencies, a referral should be
made immediately. Prompt referral for those participants with EPDS scores less than ten,
but with positive indications of suicidal thoughts, was ensured through immediate
assessment after questionnaire completion. Cronbach’s alpha coefficient of the EPDS in
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the current study was 0.91. The EPDS values were positively correlated with the CES-D
values in the present study, thereby illustrating convergent validity of the instruments.
Anxiety Symptom Instrument
The Beck Anxiety Inventory (BAI) [available at Pearson Education, Inc. (A. T.
Beck et al., 1988)] was used in this study to measure the levels of anxiety symptoms in
the participants. The BAI is a 21-item instrument that asks subjects to report the degree of
symptoms in the past week. Each item is scored on a four-point scale from zero to three.
The items are summed to obtain a total score from zero to 63. A total score of zero to 21
is indicative of little or no anxiety symptoms. A total score of 22-35 is indicative of
moderate anxiety symptoms, and a sum of 36 or greater is cause for concern (A. T. Beck
et al., 1988). Each item is descriptive of subjective, somatic, or panic-related symptoms
of anxiety. The BAI was developed to discriminate anxiety from depression by
measuring anxiety symptoms that infrequently occur with depression. The BAI is selfadministered, but can also be administered verbally by a trained administrator.
Approximately five to 10 minutes are required for completion of the BAI, and the
instrument has been recommended in populations that are 17 years or greater or fifth
grade reading level (American Psychiatric Association Task Force, 2000).
Reliability and both convergent and discriminate validity of the BAI have been
established. The BAI has high internal consistency and item-total correlations that range
from .30 to .71 (median= .60) (American Psychiatric Association Task Force, 2000).
One-week test-retest reliability is .75. Positive correlation between the BAI and clinical
evaluations has been illustrated. The BAI has been used in populations of women (Bauer,
Costa, & Hesselbrock, 2001). Internal consistency reliability for the study sample was
calculated using Cronbach’s alpha coefficient, and was 0.93.
PROCEDURE
The researcher requested permission to conduct the study from the University of
Tennessee Health Science Center Institutional Review Board. Upon obtaining approval
(Appendix E), the researcher secured use of the clinics for research purposes through the
clinic manager and medical directors. A formal letter documenting this agreement is
provided (Appendices F and G). The purpose of the study was explained to the women by
the clinic social worker (SW) during clinic visits. The clinic social worker was a vital
part of the research team and was included in the IRB application process. The principle
investigator (PI) was available to study participants for additional questions or concerns.
Women who expressed the desire to participate in the research study and met
inclusion criteria were enrolled in the study. After obtaining verbal and written consent
(Appendix H) the completed informed consents were placed in an envelope marked
INFORMED CONSENTS. The questionnaires were assembled into research packets that
were marked with a code number prior to their distribution. The SW maintained a list of
participants and their corresponding code numbers. This process allowed a method of
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tracking the participants that needed additional assessments based on their scores on the
CES-D (Radloff, 1977), EPDS (Cox et al., 1987), and BAI (A. T. Beck et al., 1988). The
tracking process ensured that those subjects needing further assessment or immediate
referral (suicidal tendencies as noted on the EPDS) were addressed promptly.
Participants completed the packets in the privacy of the examination room. The
SW distributed the questionnaires, and the PI was available for questions during the
questionnaire completion process. Instructions for questionnaire completion were
verbally delivered by the SW, following a written script prepared by the PI. The
participants were given instructions to complete the research packets, which included the
Demographic Data Questionnaire, PSQI (Buysse et al., 1989), CES-D (Radloff, 1977),
EPDS (Cox et al., 1987), and BAI (A. T. Beck et al., 1988). Participants were asked to
not write their names or any other identifier on any of the instruments, as they were
marked with code numbers. Completed questionnaires were reviewed by the SW for
missing data. The SW was trained to assist participants with unanswered questions in a
manner that allowed the participant to independently answer questions following
instruction. Any missing data were obtained and then the packets were placed in a
separate envelope marked, QUESTIONNAIRES. This procedure discouraged the
identification of the subjects by the PI. The researcher was aware that although physical
harm was not a danger in this study, much care was taken to prevent psychological harm
to the participants. The PI provided time after the completion of the questionnaires for
the participants to express thoughts and feelings.
Instrumentation was scored within a four hour period. This limited time frame
allowed those participants needing further evaluation to be identified and referred to a
health care provider for additional assessment. The signed informed consents and
completed questionnaires were kept in a secure locked file cabinet within the PI’s locked
office. The SW maintained a list of all research participants and their corresponding code
numbers. This allowed the PI to alert the SW of participants needing further evaluation
without identifying the participant. The signed informed consents and the completed
research questionnaires were secured and stored per IRB requirements.
CONSIDERATION OF HUMAN SUBJECTS
The rights of human subjects as study participants require protection and
consideration. All requirements of the Health Information Privacy and Protection Act
(HIPPA) were met and followed throughout the research process. The subjects’ protected
health information (PHI) collected in the study from medical records was used for
research purposes only. The ethical principles of (1) respect for people, (2) beneficence,
and (3) justice (National Institutes of Health, 1979) were observed during the conduct of
this study.
The ethical principle of respect for persons requires researchers to obtain
informed consent from research participants, maintain confidentiality, and protect
participants with impaired decision-making capacity (Hulley, 2001). The Belmont Report
(National Institutes of Health, 1979) describes the respect for persons as the recognition
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that individuals are autonomous agents. Respect for participants was illustrated when the
subjects completed the informed consent process, as pertinent issues regarding risks,
benefits, and alternatives to participation were covered in the informed consent
(Appendix H).
The participants were guaranteed additional privacy with the anonymity that was
built into the participant identification system. Each research packet was numbered, with
the informed consent and questionnaires assigned a numerical code. Participants were
asked to not include their names, initials, or any other identifying marks on the research
materials. Confidentiality was ensured as the participants were informed that the
researcher would not be able to identify them based on questionnaire responses.
Participants were informed that their responses would be kept confidential, stored in a
secure area, and destroyed in compliance with University of Tennessee Health Science
Center Institutional Review Board procedures.
The ethical principle of beneficence in research requires that participants be
protected from harm. Participants were protected from harm. The research study was
designed to maximize benefits and minimize risks to the participants. This study involved
minimal risk to the subjects. Psychological risks involved with being rejected as a subject
were minimized through the consistent use of clearly defined inclusion and exclusion
criteria. The benefits of the study were identification of women that needed additional
assessment through collaboration with the clinic SW. Processes were in place to ensure
that women needing additional screening were quickly referred. Follow-up was ensured
by the SW.
The ethical principle of justice was ensured as the participants were informed that
study participation was completely voluntary and refusing to participate in the study
would not affect their access to medical care. Fair treatment of study participants was
guaranteed through consistent instruction for questionnaire completion, as defined by the
prepared script. These procedures helped ensure that all participants were treated in the
same fashion throughout the screening, informed consent, and data collection process. No
participant received a monetary incentive for participation.
DATA ANALYSIS
The SW examined all completed questionnaires; missing data were gathered by
the SW prior to the subject’s departure. Data were transferred entered onto an Excel
spreadsheet with assigned code numbers in order to protect participants’ confidentiality
and anonymity. All data analysis was completed using the JMP™ statistical software
program. The specific statistical analyses used to answer the research questions are
explained in detail in the paragraphs that follow.
Nominal measurement was used to assign numbers to responses on the
demographic data form, classifying characteristics into categories. Descriptive statistics
including: measures of central tendency (i.e., mean and median), frequency distributions,
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and variability (i.e., standard deviation) were used to summarize and describe the
demographic data.
Research Question 1
a.
b.
c.
d.

What are the levels of depressive symptoms in pregnant African-American
women who are HIV-positive?
What are the levels of anxiety symptoms in pregnant African-American women
who are HIV-positive?
What are the levels of depressive symptoms in non-pregnant African-American
women who are HIV-positive?
What are the levels of anxiety symptoms in non-pregnant African-American
women who are HIV-positive?

Research questions a through d were answered through the results of the CES-D,
EPDS and BAI. Levels of depressive and anxiety symptoms in the sample were
illustrated by their scores on the CES-D, EPDS, and BAI. These scores were continuous
in nature, and results reported as descriptive statistics (i.e., mean, median, interquartile
range, and standard deviation).
Research Question 2
a.
b.

c.
d.

What is the relationship of inherited vulnerabilities (family history of mood
disorders, family history of alcohol and/or drug use) to depressive symptoms
among pregnant African American women who are HIV positive?
What is the relationship of acquired vulnerabilities (educational level, income
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of
sexual abuse or assault) to depressive symptoms among pregnant African
American women who are HIV positive?
What is the relationship of inherited vulnerabilities (family history of mood
disorders, family history of alcohol and/or drug use) to depressive symptoms
among non-pregnant African American women who are HIV positive?
What is the relationship of acquired vulnerabilities (educational level, income
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of
sexual abuse or assault) to depressive symptoms among non-pregnant African
American women who are HIV positive?

Research questions 2a-2d were answered using correlation statistical procedures.
Independent variables for inherited vulnerabilities (family history of mood disorders,
family history of alcohol and/or drug use) and acquired (educational level, income level,
alcohol and/or drug use, HIV disclosure status, sleep quality, history of sexual abuse or
assault) vulnerabilities were categorical in nature. Correlation analysis using Pearson
correlation coefficient was used to describe the relationship between variables. The
presence or absence of independent variables was addressed using dummy coding, with
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educational level, income level, alcohol and/or drug use, HIV disclosure status, sleep
quality, history of sexual abuse or assault) presence being 1, and absence being 0.
Research Question 3
a.
b.

c.
d.

What is the relationship of inherited vulnerabilities (family history of mood
disorders, family history of alcohol and/or drug use) to anxiety symptoms among
pregnant African American women who are HIV positive?
What is the relationship of acquired vulnerabilities (educational level, income
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of
sexual abuse or assault) to anxiety symptoms among pregnant African American
women who are HIV positive?
What is the relationship of inherited vulnerabilities (family history of mood
disorders, family history of alcohol and/or drug use) to anxiety symptoms among
non-pregnant African American women who are HIV positive?
What is the relationship of acquired vulnerabilities (educational level, income
level, alcohol and/or drug use, HIV disclosure status, sleep quality, history of
sexual abuse or assault) to anxiety symptoms among non-pregnant African
American women who are HIV positive?

Research questions 3a-3d were answered using correlation statistical procedures.
Independent variables for inherited vulnerabilities (family history of mood disorders,
family history of alcohol and/or drug use) and acquired (educational level, income level,
alcohol and/or drug use, HIV disclosure status, sleep quality, history of sexual abuse or
assault) vulnerabilities were categorical in nature. Correlation analyses were used to
describe the relationship between variables. Correlation analysis using Pearson’s
correlation coefficient was used to describe the relationship between variables.
Categorical variables were dummy coded as present (1) versus not present (0) to facilitate
interpretation of study results.
Research Question 4
a.

b.

What is the influence of inherited vulnerabilities (family history of mood
disorders, family history of alcohol and/or drug use) on the level of depressive
symptoms reported by non-pregnant African-American women who are HIV
positive?
What is the influence of acquired vulnerabilities (educational level, income level,
alcohol and/or drug use, HIV disclosure status, sleep quality, history of sexual
abuse or assault) on the level of depressive symptoms reported by non-pregnant
African-American women who are HIV positive?

Research questions 4a and 4b were answered using multiple regression analysis.
The influence of the independent variables (inherited and acquired vulnerabilities) on the
dependent variables (CES-D, EPDS scores) was established. Stepwise multiple
regression analysis was performed in order to determine which independent variables
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best predicted the dependent variables. Dummy coding was used to identify the presence
(1) or absence (0) of independent variables. In order to systematically test each variable,
stepwise multiple regression with backward elimination was performed. Independent
variables that illustrated statistically significant correlations were entered into the
equation, and then one by one eliminated to test the influence of each independent
variables (inherited and acquired vulnerabilities) on the dependent variables (CES-D,
EPDS scores).
Research Question 5
a.

b.

What is the influence of inherited vulnerabilities (family history of mood
disorders, family history of alcohol and/or drug use) on the level of anxiety
symptoms reported by non-pregnant African-American women who are HIV
positive?
What is the influence of acquired vulnerabilities (educational level, income level,
alcohol and/or drug use, HIV disclosure status, sleep quality, history of sexual
abuse or assault) on the level of anxiety symptoms reported by non-pregnant
African-American women who are HIV positive?

Preliminary results revealed that the non-pregnant African American women who
were HIV-positive had low levels of anxiety symptoms, as evidenced by BAI scores.
Dummy coding was used to identify the presence (1) or absence (0) of independent
variables. In order to systematically test each variable, stepwise multiple regression with
backward elimination was performed. Independent variables that illustrated statistically
significant correlations were entered into the equation, and then one by one eliminated to
test the influence of each independent variables (inherited and acquired vulnerabilities)
on the dependent variables (BAI scores).
SUMMARY
In this chapter, the design of the current study has been discussed. The
limitations, setting, population, sample, instrumentation, and procedure were reviewed.
The methods of protection of human subjects and data analysis were also identified.
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CHAPTER 4. RESULTS
The purposes of this study of HIV-positive women are fourfold: (1) to determine
the levels of depressive and anxiety symptoms in pregnant and non-pregnant African
American women who were HIV-positive; (2) to describe the association between
underlying vulnerabilities, both inherited and acquired and depressive symptoms in
pregnant and non-pregnant African American women who were HIV-positive; (3) to
estimate the association between underlying vulnerabilities, both inherited and acquired,
and anxiety symptoms in pregnant and non-pregnant African American women who were
HIV-positive; and (4) to identify the predictors of depressive and anxiety symptoms
among African American HIV-positive non-pregnant women.
Prior to conducting data analyses, subjects’ responses to study questionnaires
were entered into a Microsoft™ Excel spreadsheets then uploaded into the JMP™
statistical analysis software program. Descriptive statistics were estimated for each
variable as were skewness and kurtosis scores to determine normality. Stem and leaf plots
were also generated to assess normality. Many of the study variables were not normally
distributed, resulting in the need to use nonparametric statistics for some analyses. For
both independent and dependent variables that were normally distributed, mean scores
with corresponding standard deviations were used to describe the data; for variables that
were not normally distributed, the median (Mdn) and interquartile range (IQR) were
reported. Finally, the results of each research question were addressed. Dummy coding
was used to identify the presence (recoded as a score of 1) or absence (recoded as a score
of 0) of specific categorical variables that were originally coded with more than two
levels. This approach permitted the inclusion of these variables within regression
analyses (Penhazur & Schmelkin, 1991).
DEMOGRAPHIC FINDINGS
The mean age for the sample was 33±10.7 years. The pregnant group was
significantly younger than the non-pregnant group (24.4±4.58 versus 36±10.57 years;
t = -6.847, p <.0001) and had fewer children (1.8±1.23 vs. 2.49±1.82; t = -1.755, p =
.043). However, the groups did not differ significantly with regard to their education (X2
= .207, df = 1, p = .768) and income (X2 = .192, df = 1, p = .194) categories. The majority
of the women in the present study were poor and unmarried. Most participants reported
their marital status as single (n = 14, 70% of the pregnant women vs. n = 32, 53.3% of the
non-pregnant women). A few of the non-pregnant group (n = 6, 10%) were widowed.
One woman reported AIDS as the cause of her spouse’s death; another woman reported
that her husband committed suicide after she was hospitalized and diagnosed with AIDS.
This participant also reported that after the suicide, she learned that her husband knew
about his HIV diagnosis for many years prior to her diagnosis.
Almost half (49%) of the total sample of pregnant and non-pregnant women
reported annual household incomes of less than $5000, (63% of the pregnant women;
44% of the non-pregnant women). Employment was varied, with 47.5% of the total
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sample being unemployed, and 45% of the total sample being employed part time. Over
half of the total sample (n = 47, 58.75%) had educational levels greater than high school
graduate. Table 4.1 provides a sociodemographic summary of attributes of African
American women who were HIV positive.
INHERITED AND ACQUIRED VULNERABILITIES
The investigator assessed inherited and acquired vulnerabilities using items
included on the researcher’s Demographic Questionnaire. Inherited vulnerabilities
assessed included family history of mood disorders and family history of alcohol and/or
drug use. Acquired vulnerabilities measured were educational level, income level,
alcohol and/or drug use, HIV disclosure status, sleep quality, and history of sexual abuse
or assault. Table 4.2 provides a summary of measures of inherited and acquired
vulnerabilities for the total sample as well as for pregnant and non-pregnant women. In
general, less than half of the total sample (N = 80) reported a positive family history of
mood disorders (35%) and family history of alcohol and/or drug use (32.5%). One third
of the participants (n = 25; 31%) reported alcohol and/or drug use, with the majority of
those women being in the non-pregnant group. The majority of the total sample (N = 80)
had educational levels of high school graduate or higher (n = 71; 88.75%). Low income
levels (less than $5000/year) were seen in both groups of women, affecting over half
(63%) of the pregnant women and slightly less than half (44%) of the non-pregnant
women. The majority of the sample had disclosed their HIV status to at least one person
(n = 74; 92.5%), with sexual partners being the most commonly identified person. Poor
sleep quality was prevalent in both groups of women, with 65% of the pregnant women
and 62% of the non-pregnant women having PSQI scores indicative of poor sleep.
History of sexual assault was illustrated in both groups, with 35% of the pregnant and
44% of the non-pregnant group reporting a positive history of sexual assault. Current
alcohol and/or drug use was higher in the non-pregnant group (40%) than the pregnant
group (5%). Over one third of the total sample reported a history of mood disorder
(38%), with similar results noted in the two groups (30% of pregnant women vs. 41% of
non-pregnant women).
AIM ONE
Examine the levels of depressive and anxiety symptoms in African American
women (pregnant and non-pregnant) who are HIV-positive in a southeastern urban
university obstetrics and gynecology and infectious disease practice.
All Women: Total Scale Scores for Outcome Variables
Outcome variables were assessed based upon total scores from the CES-D, EPDS,
and BAI for the entire sample (N = 80) of both pregnant (n=20) and non-pregnant (n=60)
women. Average scores of depressive and anxiety symptoms are summarized in Table
4.3. The total score of the CES-D, a measure of depressive symptoms, is the sum of all
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Table 4.1 Sociodemographic Attributes of African American Women Who Were HIVpositive.

n

Total
(N=80)
(%)

Pregnant
(n=20)
(%)
n

Non-Pregnant
(n=60)
(%)
n

Income (annual)
<5000
5000-10,000
10,000-15,000
15,000-25,000
25,000 or higher

38
17
11
8
4

(48.72%)
(21.8%)
(14.1%)
(10.26%)
(5.13%)

12
1
4
1
1

(63.16%)
(5.26%)
(21.05%)
(5.26%)
(5.26%)

26
16
7
7
3

(44.07%)
(27.12%)
(11.86%)
(11.86%)
(5.09%)

Educational
(highest completed)
th
9 -11th grade
HS/GED
Some College
Bachelor’s Degree
Master’s Degree

9
24
28
18
1

(11.25%)
(30%)
(35%)
(22.5%)
(1.25%)

2
6
8
4
0

(10%)
(30%)
(40%)
(20%)

7
18
20
14
1

(11.86%)
(30%)
(33.33%)
(23.33%)
(1.67%)

Employment Status
Unemployed
Employed FT
Employed PT
Unemployed But looking

21
5
36
17

(26.25%)
(6.25%)
(45%)
(21.25%)

6
2
10
2

(30%)
(10%)
(50%)
(10%)

15
3
26
15

(25%)
(5%)
(43.33%)
(25%)

Marital Status
Single
Married
Divorced
Widowed
Cohabitating

46
14
3
4
11

(57.5%)
(17.5%)
(3.75%)
(7.5%)
13.75%)

14
2
1
0
3

(70%)
(10%)
(5%)

32
12
2
6
8

(53.33%)
(20%)
(3.33%)
(10%)
(13.33%)

(15%)

Note: HS=High School; GED= General Education Equivalent; PT= Part Time; FT= Full
Time. Between group differences were not significant.
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Table 4.2 Inherited and Acquired Vulnerabilities Reported by the Total Sample and
Pregnant and Non-Pregnant HIV-positive African American Women.
Significance
Between
Pregnant and
Non-Pregnant
p-value

Total
N = 80
n (%)

Pregnant
n=20
n (%)

NonPregnant
n= 60
n (%)

28(35.0)

6 (30.0)

22 (37.0)

0.59

26(32.5)

4 (20.0)

22(37.0)

0.16

25 (31%)

1(5%)

24 (40%)

0.0011

71 (88.75%)

18 (90%)

53 (88.33%)

0.88

Income level
(< $5000.00/year)

38 (49%)

12(63%)

26 (44%)

0.26

Disclosed HIV status

74 (92.5%)

19 (95%)

55 (92%)

0.59

Poor sleep quality
(PSQI >5)

50 (62.5%)

13 (65%)

37 (62%)

0.40

33 (42%)

7 (35%)

26 (44%)

Vulnerability
Inherited Vulnerabilities
Family history of mood
disorder
Family history of alcohol
and/or drug use
Acquired Vulnerabilities
Current alcohol and/or
drug use
Educational level
(High School graduate or
higher)

History of sexual abuse or
assault

Note. *PSQI = Pittsburgh Sleep Quality Instrument
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Table 4.3 Descriptive Statistics for Depressive and Anxiety Symptoms in African
American HIV-positive Women.
Outcome variable
CES-D
EPDS
BAI

N
80
80
80

M±SD
18.35 ± 13.19
9.04 ± 7.3
11.2 ± 11.54

Mdn
17
6.5
7

IQR
23.75
12.75
16

Note: CES-D=Center for Epidemiologic Studies Depression Scale; EPDS=Edinburgh
Postnatal Depression Scale; BAI=Beck Anxiety Inventory
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item responses. Results ranged from 0 to 60 with a cut-off score of 16 reflecting clinically
relevant depressive symptoms in the general population (Radloff, 1977). Total CES-D
scores for the study sample ranged from 3 (fewest depressive symptoms) to 53 (most
depressive symptoms). Less than half of the sample (n = 38, 47.5%) had CES-D scores
less than 16, which indicated the absence of significant depressive symptoms (Radloff,
1977). Twelve (15%) women had CES-D scores of 16-20 indicating clinically mild
depressive symptoms, 12 (15%) women had scores of 21-30 indicating moderate
depressive symptoms, and 18 (22.5%) women had scores greater than 31 indicating
severe distress (Radloff, 1977). A total of 42 (52.5%) women in the sample (N=80) had
CES-D scores of 16 or greater requiring referral to their case manager for follow-up.
The total score of the EPDS is the sum of all item responses and can range from 0
to 30 with a cut-off score of 10 indicating a need for further screening for depression
(Cox et al., 1987). Total scores for depressive symptoms with the EPDS for the study
sample ranged from 0 (fewest depressive symptoms) to 26 (most depressive symptoms).
The majority of the sample (n = 44, 55%) had EPDS scores of less than nine, which
indicated the absence of significant depressive symptoms (Cox et al., 1987). Thirteen
women (16.25%) had EPDS scores between 10 and 13, indicating clinically mild
depressive symptoms; and 23 (28.75%) had EPDS scores higher than 13, indicating
moderate to severe depressive symptoms (Cox et al., 1987). All participants with elevated
scores were reported to their case manager for follow-up. Table 4.4 illustrates levels of
specific categories of depressive symptoms.
Anxiety scores for the sample, which reflected the sum of all items, were lower
than expected. Most of the sample had BAI scores below the level suggestive of the need
for additional screening (Table 4.2). BAI scores for the total sample of both pregnant and
non-pregnant women ranged from zero to 45, with the majority (n = 69, 86.25%) of the
women exhibiting BAI scores of less than 21, illustrating little or no anxiety (A. T. Beck
et al., 1988). BAI scores in the 22-35 range are indicative of moderate levels of anxiety
(A. T. Beck et al., 1988). A small proportion of the total sample (n = 6; 7.5%) had BAI
scores in the moderate range (A. T. Beck et al., 1988). BAI scores that were 36 and
greater were indicative a high levels of anxiety and cause for concern (A. T. Beck et al.,
1988). Five (6.25%) women in the total sample exhibited high levels of anxiety based on
their BAI scores. Table 4.5 illustrates the specific levels of anxiety symptoms in the total
group of African American women who were HIV-positive.
Pregnant Women: Total Scale Scores for Outcome Variables
Levels of depressive symptoms in pregnant African-American women who were
HIV-positive were also examined. Data were assessed for symmetry, or skewness, using
Pearson’s skewness coefficient. Perfectly symmetrical distributions have equal means
and medians, with a Pearson skewness coefficient of 0 (Penhazur & Schmelkin, 1991).
Pearson skewness coefficient results that fall between -1 and +1 are acceptable,
indicating data that are normally distributed. Values above or below -1 and +1 are
substantially skewed distribution (Penhazur & Schmelkin, 1991). Depressive symptoms,
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Table 4.4 Descriptive Statistics for Specific Levels of Depressive Symptoms in Total
Sample of African American HIV-positive Women (N = 80).
CES-D Scores
None (0-15)
Mild (16-20)
Moderate (21-30)
Severe (≥ 31)

N
38
12
12
18

%
47.5%
15%
15%
22.5%

EPDS Scores
None (0-9)
Mild (10-13)
Moderate to Severe (≥14)

N
44
13
23

%
55%
16.25%
28.75%

Note: CES-D=Center for Epidemiologic Studies Depression Scale; EPDS=Edinburgh
Postnatal Depression Scale
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Table 4.5 Descriptive Statistics for Specific Levels of Anxiety
Symptoms in Total Sample of African American HIV-positive Women
(N = 80).
BAI Scores
None to mild (0-21)
Moderate (22-35)
Severe (≥ 36)
Note: BAI= Beck Anxiety Inventory
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n
69
6
5

%
86.25
7.5
6.25%

as measured using the CES-D, were positively skewed (Pearson’s skewness coefficient
0.78). Data were treated for the purposes of statistically analysis as normally distributed.
As seen with the CES-D, depressive symptom scores measured using the EPDS (mean
8.7; median 5.5) were dissimilar, although the Pearson’s skewness coefficient was 0.34,
which is less than +1, indicating data that are normally distributed. Results indicated that
as a group, almost half of the sample (45%) of pregnant African-American women who
were HIV-positive had CES-D scores indicative of the need for referral and additional
assessment of depressive symptoms. Consequently, over half of the pregnant women in
the sample (55%) reported depressive symptoms below the recommended cut-off for the
CES-D (total score < 16) (Radloff, 1977). The median score of the CES-D in this group
of pregnant women was 9 (interquartile range of 27.5). Results were similar for the
EPDS. A score of 0-9 is indicative of the absence of clinically relevant depressive
symptoms (Cox et al., 1987). EPDS scores for this group of pregnant women were below
the recommended cut-off needed for further evaluation (median 5.5; interquartile range
14). On average, for both measures pregnant women did not have clinically relevant
levels of depressive symptoms. Table 4.6 illustrates levels of depressive symptoms in this
sample of pregnant African American women who were HIV-positive.
Levels of anxiety symptoms in pregnant African-American women who were
HIV-positive were positively skewed (Pearson’s skewness coefficient 1.29), and greater
than +1, indicating data that were not normally distributed. Results indicated that
pregnant African-American women in the sample who were HIV-positive did not report
anxiety symptoms that needed further evaluation. The majority of the sample of pregnant
women exhibited anxiety symptoms below the recommended cut-off of 21 for the BAI
(A. T. Beck et al., 1988). The median for BAI scores in this group was 5.5 and the
interquartile range 19.5. Pregnant women in this sample did not have clinically relevant
anxiety symptom levels. Table 4.7 illustrates levels of anxiety symptoms in this group of
pregnant African American women who were HIV-positive.
All Non-Pregnant Women: Total Scale Scores for Outcome Variables
Levels of depressive symptoms in non-pregnant African-American women who
were HIV-positive were examined using descriptive statistics. Results indicated that the
levels of depressive symptoms in non-pregnant African-American women who were
HIV-positive were positively skewed for both the CES-D (Pearson’s skewness coefficient
(0.56) and EPDS (Pearson’s skewness coefficient 0.6). These Pearson’s skewness
coefficient values reflected data that were approximately normally distributed.
Results for aim one indicated that the typical non-pregnant African-American
women in the study sample who were HIV-positive had mild depressive symptoms when
measured by the CES-D (mean 18.6; standard deviation 12.53) and the EPDS (mean
9.15; standard deviation 7.29). CES-D scores for the typical non-pregnant women in this
sample ranged from 3 to 46. EPDS scores for the typical non-pregnant women in this
sample ranged from 0 to 26. In this group of non-pregnant African American HIVpositive women, CES-D and EPDS scores suggest that depressive symptoms were
typically mild. Current treatment with antidepressants was not an exclusion criterion for
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Table 4.6 Descriptive Statistics for Specific Levels of Depressive Symptoms in Sample
of Pregnant African American HIV-positive Women (n = 20).
CES-D Scores
None (0-15)
Mild (16-20)
Moderate (21-30)
Severe (≥ 31)

n
11
1
1
7

%
55%
5%
5%
35%

EPDS Scores
None (0-9)
Mild (10-13)
Moderate to Severe (≥14)

N
11
3
6

%
55%
15%
30%

Note: CES-D=Center for Epidemiologic Studies Depression Scale; EPDS=Edinburgh
Postnatal Depression Scale
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Table 4.7 Descriptive Statistics for Specific Levels of Anxiety
Symptoms in Sample of Pregnant African American HIV-positive
Women (n = 20)
BAI Scores
None to mild (0-21)
Moderate (22-35)
Severe (≥ 36)

n
17
3
0

Note: BAI= Beck Anxiety Inventory

69

%
85
15
0

the current study. Nine (15%) of the non-pregnant women (n = 60) were on
antidepressants at the time of their participation in the study, although eight of these
women had elevated depressive symptom scores. Table 4.8 illustrates levels of depressive
symptoms in this sample of non-pregnant African American women who were HIVpositive.
Levels of anxiety symptoms in the typical non-pregnant African-American
women who were HIV-positive were examined. Results were positively skewed
(Pearson’s skewness coefficient 1.29), and greater than +1, indicating data that were not
normally distributed. Results indicated that most of the non-pregnant African-American
women in the study who were HIV-positive had little or no anxiety (median 7,
interquartile range 16). Anxiety scores in this group of non-pregnant women ranged from
zero to 45. Table 4.9 illustrates levels of anxiety symptoms in this group of non-pregnant
African American women who were HIV-positive.
The Wilcoxon Signed Rank Sums test was performed to assess the significance of
between group differences (pregnant versus non-pregnant) for each outcome. Depression
scores as measured by the CES-D were similar (p =.486) in both groups as was EPDS
scores (p=.743). Anxiety scores were also similar for the groups (p=.558). Table 4.10
depicts a summary of the results of depressive and anxiety symptom scores in pregnant
and non-pregnant women. As a group neither pregnant nor non pregnant women in the
study sample had clinically relevant levels of depressive or anxiety symptoms.
AIM TWO
Examine the associations among inherited (family history of mood disorders,
family history of alcohol and/or drug use) and acquired (educational level, income level,
alcohol and/or drug use, HIV disclosure status, sleep quality, history of sexual abuse or
assault) vulnerabilities and depressive symptoms in pregnant and non-pregnant African
American women who were HIV-positive.
Correlation statistics were used to analyze the relationship of inherited
vulnerabilities (e.g. family history of mood disorders, family history of alcohol and/or
drug use) to depressive symptoms among pregnant African American women who were
HIV positive. Table 4.11 summarizes the correlation analyses in this group of pregnant
women, illustrating the statistical significance of the correlation between family history
of mood disorders and depressive symptoms.
Family history of mood disorders was captured on the Demographic
Questionnaire. Results were dummy coded, with no family history of mood disorder
coded as 0 and positive family history of mood disorders coded as 1. There was a
moderate but significant association between family history of mood disorders and
depressive symptoms on the CES-D (r= 0.58; p = 0.0073). Results for the EPDS were
similar (r = 0.59; p = .058), however the level of significance was slightly above the A
priory alpha of p ≤ 0.05. Thus, family history of mood disorders was associated with
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Table 4.8 Descriptive Statistics for Specific Levels of Depressive Symptoms in Sample
of Non-Pregnant African American HIV-positive Women (n = 60).
CES-D Scores
None (0-15)
Mild (16-20)
Moderate (21-30)
Severe (≥ 31)

n
27
11
11
11

%
45%
18.3%
18.3%
18.3%

EPDS Scores
None (0-9)
Mild (10-13)
Moderate to Severe (≥14)

N
33
10
17

%
55%
16.7%
28.3%

Note: CES-D=Center for Epidemiologic Studies Depression Scale; EPDS=Edinburgh
Postnatal Depression Scale
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Table 4.9 Descriptive Statistics for Specific Levels of Anxiety Symptoms
in Sample of Non-Pregnant African American HIV-positive Women (n =
60).
BAI Scores
None to mild (0-21)
Moderate (22-35)
Severe (≥ 36)

n
52

3
5

Note: BAI= Beck Anxiety Inventory

72

%
86.7
5
8.3

Table 4.10 Depressive and Anxiety Symptom Scores in Pregnant (n = 20) and NonPregnant (n = 60) African American HIV-positive Women.
Outcome
CES-D
EPDS
BAI

Pregnant (n=20)
Mdn (IQR)
9 (27.5)
5.5 (14)
5.5(19)

Non-pregnant (n=60)
Mdn (IQR)
17 (21)
8 (11.75)
7 (16)

Note: Median (Mdn) and interquartile ranges (IQR) were reported for data that were not
normally distributed. CES-D=Center for Epidemiologic Studies Depression Scale;
EPDS=Edinburgh Postnatal Depression Scale; BAI=Beck Anxiety Inventory. Between
group differences were non-significant. The study a priori alpha was p≤.05.
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Table 4.11 Pearson Correlation (r) Analysis between Inherited Vulnerabilities and
Depressive Symptoms for Pregnant African American Women Who Were HIV-positive
(n = 20).

Inherited Vulnerability
Family History of Mood Disorders
Family History of Alcohol/Drug Use

Depressive Symptoms
(CES-D Scores)
r (p value)
.58 (.0073)
.30 (.20)

Depressive Symptoms
(EPDS Scores)
r (p value)
.59 (.058)
.19 (.42)

Note: CES-D=Center for Epidemiologic Studies Depression Scale; EPDS=Edinburgh
Postnatal Depression Scale. A priori alpha for the study was p≤ 0.05.
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depressive symptoms in this group of pregnant African American women who were HIVpositive. Women with a positive family history of mood disorders had higher depression
scores than women with a negative family history on both measures of depressive
symptoms.
Family history of alcohol and/or drug use was captured on the Demographic
Questionnaire. Results were dummy coded with no family history of alcohol and/or drug
use coded as 0 and positive family history of alcohol and/or drug use coded as 1. There
was a non-significant association between family history of alcohol and/or drug use with
depressive symptoms on both the CES-D (r = 0.30; p = 0.20) and the EPDS (r = 0.19; p =
.42). Thus, family history of alcohol and/or drug use was not significantly associated
with depressive symptoms as measured by the CES-D, or the EPDS in this group of
pregnant African American women who were HIV-positive.
Correlation statistics were used to analyze the relationship of acquired
vulnerabilities (educational level, income level, alcohol and/or drug use, HIV disclosure
status, sleep quality, history of sexual abuse or assault) to depressive symptoms among
pregnant African American women who were HIV positive. Table 4.12 provides the
complete results of these correlation analyses
Two categories of educational level were used for analysis, HS/GED (coded as 0)
and HS/GED or higher (coded as 1). Educational level was not significantly associated
with depressive symptoms when measured with the CES-D (r = -0.12; p = 0.62) or EPDS
( r = -0.09; p = 0.72). Thus, educational level was not significantly associated with
depressive symptoms in this group of pregnant African American women who were
HIV-positive.
Income level was captured on the Demographic Questionnaire as annual
household income in a categorical fashion. Five categories of income were collapsed into
two categories, which was a reflection of the sample income distribution. Income level
was coded 0 if income was less than $5000/year and 1 if participants income was
$5000/year or greater. Income level was not significantly correlated with depressive
symptoms when measured be the CES-D (r =- 0.06; p = 0.80) or the EPDS (r = 0.09; 8; p
= 0.69). Thus, socioeconomic level was not significantly associated with depressive
symptoms in this group of pregnant African American women who were HIV-positive.
The association between substance use and depressive symptom scores on the
CES-D were non-significant (r = 0.22; p = 0.35). Likewise, the correlation between
alcohol and/or drug use and depressive symptoms using the EPDS was also nonsignificant (r = 0.42, p = 0.07). Thus, substance use was not significantly associated with
depressive symptoms in this group of pregnant African American women who were
HIV-positive.
Disclosure of HIV status was measured on the Demographic Questionnaire by the
number of persons to whom the subject had disclosed her HIV status. Pregnant women

75

Table 4.12 Pearson Correlation (r) Analysis between Acquired Vulnerabilities and
Depressive Symptoms for Pregnant African American Women Who Were HIV-positive
(n = 20).

Acquired Vulnerability
Income
Educational Level
Alcohol and/or Drug Use
HIV Disclosure Status
History of Sexual Assault
Sleep Quality

CES-D Depressive
Symptoms Scores
r (p value)
-.01 (.80)
-.12(.62)
.22(.35)
.54(.01)*
.28(.23)
.61(.0004)*

EPDS Depressive
Symptoms Scores
r (p value)
.010(.69)
-.09(.72)
.42(.07)
.37(.11)
.27(.24)
.67(.0001)*

Note: CES-D=Center for Epidemiologic Studies Depression Scale; EPDS=Edinburgh
Postnatal Depression Scale. *The study a priori alpha was p≤.05.
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Prior to conducting zero-order correlation analysis, nominal level variables that
reflected was implemented to signify no disclosure to others (coded 0) or disclosure to
others (coded 1). HIV disclosure status was significantly correlated with depressive
symptoms when measured by the CES-D (r = 0.54; p = 0.01), but not with the EPDS (r =
0.37; p = 0.11) in this pregnant subgroup. Therefore, the pregnant women that had
disclosed their HIV status displayed higher levels of depressive symptoms on the CES-D.
Mixed results were illustrated in regard to HIV disclosure status, with HIV disclosure
status being associated with higher scores on the CES-d but not on the EPDS.
Application of Pearson (r) correlation analyses allowed the researcher to determine the
direction and strength of the relationship between variables (Penhazur & Schmelkin,
1991). This statistical approach allowed the researcher to determine whether or not
inherited vulnerabilities were significantly related to depressive symptoms (See Table
4.13). Pregnant women who disclosed their HIV status had significantly higher
depression scores (more depressive symptoms) on the CES-D (mean 18.16) but not the
EPDS (mean 8.95) compared to women who had not disclosed their status (mean CES-D
score 5; mean EPDS score 4).
Sleep quality was measured using the PSQI, with a cut-off score of 5 or greater
indicating poor sleep quality. In this group of pregnant women, there was a significant
strong, positive correlation between sleep quality and depressive symptoms on the CESD (r = 0.61; p = 0.0004) and EPDS (r = 0.67; p = 0.0001). As sleep quality scores
increased (worsened), depression scores increased (worsened). Sleep quality was the
acquired vulnerability with the strongest association with depressive symptoms in
pregnant participants.
History of sexual abuse or assault was measured on the Demographic
Questionnaire. Results indicated a low positive, but non-significant correlation between
depressive symptoms and sexual abuse or assault when measured with the CES-D (r=
0.30; p = 0.23). Similarly, correlation was non-significant when the EPDS was used to
assess depressive symptoms (r = 0.27; p = 0.24). Thus, results of these analyses indicated
that there was not a significant association between history of sexual assault or abuse and
depressive symptoms when measured using both the CES-D and EPDS in this group of
pregnant African American women who were HIV-positive.
The relationship of inherited vulnerabilities (e.g., family history of mood
disorders and family history of alcohol and/or drug use) to depressive symptoms among
non-pregnant African American women who were HIV positive was examined using
correlation analyses. Pearson’s correlations were estimated to answer this research
question as most variables were normally distributed. The presence or absence of each of
the inherited vulnerabilities was obtained in the Demographic Questionnaire.
The associations between inherited vulnerabilities and depressive symptoms were
not significant in this group of non-pregnant women. Family history of mood disorders
was dummy coded as 0 if there was no family history of mood disorders and 1 if there
was a positive family history of mood disorders. The correlation between family history
of mood disorders and depressive symptoms with the CES-D was not statistically
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Table 4.13 Pearson Correlation (r ) Analyses between Inherited Vulnerabilities and
Depressive Symptoms for Non-Pregnant African American Women Who Were HIVpositive (n = 60).

Inherited Vulnerability
Family history of mood
disorders
Family history of
alcohol/drug use

CES-D Depressive
Symptoms Scores
r (p value)
.23 (0.08)

EPDS Depressive
Symptoms Scores
r (p value)
.23 (0.08)

.10 (0.46)

.25 (0.06)

Note: CES-D=Center for Epidemiologic Studies Depression Scale; EPDS=Edinburgh
Postnatal Depression Scale. A priori alpha for the study was p≤ 0.05.
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significant (r = 0.23, p = 0.08). Similarly, there was a non-significant association (r
=0.23, p =.08) between family history of mood disorders and depressive symptoms when
measured by the EPDS. Thus, family history of mood disorders was not significantly
associated with depressive symptoms in this group of non-pregnant African American
women who were HIV-positive.
Family history of alcohol and/or drug use was not significantly correlated with
depressive symptoms when measured by the CES-D (r = 0.10; p = 0.46), or the EPDS (r
= 0.25; p = 0.06). Thus, family history of alcohol and/or drug use was not associated with
depressive symptoms in this group of non-pregnant African American women who were
HIV-positive when measured by the CES-D and EPDS. Participants who had a positive
family history of alcohol and/or drug use reported greater depressive symptoms on the
CES-D (mean CES-D score 20.18) and the EPDS (mean EPDS score 11.5) compared to
women who did not have a positive family history (mean CES-D score 17.68; mean
EPDS score 7.79).
The relationship of acquired vulnerabilities (educational level, income level,
alcohol and/or drug use, HIV disclosure status, sleep quality, history of sexual abuse or
assault) to depressive symptoms among non-pregnant African American women who
were HIV positive was examined.
Educational level was captured on the Demographic Questionnaire in a
categorical fashion. Although four categories were present on the questionnaire, the
majority of the sample clustered in two categories, less than high school graduate or
equivalent diploma (HS/GED) and high school graduate or equivalent diploma
(HS/GED) or higher, therefore these two categories were used for correlation analysis.
Dummy coding was used with a score of zero assigned for women with less than
HS/GED and one for women who had HS/GED or higher educational levels. Educational
level was not significantly correlated with depressive symptoms when measured with the
CES-D (r = 0.17; p = 0.19). or EPDS (r = 0.17; p = 0.18) in non-pregnant study
participants.
Income level was also captured on the Demographic Questionnaire as annual
household income in a categorical fashion. Although there were five categories present,
the sample responses primarily clustered in two categories, less than $5000 per year and
$5000 per year or greater, thus these two categories were used for analysis. Dummy
codes of 0 and 1 were assigned to signify income less than $5000 per year and $5000 per
year or greater, respectively. Income level was not significantly correlated with
depressive symptoms when measured with the CES-D (r = 0.14; p = 0.29) or the EPDS (r
= -0.04; p = 0.76). Thus, income level was not significantly associated with depressive
symptoms in this group of non-pregnant African American women who were HIVpositive.
Current alcohol and/or drug use was captured on the Demographic Questionnaire.
Prior to conducting the zero-order correlation analysis, substance use was dummy coded
as zero if there was no history and one if there was a positive history of this
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characteristic. Athough substance use was an acquired vulnerability that was positively
correlated with depressive symptoms, the strength of the association was weak but
significant using the CES-D (r = 0.28; p = 0.03), but not on the EPDS (r = 0.24; p =
0.06). Thus, substance use garnered mixed results; significantly associated with
depressive symptoms on one of the two depressive symptom measurements in this group
of non-pregnant African American women who were HIV-positive. Depression
symptoms were significantly higher in non-pregnant women who had a positive history
of substance use compared to women who did not report alcohol and/or drug use.
The number of persons the subject had disclosed her HIV status to on the
Demographic Questionnaire reflected their HIV disclosure status. Dummy coding was
implemented to signify two categories: no disclosure to others, coded as 0, or disclosure
to others, coded as 1. HIV disclosure status was not significantly correlated with
depressive symptoms when measured by the CES-D (r = -0.15; p = 0.24) or the EPDS (r
= -0.16; p = 0.38) in this group of non-pregnant African American women who were
HIV-positive.
Sleep quality was measured using the PSQI, with a cut-off score of 5 or greater
suggestive of poor sleep quality. In this group of non-pregnant women, there was a
significant positive correlation between sleep quality and depressive symptoms on the
CES-D (r = 0.69; p < 0.001) and EPDS (r = 0.63; p <0.001). The strength of both of
these correlations was moderate. As sleep quality scores increased (e.g. poorer sleep
quality), depressive symptoms scores significantly increased (more depressive symptoms
occurred). Thus, sleep quality was significantly associated with depressive symptoms in
this group of non-pregnant African American women who were HIV-positive.
History of sexual abuse or assault was measured on the Demographic
Questionnaire. Responses were dummy coded as no history of sexual abuse or assault
(coded as 0) or history of sexual abuse or assault (coded as 1). This acquired vulnerability
was not significantly correlated with depressive symptoms on the CES-D (r = 0.24; p =
0.06) or the EPDS (r = 0.18; p = 0.16). Thus, history of sexual assault was not
significantly related to depressive symptoms in this group of non-pregnant African
American women who were HIV-positive. Table 4.14 provides a summary of findings
related to acquired vulnerabilities and depressive symptoms in this group of non-pregnant
women.
AIM THREE
Examine the associations among inherited (family history of mood disorders,
family history of alcohol and/or use) and acquired (educational level, income level,
alcohol and/or drug use, HIV disclosure status, sleep quality, history of sexual abuse or
assault) vulnerabilities and anxiety symptoms in pregnant and non-pregnant African
American women who were HIV-positive.
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Table 4.14 Pearson Correlation (r) Analysis between Acquired Vulnerabilities and
Depressive Symptoms for Non-Pregnant African American Women Who Were HIVpositive (n = 60).

Acquired Vulnerability
Income
Educational Level
Alcohol and/or Drug Use
HIV Disclosure Status
History of Sexual Assault
Sleep Quality

CES-D Depressive
Symptoms Scores
r (p value)
.14(.29)
.17(.19)
.28(.03)*
-.15(.24)
.24(.06)
.69(<.0001)*

EPDS Depressive
Symptoms Scores
r (p value)
-.04(.76)
.17(.18)
.24(.06)
-.12(.38)
.18(.16)
.63(<.0001)*

Note: CES-D=Center for Epidemiologic Studies Depression Scale; EPDS=Edinburgh
Postnatal Depression Scale. The symbol r refers to Pearson Correlation. A priori alpha
for the study was p≤ 0.05.
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Pregnant African American women who were HIV-positive were assessed. The
influence of inherited vulnerabilities (e.g. family history of mood disorders, family
history of alcohol and/or drug use) on anxiety symptoms among pregnant African
American women who were HIV positive was examined using correlation statistics.
Family history of mood disorders was dummy coded, with no family history of
mood disorders coded as 0 and positive family history of mood disorders coded as 1.
Family history of mood disorders was significantly correlated with anxiety symptoms on
the BAI (r = 0.64; p = 0.003). Thus, a positive family history of mood disorders was
associated with greater anxiety scores in this group of pregnant African American
women who were HIV-positive.
Family history of alcohol and/or drug use was captured on the Demographic
Questionnaire. Results were dummy coded for categorization, with no family history of
alcohol and/or drug use (coded as 0) and positive family history of alcohol and/or drug
use (coded as 1). Family history of alcohol and/or drug use was not significantly
correlated with anxiety symptoms in this group of pregnant women (r = 0.35; p = 0.13).
Table 4.15 provides an illustration of these results.
Correlation statistics were used to examine the association of acquired
vulnerabilities (educational level, income level, alcohol and/or drug use, HIV disclosure
status, sleep quality, history of sexual abuse or assault) to anxiety symptoms among
pregnant African American women who are HIV positive.
Educational level was captured on the demographic questionnaire in a categorical
fashion. As with the previous analyses, four categories were collapsed into two
categories, less than HS/GED (coded as 0) and HS/GED or greater (coded as 1). Most of
the participants reported educational levels in these categories. Educational level was
negatively correlated with elevated anxiety symptoms when measured with the BAI
however, the association was non-significant (r = -0.6; p = 0.81) in this group of
pregnant African American women who were HIV-positive.
Income level was captured on the Demographic Questionnaire as annual
household income in a categorical fashion. As with earlier analyses, five categories were
collapsed into two, illustrating less than $5000 per year (coded as 0) and $5000 per year
or greater (coded as 1). Income level was not significantly correlated with anxiety
symptoms when measured be the BAI (r = 0.12; p = 0.66) in this group of pregnant
African American women who were HIV-positive.
Alcohol and/or drug use was captured on the Demographic Questionnaire.
Dummy coding was implemented to signify no substance use (coded as 0) or positive
substance use (coded as 1). Substance use had a positive but statistically non-significant
correlation with anxiety scores on BAI (r = 0.25; p = 0.3).
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Table 4.15 Pearson Correlation (r) Analysis between Inherited Vulnerabilities and
Anxiety Symptoms for Pregnant African American Women Who Were HIV-positive
(n = 20).
Inherited Vulnerability

Anxiety Symptom (BAI) Scores
r (p value)
.64 (.0003)*
.35 (.13)

Family History of Mood Disorders
Family History of Alcohol/Drug Use

Note: BAI= Beck Anxiety Inventory. Study a priori alpha was *p≤.05.
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Disclosure of HIV status was measured on the Demographic Questionnaire.
Dummy coding was implemented to signify no disclosure to others (coded as 0) or
disclosure to others (coded as 1). HIV disclosure status was positively and significantly
correlated with anxiety symptoms when measured by the BAI (r = 0.52; p = 0.02). Thus,
pregnant HIV-positive African American women in the sample who disclosed their HIV
status had significantly higher anxiety scores (more severe anxiety symptoms) than
women who had not disclosed their status.
Sleep quality was measured using the PSQI, with a cut-off score of 5 or greater
indicating poor sleep quality. In this group of pregnant women, there was a significant
positive correlation between sleep quality and anxiety symptoms on the BAI (r = 0.68; p
= 0.001). Thus, women with greater sleep quality scores (poorer sleep quality) also had
greater anxiety scores (more severe anxiety) in this group of pregnant African American
women who were HIV-positive.
History of sexual abuse or assault was measured and responses were dummy
coded as no history of sexual abuse or assault (coded as 0) or history of sexual abuse or
assault (coded as 1). History of sexual abuse or assault was positively correlated with
anxiety scores on the BAI (r = 0.33; p = 0.16), but this finding was not statistically
significant at the p < 0.05 level. Thus, history of sexual abuse or assault was not
significantly related to anxiety symptoms in this group of pregnant African American
women who were HIV-positive. Table 4.16 illustrates a summary of the correlation
results for this group of pregnant women who were HIV-positive.
Non-pregnant African American women who were HIV-positive women were
assessed and associations between inherited vulnerabilities (e.g. family history of mood
disorders, family history of alcohol and/or drug use) and anxiety symptoms examined
using correlation analyses. Anxiety symptoms were measured using the BAI. Family
history of mood disorders was dummy coded 1 or 0, respectively if the characteristic was
present or absent. Family history of mood disorders was positively correlated with
anxiety symptoms (r = 0.33; p = 0.0093). Non-pregnant women with a positive family
history of mood disorders had significantly higher anxiety scores (mean BAI score 16.77)
than women who did not have a family history of these disorders (mean BAI score 8.6).
Family history of alcohol and/or drug use was not correlated with anxiety
symptoms (r = 0.19; p = 0.14). Women who had a positive family history of alcohol
and/or drug use reported more anxiety symptoms (mean BAI score 14.59) than women
who had no family history (mean BAI score 9.86). Table 4.17 shows correlation results
of inherited vulnerabilities with anxiety symptoms in the non-pregnant study participants,
with family history of mood disorders being associated with higher BAI scores.
The influence of acquired vulnerabilities (e.g. educational level, income level,
alcohol and/or drug use, HIV disclosure status, sleep quality, history of sexual abuse or
assault) on anxiety symptoms among non-pregnant African American women who were
HIV positive was examined using correlation analyses.
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Table 4.16 Pearson Correlation (r) Analysis between Acquired Vulnerabilities and
Anxiety Symptoms for Pregnant African American Women Who Were HIV-positive
(n = 20).
Anxiety Symptoms
(BAI Scores)
r (p value)
.25 (.30)
.6 (.81)
.12(.66)
.52 (.002)*
.68(.0010)*
.33(.16)

Acquired Vulnerability
Alcohol and/or Drug Use
Educational Level
Income
HIV Disclosure Status
Sleep Quality
History of Sexual Assault

Note: BAI=Beck Anxiety Inventory. Study a priori alpha was *p≤.05.
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Table 4.17 Pearson Correlation (r) Analysis between Inherited Vulnerabilities and
Anxiety Symptoms for Non-Pregnant African American Women Who Were HIVpositive (n = 60).
Anxiety Symptom
(BAI) Scores
r (p value)
.33(.0093)*
.19 (.14)

Inherited Vulnerability
Family History of Mood Disorders
Family History of Alcohol/Drug Use

Note: BAI= Beck Anxiety Inventory. A priori alpha was *p≤.05.
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Educational level was captured in a categorical fashion. Most of the sample fell
into two main categories: less than HS/GED or HS/GED or greater, the four categories
were collapsed into these two categories for statistical analysis. Educational level was not
significantly correlated with anxiety symptoms when measured with the BAI in this
group of non-pregnant women who were HIV positive (r = 0.1; p = 0.44).
Income level was captured in a categorical fashion on the Demographic
Questionnaire as annual household income. Two main categories of income were present
in the sample. Dummy coding was implemented to signify income less than $5000 per
year (coded as 0) and $5000 per year or greater (coded as 1). Income level was not
significantly correlated with anxiety symptoms when measured with the BAI (r = 0.21; p
= 0.12) in this group of non-pregnant African American women who were HIV-positive.
Substance use was coded 0 if the characteristic was absent and 1 if present.
Substance use had a positive correlation with anxiety scores on BAI (r = 0.24). The
strength of this correlation was weak, and was not statistically significant (p =
0.06).Thus, a history of substance use was not significantly associated with higher
anxiety scores for this group of non-pregnant women.
Disclosure of HIV status was reported on the Demographic Questionnaire as the
number of persons to whom the participant had disclosed her HIV status. Dummy coding
was implemented to signify no disclosure to others as a score of 0 or disclosure to others
as a score of 1. HIV disclosure status was not significantly correlated with anxiety
symptoms when measured by the BAI (r = -0.0072; p = 0.96) in this group of nonpregnant African American women who were HIV-positive.
Sleep quality was measured using the PSQI, with a cut-off score of 5 or greater
indicating poor sleep quality. In this group of non-pregnant women, there was a
significant positive correlation between sleep quality and anxiety symptoms on the BAI
(r = 0.69; p <.0001). Thus poorer sleep quality was significantly associated with more
anxiety symptoms in this group of non-pregnant women.
History of sexual abuse or assault was measured on the Demographic
Questionnaire. Responses were dummy coded as no history of sexual abuse or assault
(coded as 0) or history of sexual abuse or assault (coded as1). A history of sexual abuse
or assault was not significantly correlated with anxiety scores on the BAI (r= 0.15; p =
0.26) in this group of non-pregnant African American women who were HIV-positive.
Table 4.18 provides a summary of these correlation analyses.
AIM FOUR
Examine the influence of inherited vulnerabilities (family history of mood
disorders, family history of alcohol and/or drug use) and acquired vulnerabilities
(educational level, income status, alcohol and/or drug use, HIV disclosure status, sleep
quality,
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Table 4.18 Pearson Correlation (r) Analysis between Acquired Vulnerabilities and
Anxiety Symptoms for Non-Pregnant African American Women Who Were HIVpositive (n = 60).
Anxiety Symptoms (BAI Scores)
r (p value)
.24 (.06)
.10 (.44)
.21 (.12)
-.01 (.96)
.69 (<.0001)*
.15 (.26)

Acquired Vulnerability
Alcohol and/or Drug Use
Educational Level
Income
HIV Disclosure Status
Sleep Quality
History of Sexual Assault

Note: BAI=Beck Anxiety Inventory. Study a priori alpha was *p≤.05.
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history of sexual abuse or assault) on depressive symptoms in non-pregnant African
American women who were HIV-positive.
In the current study, variables were identified as appropriate for entry as
predictors into the multiple regression model through the use of Pearson correlation
coefficients. Pearson correlation coefficients were estimated between dependent variables
(depressive symptoms as measured by total CES-D scores) and independent variables
(inherited and acquired vulnerabilities). Statistically significant correlations were
identified as those with a p value ≤ 0.2. Only one independent inherited variable, family
history of mood disorder met this criterion and was entered into the stepwise equation.
Stepwise multiple regression analyses with backward elimination were performed and
variables were eliminated if the variable was ≥ .20 p-value. In stepwise multiple
regression analyses, all independent variables were entered one by one into the regression
model, and then one by one, each variable is deleted in order to identify a significant drop
in R2 (Penhazur & Schmelkin, 1991). The stepwise approach with backward elimination
was selected in order to illustrate the power of a single independent variable on the
dependent variables (depressive and anxiety symptoms).
For regression analysis, family history of mood disorders was the only inherited
variable that remained in the model. However, neither the model, nor the predictor,
family history of mood disorders, was statistically significant. Only 4% of the adjusted
variance in depressive symptom scores was explained by a positive family history of
mood disorder. Table 4.19 illustrates simple regression analysis for depressive symptoms
as measured by CES-D scores in this sample of non-pregnant women.
The same statistical analyses were conducted to examine the influence of
inherited vulnerabilities on depressive symptoms as measured by total EPDS scores. Two
variables were entered into the stepwise equation (family history of mood disorders and
family history of alcohol and/or drug use) because Pearson correlation coefficients were
significant at the ≤ .20 level. Backward elimination was performed and independent
variables were eliminated if the individual variable was ≥ .20 p-value. The only variable
eliminated from the model was family history of mood disorder. The final model retained
family history of substance use; however, neither the predictor nor the model was
statistically significant. Only 5% of the variance in depressive symptom scores was
explained by a positive family history of substance use. Table 4.20 illustrates the
complete simple regression results for the influence of inherited vulnerabilities on
depressive symptoms as measured by the EPDS.
Based on the zero-order correlations, the acquired vulnerabilities (educational
level, income level, alcohol and/or drug use, HIV disclosure status, sleep quality, history
of sexual abuse or assault) were entered into the first regression model conducted to
predict depressive symptoms using the CES-D.
Four variables were entered into the stepwise equation (educational level, alcohol
and/or drug use, sleep quality, and history of sexual abuse or assault) as they met the
previously described selection criteria. Two variables were eliminated from the model,
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Table 4.19 Summary of Stepwise Simple Regression Analysis by Backward
Elimination for Depressive Symptom Scores Using the CES-D* among NonPregnant African American HIV-positive Women (n = 60).

Intercept
Family History of Mood
Disorders

Parameter
Estimate
1.995271
3.295081

Predictor
16.421053
5.9425837

SE
8.23
1.80

p
<.0001
0.0765

Note. R2 =0.0531; adjusted R2 =0.036774, df =59; CES-D = Center for
Epidemiologic Studies Depression Scale. Predictor variable classified as an inherited
vulnerability

90

Table 4.20 Summary of Stepwise Simple Regression Analysis by Backward
Elimination for Depressive Symptoms Measured by EPDS* among Non-Pregnant
African American HIV-positive Women (n = 60).
Predictor
Intercept
Family History of
Alcohol/Drug Use

Parameter
Estimate
7.78947
3.7105263

SE
1.155712
1.908595

t
6.74
1.94

p
<.0001
0.0567

Note. R2 = 0.0612, adjusted R2 = 0.045, df =58;
*EPDS= Edinburgh Postnatal Depression Scale. Predictor variable is classified as an
inherited vulnerability
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educational level and history of sexual abuse or assault. The final model retained
substance use and sleep quality and both predictors as well as the model were statistically
significant. Substance use was significant at the p = .0020 level, indicating that a positive
history of substance abuse was significantly associated with higher depressive symptom
levels on the CES-D. Sleep quality was significant at the p < .0001 level, indicating that
poorer sleep quality was significantly associated with higher depressive symptom levels
on the CES-D. Thus, both predictors and the model were significant (Model statistics R2
= .5451, df = 57, p < .0001). Greater depressive symptoms were associated with a history
of substance use and poorer sleep quality. Table 4.21 provides a summary of multiple
regression analysis results.
Based on the zero-order correlations, the acquired vulnerabilities (educational
level, income level, alcohol and/or drug use, HIV disclosure status, sleep quality, history
of sexual abuse or assault) were entered into the second regression model. Stepwise
multiple regression with backward elimination was conducted to predict depressive
symptoms using the EPDS. Three variables were entered into the stepwise equation
(substance use, educational level, and sleep quality). The only variable eliminated from
the model was educational level. The final model retained substance use and sleep quality
and both predictors and the model were statistically significant. Substance abuse was
significant at the p = .0145 level, indicating that a positive history of substance abuse was
significantly associated with higher depressive levels on the EPDS total score. Sleep
quality was significant at the p < .0001 level, indicating that poorer sleep quality was
significantly associated with higher depressive symptom levels on the EPDS total score.
Acquired vulnerabilities accounted for 46% of the variance in EPDS total score. The
regression model for depressive symptoms indicated that substance use and sleep quality
were the significant acquired vulnerabilities that influenced the EPDS total score. In
contrast, education level was not a significant predictor of depression. See Table 4.22 for
complete model results.
AIM FIVE
Examine the influence of inherited vulnerabilities (family history of mood
disorders, and family history of alcohol and/or drug use) and acquired vulnerabilities
(educational level, income level, alcohol and/or drug use, HIV disclosure status, sleep
quality, and history of sexual abuse or assault) on anxiety symptoms in non-pregnant
African American women who are HIV-positive. Although anxiety symptom levels were
relatively low, regression analyses were completed for prediction purposes.
Stepwise multiple regression analysis with backward elimination was used to
answer this question. In order to identify the most appropriate variables for entry as
predictors into the regression model, Pearson correlation coefficients were estimated
between outcome variables and predictor variables. Using the bivariate results obtained in
correlation analyses, separate multiple regression analyses with backward elimination
were conducted for inherited and acquired vulnerabilities with the outcome variable (BAI
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Table 4.21 Summary of Stepwise Multiple Regression Analysis by Backward
Elimination for Depressive Symptoms Measured by CES-D among Non-Pregnant
African American HIV-positive Women (n = 60).
Predictor
Intercept
Alcohol and/or Drug Use
Sleep Quality

Parameter
Estimate
2.3882439
7.199529
1.7276818

SE
2.201078
2.227402
0.218227

t
1.09
3.23
7.92

p
0.2825
0.0020
<0.0001

Note. R 2 = .5731, Adjusted R 2 = .5420, df=55. Predictor variables are classified as
acquired vulnerabilities.
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Table 4.22 Summary of Stepwise Multiple Regression Analysis by Backward
Elimination for Depressive Symptoms Measured by EPDS among Non-Pregnant African
American HIV-positive Women (n = 60).
Predictor
Intercept
Alcohol and/or Drug Use
Sleep Quality

Parameter
Estimate
0.6813078
3.6451532
0.9085051

SE
1.428049
1.445128
0.141584

t
0.48
2.52
6.42

p
0.6351
0.0145
<0.0001

Note. R2 = .46, Adjusted R2 = .4344, df=56. Predictor variables classified as acquired
vulnerabilities. EPDS = Edinburgh Postnatal Depression Scale.
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scores to assess anxiety).
Two inherited vulnerabilities were entered into the stepwise equation, family
history of mood disorders and family history of substance use, because Pearson
correlation coefficients were significant at the ≤ .20 level. Backward elimination was
performed and variables were eliminated if the individual variable was ≥ .20 p-value. The
only variable eliminated from the model was family history of substance use. The final
model retained family history of substance use, which was non-significant (p = .1402).
Table 4.23 depicts complete multiple regression results for this model.
The influence of acquired vulnerabilities on anxiety symptoms among nonpregnant African American women who were HIV-positive was examined using
stepwise multiple regression analysis with backward elimination. In order to identify
which predictors could be used for regression analyses, Pearson correlation coefficients
were estimated between outcome variables and acquired vulnerabilities. Statistically
significant correlations were identified, and these items were used in the multiple
regression analysis. Although there were six hypothesized predictor variables identified
as potential acquired vulnerabilities, only alcohol and/or drug use and sleep quality were
significantly correlated with anxiety and included in the regression analyses.
Backward elimination was performed and variables were eliminated if the
individual variable was ≥ .20 p-value. Neither variable was eliminated from the model.
Substance use was significant at the p = .0073 level, indicating that a positive history of
alcohol and/or drug use was significantly associated with higher anxiety symptom levels
on the BAI. Sleep quality was significant at the p ≤ 0.05 level, indicating that poorer
sleep quality was significantly associated with higher anxiety symptom levels as
measured by the BAI. Thus, both predictors and the model were significant (Model
statistics R2 = .5259, F = .33.72, df = 2, p < .0001).Thus, greater anxiety symptoms were
associated with alcohol and/or drug use and poorer sleep quality. Table 4.24 provides a
summary of the model statistics.
Regression diagnostic analyses were performed to evaluate bivariate relationships
between predictor variables included in the multiple regression analyses. The use of
highly intercorrelated variables should be avoided, as their influence on one another
limits individual predictor strength. Schroeder (Schroeder, 1990) and Fox (Fox, 1997)
provide suggestions regarding identification of multicollinearity. For each predictor
variable in the regression model, correlation coefficients should be identified. Potential
problems may exist if there is a high correlation coefficient that exists between variables.
Schroeder (Schroeder, 1990) and Fox (Fox, 1997) also suggest using methods such as
estimating tolerance to test the validity of regression models. Variance inflation factor
analysis is also useful to detect multicollinearity. A tolerance close to zero is indicative of
collinearity; a variance inflation factor < 10 is indicative of no significant collinearity.
For the current study a tolerance level less than .20 and variance inflation factor greater
than 4.0 were indicative of significant collinearity.
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Table 4.23 Summary of Stepwise Multiple Regression Analysis by Backward
Elimination for Anxiety Symptoms Measured by BAI among Non-Pregnant African
American HIV-positive Women (n = 60).
Predictor
Intercept
Family History of Mood
Disorders
Family History of
Alcohol/Drug Use

Parameter
Estimate
8.10954
7.42638

SS
0
672.1055

F
0.00000
5.187

p
1.0000
0.0265*

2.09305

53.38781

0.412

0.5235

Note. R2 = 0.1174, adjusted R2 = 0.0865, df =57, p =.1402. Predictor variables are
classified as inherited vulnerabilities. BAI = Beck Anxiety Inventory
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Table 4.24 Summary of Stepwise Multiple Regression Analysis by Backward
Elimination for Anxiety Symptoms Measured by BAI among Non-Pregnant African
American HIV-positive Women (n = 60).
Predictor
Intercept
Alcohol and/or Drug Use
Sleep Quality

Parameter
Estimate
-3.46575
6.01172
1.64074

SS
0.000
520.394
4038.277

F
1.000
7.739
60.051

p
0.0073
0.0000

Note. R 2 = .5420, Adjusted R 2 = .5259, df=57, p < .0001 Predictor variables are
classified as acquired vulnerabilities. BAI = Beck Anxiety Inventory
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For each predictor variable used in this study, tolerance and variance inflation
factor was examined. Tables 4.25 through 4.28 illustrate regression diagnostic analyses
suggesting that multicollinearity was present at acceptable levels in the study models.
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Table 4.25 Collinearity Diagnostics for the Model of Inherited Vulnerabilities and
Anxiety Symptoms (n=60).

Variable
Intercept
Family History of Mood Disorders
Family History of Alcohol/Drug Use

df
1
1
1

Tolerance
.8898
.8898

Variance Inflation
Factor
0.0000
1.2385
1.2385

Note. Tolerance levels less than .20 and variance inflation factor levels greater than
4.0 indicative of significant collinearity.
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Table 4.26 Collinearity Diagnostics for the Model of Acquired Vulnerabilities and
Anxiety Symptoms (n=60).

Variable
Intercept
Alcohol and or Drug Use
Sleep Quality

Tolerance
.
.9999
.9999

df
1
1
1

Variance Inflation
Factor
0.0000
1.0001
1.0001

Note. Tolerance levels less than .20 and variance inflation factor levels greater than
4.0 indicative of significant collinearity.
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Table 4.27 Collinearity Diagnostics for the Model of Depression as Measured with
the Center for Epidemiologic Depression Scale and Acquired Vulnerabilities (n=60).

Variable
Intercept
Alcohol and or Drug Use
Education Level
Sleep Quality
History of Sexual Assault

Tolerance

df
1
1
1
1
1

.9360
.9689
.94503
.9001

Variance Inflation
Factor
.0000
1.068444
1.0321
1.0582
1.1109

Note. Tolerance levels less than .20 and variance inflation factor levels greater than
4.0 indicative of significant collinearity.
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Table 4.28 Collinearity Diagnostics for the Model of Caregiver Depression as
Measured with the Edinburg Postnatal Depression Scale and Acquired Vulnerabilities
(n=60).

Variable
Intercept
Alcohol and or Drug Use
Education Level
Sleep Quality

df
1
1
1
1

Tolerance
.
.9979
.9786
.9806

Variance Inflation
Factor
.0000
1.0021
1.0219
1.0198

Note. Tolerance levels less than .20 and variance inflation factor levels greater than
4.0 indicative of significant collinearity.
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CHAPTER 5. DISCUSSION AND IMPLICATIONS
DISCUSSION
The systematic investigation of predictors of depressive and anxiety symptoms
among African American HIV-positive women has been understudied. Thus, the aims of
this study were to identify the levels of depressive and anxiety symptoms and the
predictors of depressive and anxiety symptoms in African American women who were
HIV-positive and receiving health care in a mid-southern city in the United States. While
preliminary, these findings provide direction that can help health care providers recognize
HIV-positive women who are at increased risk for the development of mood disorders.
DEMOGRAPHIC FINDINGS
The majority of the women in the present study were poor and unmarried. Most
participants reported their marital status as single (n=14, 70% pregnant vs. n=32, 53.3%
non-pregnant). A few of the non-pregnant group (n=6, 10%) were widowed. One woman
reported AIDS as the cause of her spouse’s death; another woman reported that her
husband committed suicide after she was hospitalized and diagnosed with AIDS. This
participant also reported that after the suicide, she learned that her husband knew about
his HIV diagnosis for many years prior to her diagnosis.
Almost half (49%) of the total sample of pregnant and non-pregnant women
reported annual household incomes of less than $5000, (63% of the pregnant women;
44% of the non-pregnant women). Almost one-half (47.3%) of the total sample was
unemployed, whereas 45% of the total sample reported part-time employment. Levels of
disability were not assessed for this sample of women; however disability could explain
the high prevalence of unemployment reported by study participants. These results are
similar to findings of regional HIV demographic results, indicating that HIV is a disease
that significantly affects southern, minority women who are poor (Centers for Control
and Prevention, 2007; Centers for Disease Control and Prevention, 2007b, 2007c; Reif,
Whetten, Ostermann, & Raper, 2006).
Levels of disability were not assessed for this sample of women; however
disability could explain the high prevalence of unemployment reported by study
participants. These results are similar to findings of regional HIV demographic results,
indicating that HIV is a disease that significantly affects southern, minority women who
are poor (Centers for Disease Control and Prevention, 2005, 2007b, 2007c; Reif et al.,
2006; U. S. Census Bureau, 2006). Participants in the current study were recruited from
ambulatory clinics located within a public safety net hospital, adding to the likelihood
that the sample would consist of predominately poor women.
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AIM ONE. LEVELS OF DEPRESSIVE AND ANXIETY SYMPTOMS
Depressive Symptoms
Scores on the CES-D and EPDS defined depressive symptoms in the current
study. Although most participants denied feeling depressed in the two weeks prior to
completion of the questionnaires, approximately 50% of participants in the sample had
both CES-D and EPDS scores requiring referral to the social worker (e.g. case manager).
Denial of depressive symptoms could be related to the fear and stigma of mental illness
that is pervasive within many African American communities. Sussman and colleagues
(Sussman, Robins, & Earls, 1987) found that the proportion of African Americans who
feared mental health treatment was 2.5 times greater than the proportion of whites.
Research indicates that African Americans are more likely to be diagnosed with severe
mental illnesses like paranoid schizophrenia and less likely to be diagnosed with affective
disorders than their white counterparts (Adebimpe, 1981; Bolden & Wicks, 2005;
Neighbors et al., 1989). Stigma contributes to delays in seeking mental health care and
treatment. Moreover, African Americans are more likely to use non-psychiatric services
such as prayer, primary care, and emergency services, rather than seek specific mental
health treatment (United States Department of Health and Human Services, 1999; K.
Wells et al., 2001)
The clinically relevant depressive symptom scores found in this sample could
reflect the overlap seen between symptoms of depression and symptoms of chronic
illness. Overlapping symptoms for depression and HIV include poor appetite, weight
loss, fatigue, and poor sleep (Kalichman, Rompa, & Cage, 2000). The CES-D captures
depressed affect, positive affect, and somatic complaints, however, researchers have
illustrated similar factors in HIV-symptomatic persons (Cochran & Mays, 1994) , which
may have resulted in inflated depressive symptoms scores on the CES-D in symptomatic
HIV-positive persons (Kalichman et al., 2000). The mean CD4 count in this sample was
over 500, reflecting a clinically stable population, although HIV specific symptoms were
not assessed in this study. Some of the women who had elevated depressive symptom
scores may have been clinically depressed and were referred for further evaluation. Two
of the women were immediately assessed by their provider and started on antidepressants
the day of their participation. Researchers have found similar rates of depressive
symptoms in HIV positive women (Ickovics et al., 2001; McDaniel, Fowlie,
Summerville, Farber, & Cohen-Cole, 1995) .
The non-pregnant group of women in the present study had a higher level of
depressive symptoms than the pregnant group of women. These results may be attributed
to the fact that the non-pregnant group had a longer duration of HIV diagnoses. While
this longer duration could provide time to accept the diagnosis, many of these women
experienced multiple illness-related life events that potentially contributed to higher
depressive symptom levels. Specifically, this group of non-pregnant women more often
reported losing partners to AIDS, which may account for higher levels of depressive
symptom scores. Pregnant women in the study might have felt greater hope and optimism
than the non-pregnant group. In a meta-analysis of qualitative research (Sandelowski &
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Barroso, 2003), HIV-positive women reported that motherhood gave them a sense of
identity, reason to improve their lives, strength, hope, and joy. However these qualitative
results do not account for the greater depressive symptoms reported by non-pregnant
participants who were also mothers. HIV-positive mothers have reported negative
impacts of their disease, specifically the stigma associated with the disease, negative
impact of HIV on their children, and guilt associated with possible transmission of HIV
to their children (Sandelowski et al., 2003). HIV-positive women have also reported a
fear of disapproval from others when they decide to have children (Sandelowski et al.,
2003). In the current study, pregnant participants’ depressive symptoms scores could
have been influenced by the hope that their unborn babies would not be HIV-infected;
however this information was not elicited from the study sample.
Anxiety Symptoms
Although depressive and anxiety symptoms often occur simultaneously in the
general population, the present study did not confirm the coexistence of clinically
relevant levels of both symptom types. The levels of depressive symptoms were clinically
relevant in both groups of women, while anxiety symptoms were in general uncommon in
both groups. Most (83%) of the sample had BAI scores of less than 22, which is
indicative of little or no anxiety (A. T. Beck et al., 1988). Only three women (15%) in the
group of 20 pregnant women had BAI scores at or above a clinically relevant level
compared to eight non-pregnant women (13%). Conversely, almost half of the total
sample of 80 women had CES-D scores (52.46%) and EPDS scores (48.75%) indicating
the need for referral and additional assessment of depressive symptoms.
National data related to the co-morbidity of depressive and anxiety symptoms in
the general population (Hirschfeld, 2001; R. C. Kessler, McGonagle, Nelson et al., 1994)
indicate higher incidence rates than reported in the current sample of women. Kessler and
colleagues (R. C. Kessler, McGonagle, Nelson et al., 1994) reported a 10.3% prevalence
rate for depression, while the prevalence rate for generalized anxiety disorder was 3.1%.
In a second larger study (N=9282), Kessler and colleagues (R. C. Kessler et al., 2005)
reported anxiety as the most prevalent DSM-IV disorder in the general population
(18.1%), with over half of the participants having more than one disorder. In another
study, 75% of patients diagnosed with major depressive disorder in the primary care
setting also had an anxiety disorder (Olfson et al., 2000). Thus, the prevalence rate of
anxiety symptoms in the current study was lower than that of the general population. A
possible explanation for this finding is the underreporting of symptoms of anxiety.
Evidence suggests that persons are likely to underreport symptoms that they perceive as
embarrassing (R. C. Kessler et al., 2002; Merikangas et al., 1998). While these findings
were unexpected, it is unclear if the low levels of anxiety symptoms occurred because
women with significant depressive symptoms did not have clinical depression. Anxiety
typically precedes depression (Zimmerman & Chelminski, 2003). This point is
particularly important as the depressive symptom instruments used in this study are
screening tests rather than diagnostic tests. Clinically significant depressive symptom
scores on screening tests may reflect a false positive score which is especially common in
populations in which chronic illness symptoms overlap with symptoms of depression
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(Cavanaugh, Clark, & Gibbons, 1983). Although the current study revealed low levels of
anxiety symptoms in the presence of clinically important depressive symptoms, the
continued assessment of both anxiety and depression is warranted due to national trends
documenting their coexistence (R. C. Kessler et al., 2005).
AIM TWO. ASSOCIATIONS AMONG INHERITED AND ACQUIRED
VULNERABILITIES AND DEPRESSIVE SYMPTOMS
Inherited Vulnerabilities and Depressive Symptoms
Non-pregnant women in the study sample with a positive family history of mood
disorders, an inherited vulnerability, did not report associated increases in depressive
symptom scores as measured by the CES-D or the EPDS. Similarly, non-pregnant women
in the study sample with a positive family history of alcohol and/or drug use, an inherited
vulnerability, did not report associated increases in depressive symptom scores as
measured by the CES-D or the EPDS. Of the 80 women participating in this study only
26 reported a positive family history of alcohol and/or drug use. Additionally, the use of
dummy-coding that was implemented for the categorization of family history results
(presence or absence of the variable) limited the variability needed to show significant
correlations, as the value for the score was either 0 or 1.
Inherited vulnerabilities revealed similar mixed associations with depressive
symptom scores in the group of pregnant women. Family history of mood disorders was
significantly and positively associated with higher levels of depressive symptoms on both
the CES-D and EPDS scores, however, no association was found between family history
of alcohol and drug use and depressive symptom scores in this group of 20 pregnant
women. These findings were surprising given that research in the general population has
consistently indicated a link between depressive symptoms and a positive family history
of both mood disorders and alcohol/drug use (Gutman & Nemeroff, 2003; King et al.,
2006; Kosten et al., 1992; Weissman et al., 2005). Alternative explanations for these
findings may be denial of family history of alcohol and/or drug use or embarrassment,
which could have lead to underreporting of family histories of alcohol and/or drug use.
Of the 80 women participating in this study only 26 reported a positive family history of
alcohol and/or drug use; a similar number (n= 28) reported a family history of mood
disorder. For a correlation to be found between variables that are scored as 0 or 1 (the
presence or absence of the variable of interest) there must be sufficient numbers of
persons with and without the variable of interest to detect this association.
Acquired Vulnerabilities and Depressive Symptoms
Women who reported a positive history of personal alcohol and/or drug use and
poor sleep quality as indicators of acquired vulnerabilities had higher levels of depressive
symptoms on both the CES-D and EPDS, in both groups of women (pregnant and nonpregnant). These findings are consistent with the literature, with correlations between
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alcohol and drug use and depressive symptoms reported in women (Darko, McCutchan,
Kripke, Gillin, & Golshan, 1992; Darko, Mitler, & Miller, 1998; Dixit & Crum, 2000;
Mock et al., 2002; Norman et al., 1992; Penzak, Reddy, & Grimsley, 2000; Reardon &
Buka, 2002; Schutte et al., 1995; Tam, Weisner, & Mertens, 2000; K. Wells et al., 2001),
and African American populations (Reardon & Buka, 2002; Tam et al., 2000; K. Wells et
al., 2001).
Poor sleep quality and depressive symptoms have also been well-documented in
the literature (Neubauer, 2004). Clinically relevant depressive symptom scores were
found on the CES-D and EPDS in both groups (non-pregnant and pregnant) of women
that had PSQI scores above the cut-off (≥5). Most all of the women with clinically
relevant PSQI scores had scores above the study mandated cutoffs for both the CES-D
and EPDS. Results of the current study largely parallel published research with regard to
poor sleep quality and depressive symptoms in HIV-positive women (Lee et al., 2001)
and HIV-positive men (Perkins et al., 1994). Only seven women in the sample had
clinically relevant PSQI scores without clinically relevant CES-D or EPDS scores. This
strong association between sleep quality and depressive symptoms however could reflect
sleep difficulties related to HIV, side effect of medications, or poor sleep environment
(Darko et al., 1992; Darko et al., 1998; Mock et al., 2002; Norman et al., 1992; Penzak et
al., 2000; Reardon & Buka, 2002; Tam et al., 2000; K. Wells et al., 2001). Although
causal relationships are difficult to infer, poor sleep quality and depressive symptoms are
often concomitant problems, with one contributing to the other.
HIV disclosure status was significantly correlated with higher depressive
symptom scores on the CES-D, but not the EPDS, in the group of pregnant women. The
CES-D has a much wider scoring range than the EPDS, which may make it easier to find
a significant association between depressive symptom levels and HIV disclosure status.
When diagnostic criteria for depression according the DSM-IV are compared to the
screening content of the CES-D and EPDS, both instruments target the same symptoms.
The clinically relevant depressive symptom scores on the EPDS in the population
of pregnant women that had disclosed their HIV status was surprising. This finding was
unexpected as the act of disclosure was hypothesized to decrease depressive symptoms,
increase support services and networks, thereby decreasing depressive symptoms
(Schmidt & Goggin, 2002; D. K. Smith et al., 1996). However, Schmidt and Goggin
(Schmidt & Goggin, 2002) reported that the HIV-positive single mothers in their study
reported less satisfaction from the disclosure process, lower levels of perceived social
support, and higher levels of depressive symptoms, findings that were different than the
majority of positive results associated with disclosure. Moreover, the majority of the
sample in the current study was single and mothers, offering support to Schmidt and
Goggin’s (Schmidt & Goggin, 2002) results, as well as a plausible explanation for these
findings.
Additional alternative reasons for inconsistent results include the small sample
size (which may not adequately reflect the experiences of the population) and the feelings
of shame and abandonment that could have been felt by those women that had exposed
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their HIV to others. HIV is a disease that is not viewed by others with sympathy and
support unlike other diseases such as cancer. When a disease, such as HIV, is frequently
acquired through behavioral choices, the resulting perception may be that the person
“deserves” the disease. If this is the perception, psychological and social support may be
withheld. These confounding findings are noteworthy. Sensitivity of instrumentation
should be evaluated when instruments designed to measure the same variable reveal
different results. Mosack and Shore (Mosack & Shore, 2003) reported that the CES-D
identified higher numbers of women with depressive symptoms than the EPDS when
administered to the same group of women. Although the family history of the sample in
Mosack and Shore’s study (Mosack & Shore, 2003) was not discussed, the affect of
family history cannot be ignored, and could have impacted their study results.
AIM THREE. ASSOCIATIONS AMONG INHERITED AND ACQUIRED
VULNERABILITIES AND ANXIETY SYMPTOMS
Inherited Vulnerabilities and Anxiety Symptoms
Women in the present study (N = 80) who reported inherited vulnerabilities of
family history of mood disorders had higher BAI scores than women who did not report
family history of mood disorders. Similar findings were noted for women who reported a
positive history of family history of alcohol and/or drug use, with their BAI scores higher
than the women who did not report a family history of alcohol and/or drug use. Similar
findings are reported in the literature. McLeod and colleagues (McLeod, Foster, HoehnSaric, Svikis, & Hipsley, 1994) investigated the relationship between family history of
alcoholism and increased levels of anxiety symptoms in a group of women that were
being treated for generalized anxiety disorder (n = 54). The majority of the sample (76%)
reported an alcohol use disorder in a first degree relative. Investigators specified that
within the group of women that reported a family history of alcohol use disorder, the
majority of them (74%) reported paternal family history. The current study did not
specify which relative had a history of alcohol and/or drug use. Determining maternal or
paternal history, as well as multi-generational information would have added depth to the
family history aspect of the current study.
Similarly, anxiety disorders were prevalent among subjects (N = 454) with a
family history of alcohol dependence in a longitudinal study of college students
(Kushner, Sher, & Erickson, 1999). Additional literature reflects that children born to
parents with a history of substance use disorders have been shown to be at greater risk for
developing drug and alcohol abuse problems of their own, as well as problems with
anxiety and depression (Barnard & McKeganey, 2004; Clark, Cornelius, Wood, &
Vanyukov, 2004; S. L. Harter, 2000). Family history of alcohol and/or drug use revealed
inconsistent associations, with elevated BAI scores noted in the group of non-pregnant
women but not the pregnant group. Alternative explanations for the confounding results
could be a result of participants’ inability to accurately recall family histories or possible
reluctance to report potentially embarrassing family histories.
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Acquired Vulnerabilities and Anxiety Symptoms
The findings indicated that the women, both pregnant and non-pregnant, who
reported active substance use and poor sleep quality, had elevated BAI scores. Similar
results are noted in published studies, with elevated anxiety symptoms found in
populations of alcohol and drug using women (Dixit & Crum, 2000; Holahan et al., 2003;
Schutte et al., 1995). As noted with depressive symptoms, HIV disclosure status was
unexpectedly associated with increased anxiety symptoms in the group of pregnant
women, indicating that women who had disclosed their HIV status demonstrated elevated
anxiety symptom scores on the BAI. Negative consequences of HIV disclosure, such as
rejection and isolation, have been reported (Lovejoy, 1990). However, suppressing
communication about difficult experiences increases the likelihood of stress-related
problems (Greenberg & Stone, 1992; Holahan et al., 2003; Pennebaker, Colder, & Sharp,
1990). Therefore, the concept that disclosing one’s HIV status would be the first step in
communicating about HIV and thereby gaining social support, which in turn could
decrease stress and anxiety. The unexpected findings in the current study could be
attributed to the shame and stigma that is often associated with HIV, and possibly
experienced by this group of pregnant women after they disclosed their HIV status.
The study findings indicated that poor sleep quality was significantly and
positively associated with anxiety symptoms in both groups (pregnant and non-pregnant)
of women, although conflicting reports are noted in the literature. Published literature
reveals sleep disturbances in persons with anxiety symptoms in studies involving both
objective (e. g. sleep somnography) assessments (Fuller, Waters, Binks, & Anderson,
1997; Kripke et al., 2004) and subjective (e. g. self reported) sleep assessments (Kripke et
al., 2004; Neubauer, 2004; Nokes & Kendrew, 2001). Other studies report the absence of
significant associations between sleep disturbances and anxiety (Darko, Mitler, & White,
1995; Norman et al., 1992).
AIM FOUR. PREDICTORS OF DEPRESSIVE SYMPTOMS
Inherited Vulnerabilities and Depressive Symptoms
Although both inherited and acquired vulnerabilities were explored, acquired
vulnerabilities were the only significant predictors of depressive symptoms in this sample
of non-pregnant women. Neither family history of mood disorders nor family history of
alcohol and/or drug use was a significant predictor of depressive symptoms in the current
study. These findings were in contrast to much of the published literature, which reports
these inherited vulnerabilities as predictors for depressive symptoms. Family history of
mood disorders has been a strong predictor of mood disorders (Gershon et al., 1982;
Klein et al., 2001; Weissman et al., 1987; Weissman et al., 1997; Weissman et al., 2005).
Many studies of families of adults have shown that children born to parents with major
depressive disorder have a three-fold risk of experiencing major depressive disorder
themselves (Downey & Coyne, 1990; Lieb et al., 2002; Williamson et al., 2004). Results
of multiple studies have also found a significant positive association between family
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history of substance use and mood disorders (Clark et al., 2004; Kendler, Davis, &
Kessler, 1997; Maier et al., 1994). Differences noted in the current study and previously
published literature could be related to the small number of women who reported positive
family histories. Only 22 of the 60 non-pregnant women in the sample (36.67%) reported
a family history of alcohol and/or drug use. Thus, the study may have not been
sufficiently powered to detect the influence of this variable on depressive symptoms.
Acquired Vulnerabilities and Depressive Symptoms
The findings indicated that the acquired vulnerabilities of current alcohol and/or
drug use and poor sleep quality were predictive of higher depressive symptom scores in
this population of non-pregnant African American women. Substance use has been
consistently identified in the literature as a predictor of depressive symptoms. The results
of the current study are consistent with previous literature (Clark et al., 2004; Holahan et
al., 2003; Kendler et al., 1997; Olfson et al., 2000). Alcohol and/or drug use has been
associated with depressive symptoms in the general population and many studies have
described the relationship between alcohol use and mood disorders (Clark et al., 2004;
Dixit & Crum, 2000; Holahan et al., 2003; Schutte et al., 1995).
Poor sleep quality was a significant predictor of depressive symptoms in this
population of non-pregnant African American women. The findings in the current study
are consistent with much of the previous literature. Norman and colleagues (Norman et
al., 1992) report similar findings in their sample of asymptomatic HIV-infected men and
Lee and Miramontes (Lee et al., 2001) report similar findings in their sample of HIVpositive women. The latter study examined the relationship between sleep, depression,
and fatigue in a group of HIV-positive women (N=100). While the Lee and Miramontes
(Lee et al., 2001) study examined subjective measurements of depressive symptoms and
fatigue and objective measurements of sleep efficiency, and the current study examined
subjectively reported sleep quality and depressive symptoms, results are comparable.
AIM FIVE. PREDICTORS OF ANXIETY SYMPTOMS
Inherited Vulnerabilities and Anxiety Symptoms
The findings indicated that acquired vulnerabilities served as predictors of anxiety
symptoms in this group of non-pregnant women. Again, the acquired vulnerabilities of
current alcohol and/or drug use and poor sleep quality were the only predictors of anxiety
symptoms in this group of non-pregnant women. Inherited vulnerabilities, family history
of mood disorders and family history of alcohol and/or drug use, were not predictors of
anxiety symptoms in this sample. Although important historical markers, the presence of
these inherited vulnerabilities were not significant predictors of anxiety symptoms. In
addition, family history of mood disorders was present in 22 of the non-pregnant women
in the sample (36.67%), while 22 women (36.67%) in the group of non-pregnant women
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reported a family history of alcohol and/or drug use. Low numbers of participating
pregnant women could have hindered the ability to detect significant associations.
Acquired Vulnerabilities and Anxiety Symptoms
The acquired vulnerabilities that were predictors of depressive and anxiety
symptoms in this group of non-pregnant African American women who are HIV-positive
were alcohol and/or drug use and sleep quality. The findings indicated that the acquired
vulnerability of alcohol and/or drug use significantly predicted anxiety symptoms in this
group of non-pregnant African American women. Consistent with previous studies,
higher levels of anxiety symptoms have been associated with alcohol and/or drug use in
populations of adults (Burke, Burke, & Rae, 1994; Christie et al., 1988; Kushner et al.,
1999) women (K. P. Conway, Compton, Stinson, & Grant, 2006), African Americans
(Ginsburg & Drake, 2002), and HIV-positive persons (Bing et al., 2001). Alcohol use
disorders have been associated with higher rates of major depressive disorders (Goodwin,
Kroenke, Hoven, & Spitzer, 2003).
Although substance use has been well documented as a correlate of mood
disorders (R. C. Kessler, McGonagle, Zhao et al., 1994; Regier et al., 1990), the evidence
related to sleep assessment, including sleep quality and sleep hygiene is limited. Sleep
quality and dysfunction have been studied in HIV-positive women as predictors of
fatigue (Mock et al., 2002). Overlapping characteristics may have been present within the
current study, as poor sleep quality is a common complaint among patients with HIV
infection (Darko et al., 1998; Darko et al., 1995; Mock et al., 2002; Penzak et al., 2000),
alcohol use disorders (Dahl et al., 2003), depression (Darko et al., 1992; Mock et al.,
2002; Norman et al., 1992), and anxiety (Neubauer, 2004).
Poor sleep quality was noted in the majority of the sample. Although poor sleep
quality has been associated with mood disorders (Darko et al., 1992; Mock et al., 2002;
Neubauer, 2004; Norman et al., 1992) sleep assessments are not routinely obtained or
documented in the medical record (Rubinstein & Selwyn, 1998). Although the PSQI has
been widely used as an instrument for measuring sleep quality, it does not address the
physical or environmental characteristics that directly affect sleep quality. The synergistic
and circular nature of insomnia and mood disorders has been discussed and bidirectional
relationships revealed (Neubauer, 2004). Therefore, comprehensive sleep quality
assessments, which include environmental aspects, should be incorporated into routine
HIV care.
LIMITATIONS AND STRENGTHS
This study had four limitations. First, this study implemented a cross-sectional,
descriptive correlation design. This research design identifies associations present
between and among variables during a specific point in time. Cross-sectional designs do
not permit the exploration of changes over time, nor do they permit exploration of cause
and effect. Neither the chronicity of symptoms, nor the recurrences of symptoms are
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captured in cross-sectional studies. Thus, these results concerning levels of anxiety and
depressive symptoms, support associations with inherited and acquired vulnerabilities,
but do not address causality, changes over time, or disease progression.
The second limitation was convenience sampling; the fact that the entire sample
was recruited from health care clinics indicated that these women were receiving health
care. Consequently, women who did not receive routine health care were excluded from
the sample. This subgroup women, who were not available to participate in this study
could have experienced higher or lower rates of depressive and anxiety symptoms than
the participants in the current study. Therefore, the results of the current study may be
biased, limiting the external validity of the study findings to other populations. Randomly
selected study participants would have strengthened the design of the study however this
is seldom possible in health-related research.
The majority of the sample in the current study was poor, reporting an annual
household income below 5000.00. Higher rates of depressive illness have been reported
in poor populations (Everson et al., 2002; Gazmararian et al., 1995; Huurre, Eerola,
Rahkonen, & Aro, 2007). Low levels of education (less than high school degree or
equivalent) were noted in only nine (11.25%) of the participants. A third of the sample
[28 (35%)] had some college experience, and 19 (23.75%) reported a Bachelor’s degree
or higher. Study results show that educated women expose themselves to the risk of HIV
infection. The inclusion of a wider range of socioeconomic levels would have enhanced
the external validity of the study, although the sample in the current study reflects current
HIV demographic trends (Centers for Disease Control and Prevention, 2007c).
Lastly, self-rated and self-reported measures of anxiety and depressive
symptoms, as well as alcohol and/or drug use may not accurately capture precise
information. Self-reporting of anxiety and depressive symptoms may be limited due to
embarrassment and may not address the actual presence of symptoms. The ability of selfreport measurements for depressive and anxiety symptoms to discriminate between
persons with true depressive and anxiety symptoms and persons with false positive
results is never 100% accurate (Sharp & Lipsky, 2002). The CES-D, EPDS, and BAI are
all recommended as screening instruments. Self-rated evaluations of depressive and
anxiety symptoms have demonstrated both harms and benefits. According to the United
States Preventive Services Task Force (United States Preventive Services Task Force,
2002), the potential benefits of screening for depressive disorders include identifying
those who need treatment, reducing morbidity and mortality, and improving quality of
life, while potential harms of screening include false-positive screening results, adverse
effects related to labeling persons with false positive results, as well as treating persons
with false-positive results. Since all symptom information was self-reported, a complete
accurate account of symptomatology may not have been portrayed, due to factors such as
denial or hurried completion of instrumentation.
Conflicting accounts have been published regarding the reporting of
psychological symptoms by African Americans. Plant and Sachs-Ericsson (Plant &
Sachs-Ericsson, 2004) and colleagues report that ethnic minority women report more
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depressive symptoms than Caucasian women, while Wallsten (Wallsten, 2000) reports
that African Americans also are less likely to report psychological symptoms. George and
Lynch (George & Lynch, 2003) report that African Americans experience greater stress
than White Americans, therefore experience greater depressive symptoms than White
Americans. However, African Americans are less likely to seek outpatient mental health
care (Alegria et al., 2004; K. Wells et al., 2001) than their white counterparts and are
underrepresented in published research studies, further limiting comparisons across
studies.
Self-reporting of current alcohol and/or drug use was used in the current study.
This created another bias; participants may have chosen to not report illegal drug use.
Literature illustrates several reasons person may be untruthful regarding alcohol and/or
drug use. Fear of being reported to the authorities, fear of legal implications,
embarrassment, or distrust of the healthcare system (S. M. Smith et al., 2006).
Participants may have engaged in alcohol and/or drug use, but did not want their medical
care provider to know, therefore reported no use or lower levels of use. The under
reporting of alcohol and/or drug use may have occurred in the pregnant group, as society
does not view substance use as acceptable behavior in pregnant women. Despite these
factors related to accuracy of self-reported alcohol and /or drug use assessments,
literature suggests the majority of self-reports are valid (Alegria et al., 2004; Latkin,
1997; Sobell & Sobell, 1978). Literature reports the accuracy of self-reported
measurements of substance use can be enhanced if the participant is not under the
influence of alcohol and/or drugs, completes the assessment or interview in a clinical
research setting, and is ensured confidentiality (Sobell & Sobell, 1978). Although
assessments were performed at clinical locations and participants were informed of
confidentiality and questionnaire coding, the possibility of inaccurate reports of substance
use remains.
Concomitant psychological assessment by a psychologist or psychiatrists would
have strengthened the results and possibly given a more accurate portrayal of the mental
health of the participants. Additional interviews with the researcher and health care
providers could have added to a complete assessment of symptomatology. Follow-up data
could have provided additional information regarding results of psychiatric evaluations
that were conducted as a result of reported depressive and anxiety symptomatology.
Furthermore, the comparison of clinical assessments with questionnaire scores would
have provided additional validity to the study. The present study results are reflective of
self-reported assessments of depressive and anxiety symptoms in this population of
African American women.
Despite these methodological limitations, the present study has several strengths.
This was the first study to examine specific inherited and acquired vulnerabilities in
African American women who were HIV-positive. Most studies have examined the
effects of family history of mood disorders or family history of alcohol and drug use in
mentally ill or clinically depressed populations. The present study examined actual
predictors of symptoms, which may aid health care providers in the comprehensive care
of patients, increasing their ability to anticipate complications based on patients’ specific

113

family and personal histories. Educational level, income level, alcohol and/or drug use,
history of sexual assault or abuse, HIV disclosure status, and sleep quality were acquired
vulnerabilities that was explored in the current study. Although educational level, income
level, and alcohol and/or drug use are aspects that have previously been identified and
studied as predictors of mood disorders, the relationships of these variables as they apply
to HIV-positive women have not fully been explored. Women and minorities continue to
be underrepresented populations in research studies, particularly research pertaining to
HIV/AIDS. As women of color are significantly affected by HIV, and AIDS is the
number one killer of African American women between the ages of 25 and 34 in the
United States, their inclusion in research becomes important and necessary.
The assessment of history of sexual abuse or assault, HIV disclosure status, and
sleep quality were vulnerabilities that have not fully been explored in this population of
HIV-positive African American women. Although history of sexual abuse and assault
and HIV disclosure status were not predictors of depressive or anxiety symptoms in this
population of African American women, these vulnerabilities should be assessed in
clinical settings, as they have been shown to be relevant to mood disorders in other
studies pertaining to women (Barbe et al., 2004). In this group of HIV-positive women,
33 (41.25%) reported a history of sexual assault. However, 40 women (50%) reported
first sexual experience that occurred when they were younger than age 18 and their
partner was at least 3 years older, which legally constitutes statutory rape in the state of
Tennessee. Seventeen of these women reported histories of sexual assault; therefore, if
the additional 23 women were added to the total number of sexual assault histories, the
total would be 53 (66.25%) of the sample.
Additionally, the exclusively African American sample of women in the current
study’s sample provides an important contribution. Women and minorities continue to be
underrepresented in research studies; therefore this study adds information to the body of
literature. Although much of the earlier HIV literature reflected White, male, homosexual
populations, the demographic characteristics of more recent studies reflect the changing
face of AIDS. As HIV continues to disproportionately affect minorities in the United
States, additional studies comprised of African American samples becomes imperative.
An additional strength of the study was that subjects were recruited from
outpatient clinics that employed specialists in the field of HIV. The reputation of the
clinics for their expertise in HIV care and management resulted in population of patients
that encompassed a variety of socio-economic levels. Although most of the sample that
participated in the current study was poor and unemployed, the expertise of the clinical
sites increased the likelihood that patients from a wider range of socioeconomic levels
was available in the population from which the sample was recruited. Wider ranges of
socioeconomic levels and inclusion of both rural and urban populations would have
enhanced the external validity of the study.
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IMPLICATIONS
The results of this study have important implications for health care practice.
Increased awareness of potential vulnerabilities to depressive and anxiety symptoms by
healthcare providers may lead to increased screening for mood disorders. Research has
shown that primary care physicians fail to recognize and treat 30% to 50% of adult
depressed patients (Simon, Goldberg, Von Korff, & Ustun, 2002; Von Korff & Simon,
1996). Moreover, failure to detect depression may be greater for African American or
Hispanic patients and for patients under 35 years (Borowsky et al., 2000). Therefore, the
need for accurate, comprehensive screening and assessment of depressive and anxiety
symptoms in the health care setting remains crucial. Comprehensive screening as a
holistic approach may assist in the integration of mental health services into primary care
(Dodds et al., 2000).
The current study revealed the presence of sub-clinical levels of anxiety and
depressive symptoms in some participants and potentially clinical levels in others,
establishing the need for individual, ongoing assessment of vulnerabilities. Identification
of patients needing further evaluation and treatment may decrease adverse events and
psychological related hospitalizations. About 50% of women in the sample had scores
requiring referral to the social worker. Although no participant in the current study
required immediate hospitalization, two of the participants were started on antidepressants the day of study participation. These two women were referred to their
provider based on their elevated study questionnaire scores and additional clinical
assessment prior to initiating treatment antidepressant drugs. Current treatment with
antidepressants was not an exclusion criterion for the current study. Nine (15%) of the
non-pregnant women (n=60) were on antidepressants at the time of their participation in
the study; nevertheless eight of these women had elevated depressive symptom scores.
Therefore, the assessment of adequacy and efficacy of psychiatric medications is
indicated as an ongoing aspect of comprehensive health care. In this sample of women,
medication treatment was not consistently associated with sub-clinical symptom levels.
No assessment was made, however regarding the duration of antidepressant therapy.
The overwhelming presence of poor sleep quality in the sample, combined with
the association of poor sleep quality with anxiety and depressive symptoms, demonstrates
the need for routine assessment and documentation of sleep practices. Although sleep
disturbances were common in the HIV-positive women in this study and other studies,
assessment of sleep is not routinely documented in patients’ medical records (Rubinstein
& Selwyn, 1998). The adverse effects of poor sleep quality are multifaceted. Sleep and
health are impacted by the immune system. Sleep disturbances have been shown to
worsen as the course of HIV worsens (Darko et al., 1998; Mock et al., 2002; Nokes &
Kendrew, 2001; Sobell & Sobell, 1978). Poor sleep quality has been associated with
increased morbidity and mortality in HIV-positive persons (Darko et al., 1998).
Immunological molecules, including cytokines, impact sleep regulation (Motivala,
Sarfatti, Olmos, & Irwin, 2005). Impaired sleep is often a symptom of psychiatric
disorders, including anxiety and depression (Neubauer, 2004), while chronic insomnia is
a risk factor for the development and recurrence of psychiatric disorders (Lustberg &
Reynolds, 2000). Women with poor sleep quality were not being treated for insomnia,
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indicating either a lack of appropriate screening or insufficient communication with their
provider. Therefore, assessment of sleep quality and sleep disturbances should be part of
comprehensive medical care, and documented as such particularly in patients who are
HIV positive.
Increased adherence to antiretroviral medications may prolong the duration of the
regimen as well as decrease transmission of medication resistant virus (A. Ammassari et
al., 2004). The relationship of decreased antiretroviral adherence and mood disorders has
been well established. Depression in persons who are HIV-positive often results in
decreased adherence to antiretroviral medications (Chander, Lau, & Moore, 2006;
Starace et al., 2002) and increased risk-taking behaviors (Croughan, Miller, Wagelin, &
Whitman, 1982; Hutton, Lyketsos, Zenilman, Thompson, & Erbelding, 2004; Valente,
2003). A significant percentage of the participants in this study had CES-D, EPDS, and
BAI scores requiring immediate referral to the social worker, suggesting that patients
were not routinely assessed for signs and symptoms of depression or anxiety, despite the
fact that they were routinely receiving health care. As adherence to HAART can be
reduced by comorbid psychiatric disorders (Starace et al., 2002) it is imperative that
comprehensive psychosocial assessments, including routine screening for depressive and
anxiety symptoms, be a routine aspect of HIV care, similar to the practice of obtaining
laboratory evaluations.
Adherence to antiretroviral medications has been inversely related to substance
use in HIV-positive persons (Chander et al., 2006; Welch, 2000). The most common
substance used by women in the current study was alcohol, with 19 of the 24 women that
reported substance use reporting recent alcohol use. Routine assessment of substance use
is crucial to comprehensive HIV care. Collectively, these study results indicate the
importance of comprehensive assessments of potential vulnerabilities. Inquiry regarding
substance use and sleep quality, along with interval antiretroviral adherence assessments,
may increase the early identification of adherence problems. Noncompliance is one of the
main causes of antiretroviral resistance. Identification of barriers to adherence may
lengthen the time the person is able to use a specific antiretroviral regimen. In addition to
comprehensive assessment, thorough documentation is vital to patient care.
The vast majority (92.5%) of the sample had disclosed their HIV status to others.
Thus, it was not possible to show an association between disclosure and depressive and
anxiety symptoms as there was limited variability in HIV disclosure status. Despite this
finding, disclosure remains an important aspect of HIV. Increased disclosure of HIV
status to sex partners has the potential to decrease HIV transmission. Failure to disclose
HIV status can have devastating effects on public health. The most effective means of
HIV prevention among sexually active persons is consistent condom use (Centers for
Disease Control and Prevention, 2005). Lack of consistent condom use has been shown
to be prevalent in persons that did not disclose their HIV status to their partner (Chander
et al., 2006; Niccolai et al., 1999; Stein et al., 1998; Stein & Samet, 1999). Disclosure of
HIV status to family members and/or friends may help decrease stigma related to HIV,
while increasing support systems for patients. Stigma has been shown to “thrive in an
environment of ignorance and half-truths” (Valdiserri, 2002) p. 342). Therefore, HIV
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education and awareness would be the first step utilized to decrease stigma. Although
HIV disclosure was not a predictor of anxiety or depressive symptoms in the present
study because virtually all participants reported disclosing their status, the assessment of
HIV disclosure remains an important aspect of HIV care, and should be addressed
regularly as part of an ongoing psychosocial assessment.
Although cross-sectional data do not describe incidences that are present over
time, they do describe a snapshot assessment of individual characteristics. In the present
study, the participants expressed a multitude of psychological and social burdens that
would not have been assessed in a regular clinical appointment. The completion of the
study instruments led many patients to expound upon their experiences, thereby opening
communication with the clinical researcher. This type of revelation was often
accompanied by tears and expressions of relief that they were able to share their
experiences, concerns, and secrets with someone. Some participants reported being
victims of incest; while others disclosed a spouse’s suicide after a participant was
diagnosed with HIV; another reported weekly childhood rape by the man that transported
the participant to church every Sunday; and another reported displacement from her New
Orleans home and trauma related to hurricane Katrina. These unplanned discoveries
suggest that including psychosocial assessments in the care of persons who are HIV
positive would add additional support for the patient, as well as enhance providers’
insights into the lives of patients. Ongoing assessments, such as social work or case
management assessments at every visit, not only when a patient expresses a concern or
crisis, could provide an opportunity for patients to share some of these challenging
aspects of their lives. The inability to share traumatizing experiences may increase
depressive symptoms in this population. Depressive symptoms have been shown to
negatively affect HIV/AIDS treatment outcomes (A. Ammassari et al., 2004; Ickovics et
al., 2001; Lyketsos et al., 1996; Starace et al., 2002; Vyavaharkar et al., 2007), often
impacting adherence with HAART (A. Ammassari et al., 2004; A. A. M. Ammassari et
al., 2003; Starace et al., 2002; Vyavaharkar et al., 2007).
THEORETICAL IMPLICATIONS
Study findings provide partial support for the stress diathesis model as two of the
acquired vulnerabilities were significant predictors of anxiety and depressive symptoms.
The identification of vulnerabilities, both inherited and acquired, is an important tool in
comprehensive psychosocial assessments. The occurrence of stressful life events has
been found to increase the probability of a depressive episode in elderly populations
(Emmerson, Burvill, Finlay-Jones, & Hall, 1989), as well as populations of HIV-positive
women (Moore et al., 1999). Two acquired vulnerabilities, alcohol and/or drug use and
poor sleep quality, were significant predictors of anxiety and depressive symptoms.
Comorbid alcohol and/or drug use and psychiatric disorders have been well-documented
in the general population (Helzer & Pryzbeck, 1988; R. C. Kessler et al., 1997; Regier et
al., 1990; Starace et al., 2002; Vyavaharkar et al., 2007). The relationship between sleep
quality and depression in the HIV-positive population is also well documented (Darko et
al., 1992; Mock et al., 2002; Norman et al., 1992). The inherited vulnerability of family
history of mood disorders was associated with higher CES-D, EPDS, and BAI scores in
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the study sample. Findings were similar to previously published literature (Gutman &
Nemeroff, 2003) suggesting that the assessment of pertinent inherited and acquired
vulnerabilities should be a part of the routine assessment of African American women
who are HIV-positive to identify women that may be at an increased risk for mood
disorders.
FUTURE RESEARCH
Study findings provide guidance for future research in this population of women.
Future directions might include a longitudinal study that would follow participants over
time, thereby assessing the presence of vulnerabilities, depressive and anxiety symptoms
and other long-term outcomes related to the HIV-diagnosis. This type of research would
add to the understanding of the effects of stress over time, which may be especially
important in immunocompromised populations, such as those persons with HIV. Poor
sleep quality was a predictor of anxiety and depressive symptoms in the current study and
insomnia has been associated with psychiatric disorders, including depression (Lustberg
& Reynolds, 2000). Future studies should include assessment of sleep quality and sleep
hygiene, as well as test of established interventions that could improve sleep quality in
the study population.
Conflicting evidence regarding the impact of sleep quality and HIV disease
progression is noted in the literature. The impact of sleep quality on immunity (decrease
in CD4 count) has been illustrated in several studies (Darko et al., 1992; Mock et al.,
2002; Norman et al., 1992). Confounding results were noted in other studies involving
HIV-infected populations (Nokes, Chidekel, & Kendrew, 1999; Perkins et al., 1994;
Rubinstein & Selwyn, 1998), showing no effect of insomnia on immunologic markers
(CD4 count). The relationship between sleep and CD4 counts was not assessed in the
current study, although on average participants had counts of 505. The effect of poor
sleep quality in HIV-positive women has been well documented (Lee et al., 2001; Mock
et al., 2002). Sleep quality has the ability to affect many facets of well-being. Quality of
life in HIV-positive women has been associated with increased sleep quality and other
health-promoting behaviors such as exercise, stress management, and healthy eating
habits (Gielen, McDonnell, Wu, O'Campo, & Faden, 2001). Therefore, future studies
should include not only sleep assessments, but also interventions that can improve sleep
quality.
Stigma, shame, and fear continue to be additional stressors related to HIV, which
often delay or prevent treatment (Valdiserri, 2002). In the current study, six of the
participants (7.5%) had not disclosed their HIV-positive status. The CDC (Branson et al.,
2006) estimates that of the approximately 1 to 1.2 million persons living with HIV in the
United States about 25% (252,000-312,000 persons) were unaware of their infection. It is
thought that many of these persons have unknowingly transmitted HIV. The lack of
awareness of current HIV infection leads to two main issues: 1) increased numbers of
HIV transmission and 2) lack of medical care, thereby increasing morbidity and mortality
related to HIV/AIDS (Branson et al., 2006). Therefore, future research should
concentrate on the factors that are related to these difficulties.
118

Future research studies should include structured clinical interviews as well as
self-report measurements of depressive and anxiety symptoms. This comprehensive
approach would provide a more thorough and accurate mental health assessment, as selfreport measures are often confounded by denial and under reporting of symptoms. This
comprehensive approach would identify persons in need of additional screening, referral,
and treatment. Self-esteem measurement might provide insights regarding the mental
health status of African American women who are HIV-positive. Research has shown
that self esteem decreases as a result of severe mental illness (Shahar & Davidson, 2003).
Additionally, poor self-esteem commonly occurs in the context of depressive symptoms,
particularly in women.
Future research should also include a comprehensive housing assessment, as
housing situations in this population are often unstable, unsafe, and nonpermanent.
Almost half (45%) of the HIV-positive persons served by the Ryan White Care Act in
2002 (N=844,687) reported non-permanent housing (USDHHS Health Resources and
Services Administration, 2002). Although housing is transient, and often temporary for
persons with HIV, this issue was not systematically explored in the study sample.
However, several study participants (9, 11.25%) shared concerns related to this issue.
Concerns such as these, if persistent, likely serve as an acquired vulnerability that
contributes to the risk for depression and anxiety.
Early postnatal screening measures should be studied further, especially in
minority populations, as they have been grossly underrepresented in previous research.
Literature suggests that EPDS scores within the first few days of delivery are highly
correlated with EPDS obtained at four to six weeks postpartum (Chabrol & Teissedre,
2004; Hannah et al., 1992). Implementing routine screening of postpartum women before
hospital discharge may identify those women at risk for postpartum depression earlier,
thereby decreasing risks associated with postpartum depression for both mother and baby.
Finally, additional research should include qualitative or mixed methods studies
to explore the specific factors that contribute to mood disorders, HIV disclosure, and
decision making processes related to family planning in the HIV-positive population.
Qualitative research can aid the progress of nursing research by guiding research that has
a direct impact on nursing practice (Barroso & Powell-Cope, 2000). There are existing
qualitative research studies in the HIV literature regarding adherence to antiretroviral
medication and barriers to care (Bunting et al., 1999; Bunting & Seaton, 1999), and a
qualitative meta-analysis, or metasynthesis, explored the experience of living with HIV
(Barroso & Powell-Cope, 2000). Future research could use focus groups in different
types of populations to explore sleep quality and sleep hygiene practices, as poor sleep
quality had an impact on depressive and anxiety symptoms in this study. Sleep is affected
by many factors which should be explored in other populations as well. Environmental
factors such as temperature, noise levels, numbers of children in the home, numbers of
people in the bed, and insect infestation in the home were some of the points the
participants reported at the end of questionnaire completion. Findings from the current
study reveal that women present with a multitude of histories and vulnerabilities that are
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often complex. Qualitative research may lead to a greater understanding of the meaning
of being HIV-positive, which may help researchers and healthcare providers gain
understanding, rather than relying on preconceived ideas of what the experience of living
with HIV is truly like.
CONCLUSIONS
This study provided insights regarding the impact of vulnerabilities, both
inherited and acquired, on depressive and anxiety symptoms. Study findings emphasize
the importance of comprehensive assessments and ongoing communication with patients.
Participants were willing to disclose additional challenges they faced on a daily basis and
often valued the opportunity to share their personal stories. Disclosing their concerns, for
many participant, was therapeutic. This study highlighted alcohol and/or drug use and
poor sleep quality as predictors of depressive and anxiety symptoms in a sample of nonpregnant African American women who were HIV-positive. Key findings in both groups
of women included significant associations between both inherited and acquired
vulnerabilities and elevated depressive and anxiety symptom scores. Alcohol and/or drug
use and poor sleep quality were the acquired vulnerabilities that were significantly and
positively associated with increased depressive and anxiety scores in both groups of
women. Family history of mood disorders was significantly and positively correlated
with depressive and anxiety symptoms in the group of pregnant women; while family
history of mood disorders was significantly and positively associated with elevated
anxiety symptom scores in the group of non-pregnant women. Additional findings in the
non-pregnant group revealed an unexpected significant positive association between HIV
disclosure status and elevated CES-D scores, indicating that women that had disclosed
their HIV status reported more depressive symptoms. However, this association did not
occur for EPDS scores.
Developing specific evidence-based interventions remains an important aspect of
clinical research and practice, particularly with regard to the poor sleep quality that
occurred in an important proportion of study participants. While the participants in this
study were exclusively African American women who were HIV-positive, findings could
be relevant for other populations who share similar experiences and vulnerabilities.
Underserved populations, including racial and ethnic minorities, continue to receive
inadequate mental health treatment, often because of stigma and poor access to care.
Decreasing the stigma related to both HIV and mental illness, may increase access to
healthcare services and improve health outcomes in this population. Addressing unmet
needs of traditionally underserved populations in the United States is a social imperative
for all Americans as the experiences and unmet needs of these populations have
important implications for the future health of this nation.
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